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ABSTRACT 
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Doctor of Philosophy 
 
REGRESSION MODELLING OF CERVICAL CANCER AND 
CHLAMYDIA INCIDENCE IN THE CONTEXT OF 
NATIONAL SCREENING PROGRAMMES  
 
by 
Man Ying Edith Cheng 
 
Prevention of cervical cancer development or reduction in undetected Chlamydia 
incidence and further onward Chlamydia transmission can be achieved through 
regular screening. Early detection through a regular screening programme is 
essential to achieve this goal. A well established screening policy is needed to 
improve screening efficiency. 
 
This PhD study demonstrated the use of mathematical and spatial modelling to 
explore the risk factors through various regression models, to explore the relation 
between socio-economic conditions and disease incidence, and also other 
techniques including classification analysis, decision models, and simulation to 
evaluate screening options. Based on the risk factors and risk grouping, different 
groups may have different screening policies. Alternatively, geographical 
differences can be taken into account by dividing areas into a few parts; the 
population living in each part may be considered to have different risks of 
developing cervical cancer or Chlamydia in their life time. Therefore, different 
screening programmes and services could be provided to those populations 
according their location or the risk groups which they belong to. Contents 
  ii
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Chapter 1 Introduction 
 
 
1.1 Introduction 
This PhD study concentrates on two diseases of interest, cervical cancer and 
Chlamydia. This research investigates geographical variation in the incidence of 
cervical cancer and Chlamydia in England and the links between these and 
deprivation, social grade status and family structure (i.e. factors which may reflect 
sexual behaviour). This study is mainly concerned with the use of regression 
models to identify the risk factors relating to development of the diseases and any 
spatial variation in disease patterns that may be related to these risk factors. A 
number of mathematical methods were applied to understand the disease 
processes and to identify the associated risk factors concerning their development. 
Various regression models were used as the main method to explore the 
relationships between observed incidence cases and deprivation social grade 
status and family structure variables and other methods including: (i) 
classification analysis was used to partition the population into different risk 
groups according to the probabilities of developing disease, and from this, risk 
groups were created, (ii) a decision tree model was used to evaluate the screening 
options, and (iii) a simulation model was used to study the natural history of 
disease processes. Disease mapping techniques were used to display disease 
incidence patterns, which allowed for visualization of these patterns. The 
regression models can increase current disease knowledge and potentially can be 
used to increase screening efficiency by suggesting changes from the current fixed 
national policies to more adaptive regional policies. Thus, different risk groups or 
different regions may be allocated different screening policies, such as screening 
tests and test intervals, based on need. The data that are required for these 
analyses and modelling are described in detail in Chapters 2 and 3. 
 
The reasons for having such a flexible screening programme are to increase 
efficiency in managing resources; to increase the probability of detecting 
abnormal cells at pre-cancer states (and to reduce the number of undiagnosed 
Chlamydia cases) by targeting high risk groups, encouraging them to take 
screening tests at potentially more frequent regular periods (e.g. every six Chapter 1 Introduction 
  2
months). Simulation models are used to study the natural history of disease 
processes. The models provide more knowledge of the natural pre-cervical cancer 
processes (and Chlamydia and related infertility, caused by untreated Chlamydia 
cases). It is possible to estimate the number of patients in each disease state and 
the length of period of stay in each disease state through simulation models. 
Ultimately, based on analysis of the data collected, the population will be divided 
into different risk groups, which can each be allocated different screening 
frequencies and specific screening tests according to their needs from the results 
obtained from the analysis. Finally, disease mapping techniques were used to 
display disease incidence patterns and also patterns in the estimated model 
parameters, allowing researchers to examine any spatial variation over space. 
 
 
1.2 Research plan 
Table 1.1 shows the summary of the research plan, the required data for each unit 
of analysis, and model. This thesis is organised into nine chapters with the 
following structure: 
 
Chapter 1: General introduction,  
Chapter 2: The methods that were used in this research study,  
Chapter 3: Data section: A description of all the necessary data in detail,  
Chapter 4: Explanatory analysis of cervical cancer,  
Chapter 5: Regression models for cervical cancer,  
Chapter 6: Explanatory analysis of Chlamydia, 
Chapter 7: Regression models for Chlamydia, 
Chapter 8: Discussion 
Chapter 9: Conclusion 
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Table 1.1 The research plan. 
  CERVICAL CANCER  CHLAMYDIA 
 
NATIONAL DATA 
(REGRESSION) 
 
1. Cervical cancer national regression 
model (Chapter 5) 
 
Data 1: Data acquired on 354 Districts 
or unitary authorities from Association 
of Public Health Observatories 
(APHOs). 
Data 2: Deprivation, social grade 
status and family structure variables 
from census data acquired at District or 
unitary authorities levels 2001. 
 
EDA: Townsend index etc. 
 
Model 1: Generalised linear regression 
(GLM) model  for incidence counts 
and standardised incidence ratio (SIR).  
Model 2: Bayesian hierarchical model 
for incidence rates. 
Model 3: Geographically weighted 
regression (GWR) model for incidence 
counts and SIR. 
 
LOCAL DATA 
(REGRESSION) 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.Chlamydia local regression models   
(Chapter 7) 
 
Data 4: Individual Chlamydia data 
acquired from Portsmouth St Mary 
Hospital (Postcode information is 
available). 
Data 5: Output Area and Census area 
statistics (CAS) Ward deprivation, 
social grade status and family 
structure variables from the Census 
data from Portsmouth, plus postcode 
headcounts to allow redistribution to 
postcodes. 
 
EDA: Townsend Index. 
 
Model  1: GLM Regression. 
Model 2: Multilevel regression model.. 
Model  3: GWR.  
LOCAL 
(ANALYSIS OF 
SCREENING 
PROGRAMME) 
2. Model for early detection of cervical 
cancer through cervical cancer 
screening programme, (Chapter 4) 
 
Data 3: Individual Colposcopy data 
1998 – 2006. 
 
Model 4 Classification and Regression 
Trees (CART) analysis (to split 
patients from Data 3 into several risk 
groups). 
Model 5: Decision tree and simulation 
model which can be used to evaluate 
different options for cervical cancer 
screening. These models describe the 
natural history of the disease process, 
and can evaluate various intervention 
options, including screening, for 
cervical cancer. 
4. Models for early detection and   
reduction of the number of undetected 
Chlamydial infections, (Chapter 6)  
 
Data 4: Individual Chlamydial 
infection data (e.g. patients’ age) 
 
Model 5.Explanatory analysis  
Model 6: Decision tree and simulation 
models for Chlamydial infection. This 
model describes the natural history of 
the infection. This model will evaluate 
various intervention options, including 
screening, for Chlamydia. Chapter 1 Introduction 
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1.3 Research objectives 
There are five specific research objectives:  (i) to study cervical cancer at the 
national level and Chlamydia at local levels, (ii) to undertake geographical 
mapping of cervical cancer across England and Chlamydia incidence patterns in 
Portsmouth at various spatial levels (e.g. Output Areas level and Ward level), to 
examine the spatial patterns, (iii) to determine the relationships between disease 
incidence and a range of deprivation indicators, social grade and family structure 
factors through various regression models. Such factors that have relationships 
with disease incidence may be considered as high risk factors or associated risk 
factors as identified through regression models. It is important to understand that 
associated factors do not directly cause the development of cervical cancer or 
Chlamydia, but are associated with the development of these diseases, (iv) to 
examine any spatial variation that may exist, and finally, identify those risk 
factors that would help to inform planning, and target national and local 
screening.  
 
The aims of this research were to understand the key aspects of pre-cervical 
cancer processes and Chlamydia infection through modelling, with the desired 
outcome of promoting the understanding of, and justification for, targeted 
screening policies and intervention events (for example, sex education for the 
young sexually active population). An additional aim was to increase the chances 
of preventing cancer development and detecting early pre-cancer and/or cancer 
cases through national cervical cancer screening programmes. In the case of 
Chlamydia, it was aimed to reduce the number of undetected asymptomatic cases, 
which in turn would help to reduce further, or onward, transmission by the 
infected patients and further complications for the patients. When the cervical 
cancer and Chlamydia cases can be diagnosed early enough, the appropriate 
treatments can be provided to patients at an early disease stage, which can 
increase the chance of recovering from cervical cancer and or Chlamydia. Thus, 
an effective and efficient screening programme is needed. 
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 1.4 Cervical cancer 
Cancer can happen to anyone at any time in their life; it is a common cause of 
death worldwide. The World Health Organisation (WHO, 2008a) reported that 
approximately 13% of deaths worldwide in 2007 were caused by cancer. Cancer 
can be a long term disease caused by abnormal and uncontrollable cells; a tumour 
arises from the abnormal and uncontrolled cells (Cooper, 1993). The process of a 
cancerous tumour developing takes a long time; therefore, it is often possible to 
detect any abnormal cells at the early disease stages and even treat and/or remove 
them before a tumour arises. Once the cancerous tumour forms the cells may 
invade and destroy the surrounding tissues, and in time, also begin to spread to 
other parts of the body through the bloodstream or the lymphatic channels 
(Martin, 2000). Details of medical terms can be found in Appendix A. 
 
For women, the most common cancers worldwide are (i) breast, (ii) lung, (iii) 
stomach, (iv) colorectal and (v) cervical cancer (WHO, 2008a). Cervical cancer 
occurs in the cervix, or neck of the womb (Figure 1.1). Some research has shown 
evidence of an association between Human Papilloma Virus (HPV) and cervical 
cancer development (Singer and Monaghan, 2000). In particular, HPV 16 and 18 
are highly related to cervical cancer development (Jenkins et al., 1996; Arias-
Pulido et al., 2006). Nearly 100% of cervical cancer cases presented with various 
HPV; and 70% of the cases were associated with HPV 16 and 18. HPV 16 and 18 
were considered as the high risk HPV (WHO, 2007), some examples of high risk 
HPV are listed in Table 1.2 (Moore-Higgs et al., 2000; Patnick, 2008). 
 
 
Figure 1.1 The female cervix (Wikimedia, 2007) 
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Table 1.2 Risk types of HPV (Moore-Higgs et al., 2000) 
Risk level  HPV 
Low risk  6, 11 
Medium risk  31, 33, 35 
High risk  16, 18, 31, 45, 56 
 
The chance of developing cervical cancer is also closely related to the patient’s 
sexual behaviour, reproductive history and family history. In addition, 70% of all 
cancer deaths in 2007 occurred in low and middle-income countries (WHO, 
2008b). Deaths from cancer worldwide are projected to continue rising, with an 
estimated 11.4 million deaths predicted for 2030 (WHO, 2008b). On the other 
hand cancer is commonly preventable and curable (but not always) at early 
disease states, and the WHO reported that over 40% of all cancers can be 
prevented (WHO, 2008b).  
 
Three main elements of early detection of cervical cancer are (i) regular screening, 
(ii) the types of diagnostic tests used in screening programmes, and (iii) cervical 
cancer vaccination. The National Health Service (NHS) reported that there is 
evidence of a decreasing number of cervical cancer cases since the national 
screening programme became available in the 1960s (Patnick, 2004; 2008). Some 
studies showed that the use of the HPV test can increase the chance of detecting 
pre-cancer patients (Jenkins et al., 1996), and other studies have shown that the 
combination of Liquid Based Cytology (LBC) and HPV tests may increase the 
detection rates, but may cause a higher chance of the inappropriate use of 
colposcopies (Sherlaw-Johnson and Philips, 2004).  In addition, the length of 
screening interval does affect the detection rate (Sherlaw-Johnson et al., 1997). 
Thus, consideration of which diagnostic test should be used in screening 
programmes may affect the cost-effectiveness of the screening programme. 
Vaccination is 100% effective in protecting a woman from getting infected by 
HPV 16 and 18. These HPVs are assumed to be highly related to the development 
of cervical cancer. However, it is estimated that 70% of cervical cancer incidence 
was associated with HPV 16 and 18. The other 30% incidence was associated 
with other types of HPV, which are not prevented by the vaccination, so screening 
is still needed to prevent the other 30% of cases (WHO, 2007). In practice, it is 
best to vaccinate the female population between the ages of nine to twenty-six Chapter 1 Introduction 
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and/or those members of the population who have not yet been affected by HPV 
16 and HPV 18. The cost of the full vaccination is approximately £500 per person 
(Cancer Research UK, 2008). A UK based study summarised that the HPV 16/18 
vaccine led to an estimated reduction of 66% of the prevalence of high grade pre-
cancerous lesions and a 76% reduction in cervical cancer deaths (Kohli et al., 
2007). In addition, the vaccines are the most cost effective ways of preventing 
cervical cancer, and increasing the chances of surviving from cervical cancer, and 
constitute the best use of limited resources (Ferko et al., 2007; Hammerschmidt et 
al., 2007).  
 
1.4.1 NHS cervical cancer screening programme in the UK 
In the UK context, cervical screening began in Britain in the mid-1960s. The NHS 
Cervical Screening Programme in the UK was set up in 1988 when the 
Department of Health (DOH) instructed all health authorities to introduce 
computerised call-recall systems. The screening programme was, and still is, 
available free-of-charge to women in the UK between the ages of 25-64 to attend 
once every three to five years (Table 1.3). The National Coordination Office was 
set up in 1994, based in Sheffield. This office is responsible mainly for the 
improvement of the overall performance of the programme (Patnick, 2004). 
 
Table 1.3 NHS cervical cancer screening frequency 
Age group (years)  Frequency of screening 
25 First  invitation 
25-49 Three  yearly 
50-64 Five  yearly 
 
1.4.2 Diagnostic tests within the screening programme in the UK 
The principal tool for detection in the Cervical Screening Programme is the smear 
test. Smear tests and LBC examine the cells of the cervix to identify abnormalities 
and any changes within the cells. The first stage of the screening is either the 
smear test or LBC.  
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(i) The smear test is a process of taking a sample of cells from the cervix for 
analysis. A speculum (an instrument, see Figure 1.2 and 1.4) is used to open the 
woman’s vagina and a spatula is used to sweep around the cervix; then the sample 
is smeared on a slide. Therefore the test is called “smear” or “sweep” test. Finally, 
the sample is sent to the laboratory for examination.  
 
(ii) The LBC is more accurate than the smear test and it is available in the 
screening programme. Other similar tests are available and are also applied in 
different societies and/or organizations. The LBC is very similar to the smear test; 
the only difference is that the head of the spatula is broken off into a small glass 
vial containing preservative fluid or rinsed directly into the preservative fluid 
rather than smearing the sample on a slide.  
 
 (iii) The test for HPV is used to examine whether HPV DNA is present or not, 
and NHS staff have been trained to use the new HPV technology and techniques 
in NHS cervical cancer screening (Patnick, 2008) and also other countries.  
 
 
Figure 1.2 Smear procedure (American Academy of Family Physicians, 2008) 
 
The second stage of the NHS cervical cancer screening programme uses the 
Colposcopy, which is a more advanced tool used for the diagnosis of cervical pre-
cancer, to determine the cause of abnormalities found in smear test results. A 
colposcope is used in this process; this tool (Figure 1.3a) is a microscope 
providing illuminated magnification, which allows the viewing of the cervix at 6-
fold to 40- fold magnification. It was invented by Hans Hinselmann in 1925 Chapter 1 Introduction 
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(Singer and Monaghan, 2000). There is also a video colposcope available (Figure 
1.3b), which utilises a camera and a colposcope with an electronic green filter, 
motorised zoom magnification and fine focus controls, combined within a single 
unit. The Colposcopy accessories are shown in Figures 1.4 and the process can be 
found from Singer and Monaghan (2000). The samples are sent to laboratories for 
full examination including cervical biopsy. If patients have been diagnosed with 
cervical precancerous lesions (CIN 1, 2 and 3), treatments will be given to remove 
these (Figure 1.5). 
 
(a)       (b) 
   
Figure 1.3 (a) colposcope and (b) video colposcope (Singer and Monagham, 
2000). 
 
 
Figure 1.4 The accessory tools for colposcopy: 1. pots with solution (acetic acid, 
saline, and Lugol’s iodine), 2. vaginal speculum, 3. sponge holding forceps, 4. 
Desjardin’s endocervical forceps, 5. three-pronged probe for retraction, 6. cotton 
tipped fine swab sticks, 7. Aylesbury cytology spatula, 8. larger cotton tipped Chapter 1 Introduction 
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swab sticks, 9. local anaesthetic syringe, 10. silver nitrate sticks for hemostasis, 
11. endocervical brushes, 12. antibiotic cream, 13. cotton swabs, 14. diathermy 
electrodes for diagnosis or treatment, 15. Monsell’s solution, 16. local anaesthetic 
ampules, 17. Eppendorfer cervical biopsy forceps (Singer and Monagham, 2000). 
 
 
Figure 1.5 This is a video colposcopy image, which can be stored with a patients’ 
history. It allows for the capture and measuring of the CINs from the image. It is 
clear this patient had moderate Cervical Intraepithelial Neoplasia (CIN2), severe 
Cervical Intraepithelial Neoplasia (CIN3), Original Squamous (OS) and Original 
Squamous Epithelium (OSE); therefore treatment can be given based on such an 
image (Singer and Monagham, 2000).  
 
1.4.3 Treatments 
Once cervical cancer is diagnosed, treatment is given by the NHS. Cervical cancer 
treatments include (i) surgery, (ii) radiation therapy, (iii) chemotherapy, (iv) 
hormone therapy, and/or (v) combination of therapies. The most suitable 
treatment might vary between patients; it really depends on the disease state and 
the patient’s response to the treatment. If cancer cells have not yet spread to other 
parts of the body, it is possible to apply surgery to remove the tumour; otherwise 
another therapy or combination of therapies can be adopted. 
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1.5 Chlamydia 
Chlamydia trachomatis is a bacteria (Figure 1.6), which is the most common 
sexually transmitted infection (STI) disease in England (Primarolo, 2006). The 
national positive rate is estimated at about 10% (Primarolo, 2006). It can be 
treated easily by antibiotics. The rate of new diagnoses of cases of Chlamydia in 
those who attended Genito-Urinary Medicine (GUM) clinics greatly increased 
from 116 to 175 per 100000 patients between 2000 and 2004 (National Statistics, 
2006), and  rose by 5% (in terms of cases) between 2004 and 2005 (NHS, 2008a). 
However, over 70% (Health Protection Agency, 2007) of female infected patients 
and 50% (Health Protection agency, 2007) of male infected patients are 
asymptomatic at the early period. If Chlamydia remains undetected long enough, 
it can be lead to complications, such as increasing the risk of developing pelvic 
inflammation disease (PID) for woman, causing ectopic pregnancy, and even 
infertility. While the condition remains undetected, the patient is at risk, and 
approximately 10-40% of infected, untreated women develop Pelvic Inflammation 
Disease (PID) (Health Protection Agency, 2007). In England, 75% of Chlamydia 
cases are found in the young population between the ages of 16 to 24, and only 
25% of cases are present in those over 25 (Health Protection Agency, 2006). 
Details of medical terms can be found in Appendix A. 
 
 
Figure 1.6 Chlamydia bacteria at 0.15 microns (www.chlamydiae.com). 
 
For female patients who develop Chlamydia during pregnancy, the patient should 
seek treatment; otherwise, the mother can transmit Chlamydia to the baby through 
the birth process. Once the baby has been infected by the mother, the baby 
remains asymptomatic for a certain period (about 40 days), and this can cause 
great damage to the baby’s health (NHS, 2007).  
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Therefore, the earlier the disease is detected, the easier it is to treat it by using 
antibiotics. During the treatment period, all sexual partners should be treated at 
the same time to avoid any re-infection or spread of Chlamydia. 
 
1.5.1 National Chlamydia screening programme (NCSP) 
The national Chlamydia screening programme was introduced in England in 
2003; its objective is to prevent asymptomatic infection cases remaining 
undetected.   Optimally, it can reduce onward transmission to sexual partners and 
avoid further complications or damage. Thus, the national positive incidence rate 
can be reduced. Since most cases are found in the young age group under 25 (i.e. 
16-24), the programme targets those young populations as the highest risk group 
(NHS, 2007).  
 
The aim of the NCSP is to control and prevent undetected cases across England 
through screening, and it provides access to services, screening, and treatment 
(NHS, 2007; Low et al., 2006). 
 
1.5.2 Chlamydia screening tests 
The Chlamydia test is free of charge in England; patients only need to provide a 
urine sample. For female patients, a swab test is also available, but the test result 
only shows whether Chlamydia is positive or negative; it does not indicate any 
other positive STIs. However, the test site or centres can provide information 
about other STI tests and necessary help for patients. The Chlamydia test is 
available from most of the NHS local GUM and other sexual health services. For 
example, in Southampton, the GUM department, located in the Royal South Hants 
hospital, provides a free Chlamydia test. Further information about local 
Chlamydia test centres and treatments can be found at the following website: 
http://www.chlamydiascreening.nhs.uk. 
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1.5.3 Chlamydia treatments 
Treatments are needed for patients testing positive for Chlamydia. If a patient has 
positive Chlamydia only, it can be treated by antibiotics in the form of a single 
dose of Azithromycin, and doxycycline twice a day for seven days in total (NHS, 
2008b). If any patients have PID, it can be treated by antibiotics; for example 
Amoxicillin, Streptomycin and Erythromycin, for 14 days (NHS, 2008b; c). 
Treatments are very straight forward, simple and effective. 
 
 
1.6 Summary 
Large proportions (70%) of cancer deaths occur in the low and middle-income 
countries; thus it is possible to infer a link between cervical cancer incidence and 
deprivation conditions, social grade status and family structure.  This research 
demonstrates the use of various statistical techniques to explore the relation 
between the incidence of cervical cancer and deprivation condition, social grade 
status and family structure variables in the UK. 
 
The majority of Chlamydia cases occur in the young population, and it remains 
asymptomatic at the early stages, until the patients reach further stages. Therefore, 
it is necessary to ensure that the young population is aware of this. It is interesting 
to explore the relationships, if any, between the incidence of the disease and 
prevailing deprivation indicator, social grade status and family structure variables, 
which would increase the current knowledge about Chlamydia and provide 
strategies for targeting the high risk populations. 
 
An effective national screening programme might increase the early detection rate 
for cervical cancer and increase awareness of Chlamydia infection. The quality of 
human life can increase through screening programmes. However, designing an 
effective programme requires us to have a better understanding of the disease 
process, to identify risk factors, associated factors and to examine spatial 
variation. Combining all the above factors will lead to a greater understanding of 
the disease and the link with deprivation indicator, social grade status and family 
structure factors, and provide information on how to improve and increase the 
efficiency of screening with a given amount of (limited) resources. To summarise:   Chapter 1 Introduction 
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The overall aims were 
  To understand pre-cervical cancer processes and Chlamydia infection 
through modelling, with the desired outcome of promoting the 
understanding of and justification for, targeted screening policies and 
intervention events, 
  To increase the chances of detecting the early pre-cervical cancer or 
cervical cancer cases (and to reduce the number of undetected Chlamydia 
cases), so that the chances of detecting the diseases at early stages 
increase. 
  Allowing the necessary and appropriate treatments to be provided to the 
patients at the earliest possible stage, which can increase the chances of 
recovery from the disease. 
  Therefore, a more effective and efficient screening programme is needed 
in order to improve the quality of screening.  
  The overall aims will be investigated using two available datasets. 
o  Cervical cancer in England 
o  Chlamydia in Portsmouth. 
 
The key objectives 
  Study cervical cancer and Chlamydia at national and local levels, 
respectively. 
  Map cervical cancer and Chlamydia incidence patterns in England and 
Portsmouth, respectively. 
  Determine the relationships between incidence and deprivation indicator, 
social grade and family structure factors. 
  Determine the associated factors through regression modelling, which can 
help to plan and target screening programmes and policies. 
 
There is a CD attached at the back of the thesis, which contain four models listed 
below: 
(i)  Cervical cancer decision tree model, details can be found from Chapter 
4 and Appendix C 
(ii)  Cervical cancer simulation model, details can be found from Chapter 4 
and Appendix D Chapter 1 Introduction 
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(iii)  Chlamydia decision tree model, details can be found from Chapter 6 
and Appendix F 
(iv)  Chlamydia simulation model, details can be found from Chapter 6 and 
Appendix G 
 
The simulation insert requires generator, which is called “ITVCMath.dll”. Please 
follow the instructions in Appendix D and G in order to link the generator and the 
models together. 
 Chapter 2 Methods 
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Chapter 2 Methods 
 
 
2.1 Introduction 
Disease modelling is a large topic with many mathematical methods available. 
However, the choice of which method to use depends on the main purposes of the 
study. To achieve the goal of this PhD study, various methods were applied such 
as (i) regression models, (ii) classification analysis, (iii) decision theory, and (iv) 
simulation. The details of each method are discussed and explained in this chapter.  
 
Regression models were used to explore the relationship between variables, 
whereas classification techniques were used to divide a population into groups 
according to potential risk (e.g. low risk, high risk groups etc.). Both decision 
theory and simulation were used to understand the natural disease process; how 
patients flow through (i.e. transfer from one disease state to another) the disease 
system, and to evaluate the screening options. A summary of the results from the 
above mentioned methods will help to identify the associated risk factors for 
cervical cancer development and Chlamydia infection and transmission. 
Incorporating those associated risk factors into the national screening system may 
increase the level of prevention of cervical cancer development and reduce the 
number of undetected asymptomatic Chlamydia cases, and avoid further or 
onward Chlamydia infection. In this study, regression models are the main 
method of analysis. Other methods were included as a demonstration of what is 
possible, but were not applied in detail due to a lack of suitable data. 
 
 
2.2 Definition of variables 
General variables were used for both cervical cancer and Chlamydia as listed in 
Table 2.1. The total number of study regions is denoted as N, for each i = 1, 2, …, 
N. Let  i e  be number of expected cases,  i Y  the incidence (i.e., number of cervical 
cancer cases or number of positive Chlamydia cases),  i D  the  mortality  (i.e., 
number of deaths due to cervical cancer) and  i S  the survival rate (i.e., number of Chapter 2 Methods 
  17
survivors from cervical cancer), where i = 1, 2, …, N.  All variables are listed in 
Table 2.1 below. 
 
Table 2.1 Summary of variables in cervical cancer and Chlamydia studies 
Variables Cervical  cancer  Chlamydia  Region general  Population general
No. of study 
regions 
cc N   ch N   N   
Expected 
cases 
cci e   chi e   i e   e 
Incidence  cci Y   chi Y   i Y   Y 
Mortality  cci D   ---  i D   D 
Survival  cci S   ---  i S   S 
Region  i i  i  i 
 
2.2.1 Incidence rate 
The full definition of incidence is the number of events (e.g. positive cases) 
happening within a given time period,  for example,  between 2003 and 2004 
(Waller and Gotway, 2004). Therefore, the incidence rate  i   measures  the 
proportion of positive cases within a given population. Alternatively, it represents 
the probability of a person contracting the disease within a specified time period 
or a given time period, which might be determined by some personal 
characteristics and/or attributes; e.g. gender, age, family history, occupation and 
so on. An assumption might be needed to calculate the rate; for example, the at-
risk population is assumed stationary and fixed. The calculation is defined below: 
 
i
i
i p
Y
           w h e r e   i=1, 2, …, N (2.1) 
 
The overall incidence rate is defined as: 
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1
1         w h e r e   i=1, 2, …, N (2.2) Chapter 2 Methods 
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Mortality and survival rates which measure the probabilities of death and survival 
from disease follow the same principles. Mortality rate d  and survival rate s are 
defined below: 
 

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1        w h e r e   i = 1, 2, …, N (2.3) 
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     where  i = 1, 2, …, N (2.4) 
 
when the incidence is large, the number of survivors can also be expected to be 
large. Therefore, the number of survivors is standardised by incidence to produce 
a survival rate s. Note that to aid clear interpretation, the word ‘rate’ is used 
whenever variables are standardised. 
 
2.2.2 Direct standardised expected cases  
Some variables can be estimated directly, when the expected cases provide 
information which can give an idea as to the number of expected cases for a 
particular location over a particular time period. The standardised expected case 
i e  is defined below: 
 
i
j
j
j
j
i p
p
Y
e




1
     where  i = 1, 2, …, N                (2.5) 
 
i e   is the number of expected incidence cases, and  i p   represents the total 
population in region i and j represents the age group. If age information is 
available from the observed incidence cases  i Y   then the age-specific expected 
cases can be calculated based on the same equation (2.5).  
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2.2.3 Indirectly standardised incidence ratio (SIR) 
In practice, the standardised incidence ratio (SIR) and standardised mortality ratio 
(SMR) are commonly used to measure and compare regional incidence and death 
rates. In this study, the property of interest is the incidence rate rather than 
mortality ratio, and so the standardised incidence rate is used. The regional SIR 
and SMR are defined below (Waller and Gotway, 2004): 
 
i
i
i e
Y
SIR         w h e r e   i = 1, 2, …, N      (2.6) 
 
i
i
i e
D
SMR         w h e r e   i = 1, 2, …, N       (2.7) 
 
where the expected number of cases  i e was defined in equation (2.5). Since SIR 
and SMR are standardised indicators of incidence and mortality rates, which vary 
around one, if the rate is above one, the observed incidence is greater than 
expected; if the rate is less than one, the observed incidence is less than expected 
(Waller and Gotway, 2004). 
  
2.2.4 Deprivation 
It is important to distinguish between deprivation and poverty. Poverty describes 
the population with low income and lack of material resources; deprivation is 
defined as a population or society having disadvantage in local society, for 
example, poor access to social services (e.g. health services) affecting life chances 
(Rees et al., 2002).  Deprivation could vary over space and over time. The Black 
report (Townsend et al., 1982) discussed that higher income populations 
commonly make better use of health services and there are significant social 
inequalities in using local health services. Therefore, deprivation is highly related 
to ill-health condition (Townsend et al., 1982).  
 
Deprivation can be used to measure local welfare and behaviour which can be 
useful in health care studies, because some studies have shown that there is a 
linkage between health condition and welfare condition. Health condition may 
also be related to human behaviour which is a function of background as well as Chapter 2 Methods 
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educational level. There are many deprivation indices or measurements (Table 2.2) 
(Rees et al., 2002). Different indices may use different deprivation and different 
numbers of indicators. The index is commonly measured in different areal units 
which depend on the purpose of the study and the areal units available for study. 
Since the deprivation indicators are measured in areal units and the units are likely 
to vary over space, some of the regions might be relatively larger than others. For 
this reason the index may be more sensitive to the size of the denominators. 
 
Most of the deprivation indicators are available from the UK census. However, 
there are still certain limitations in terms of data coverage. For example, all the 
data are aggregated into certain areal levels (i.e. not available at individual level) 
and some information is not available (e.g. personal income, environmental 
conditions). In most healthcare studies, a deprivation index is used to measure 
deprivation at the regional level, which is used to analyse and examine the relation 
between health and social grade status, family structure variables and deprivation. 
A deprivation index may also be useful in assessing public health services, health 
policy and to target resources at the regional level. 
 
In this study, the Townsend index was chosen to measure deprivation. It is one of 
the more common choices and it has been well used in health studies. The four 
indicators are the common choice within most indices. There is a disadvantage of 
using the Townsend index. It only takes account of socio-economic information, 
but no family structure information is included. Therefore, in chapters 5 and 7 
some other variables were added into the regression to represent family structure 
and social status.  
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Table 2.2 Deprivation indexes and indicators. 
Deprivation indexes   Deprivation indicators 
Townsend  Unemployment,  
Households with no car,  
Over crowded housing,  
Households not owned. 
Carstairs  Male unemployment,  
Households with no car,  
Over crowded housing,  
Social classes IV or V. 
Jarman UPA  Unemployment,  
Over crowded housing,  
Single pensioners,  
Lone parents,  
Unskilled manual,  
Ethnicity,  
Children under 5,  
Residential mobility. 
DoE81  Unemployment,  
Over crowded housing,  
Lacks basic amenities,  
Single pensioners,  
Lone parents,  
Ethnicity. 
 
2.2.4.1 Townsend index Z  
The Townsend index is used to measure relative deprivation (Townsend et al., 
1988). Deprivation is thought to be strongly related to ill-health (i.e., personal 
health condition is related to personal behaviour; for example, lifestyle, diet, 
smoking etc.). Social deprivation is very important to the investigation of small 
area health studies (Townsend et al., 1982; Townsend et al., 1988; McCullagh and 
Nelder, 1952). The Townsend index is a combination of four socio-economic 
indicators, which are:  
 
i.  Percentage of unemployed population,  
ii.  Percentage of households with no car or van,  
iii.  Percentage of households not owned, 
iv.  Percentage of over-crowded housing (over one person sharing one 
bedroom).  
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The calculation of the Townsend score for each variable is defined below. Let  ih V  
be the value of socio-economic variables, for variables h = 1 to 4 and i = 1 to N 
area units in the data. The Townsend score  ih z  is a standardised measure for each 
of the four deprivation variables obtained by subtracting from  ih V  the mean  ih m  
and dividing by the standard deviation  ih   as below.  
 
ih
ih ih
ih
m V
z


   where  i = 1, 2, …, N and h = 1, 2, 3, 4  (2.8) 
 
Both variables (i) unemployed population and (iv) over-crowded housing were 
transformed by a natural log  ) 1 ln(   x y , where y is the value after the 
transformation and x is the observed value of the socio-economic variables, to 
make the variables approximately normally distributed. 
 
The Townsend index is calculated from the sum of  ih z  as follows: 



4
1 h
ih i z Z     where  i = 1, 2, …, N and h = 1, 2, 3, 4  (2.9) 
The greater the Z value the greater the deprivation.  
    
2.2.5 Disease mapping 
Disease mapping can be used in many applications; for example, describing 
spatial variation and patterns in observed incidence, mortality, survival and risk 
and helping in the understanding of disease aetiology. It allows for the display of 
information graphically and can be visual; therefore, the general population can 
understand the information more easily. Disease mapping has been used widely in 
disease applications, such as in identifying the relationship between explanatory 
factors and health condition, and analysing communicable diseases (Elliott et al., 
2000). Disease mapping has also been used in the cases of cervical cancer and 
Chlamydia, where the incidence maps summarise complex geographical variation. 
Such information can be used for simple descriptive purposes, to assess whether 
health targets are being met or whether a new set of policies is needed. 
Furthermore, such maps reveal spatial patterns, which may help to highlight 
structure in spatial variation.  Chapter 2 Methods 
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2.3 Regression modelling 
Regression is a well-known statistical tool for exploring relations between target 
and explanatory variables. Various types of regression techniques are available 
and are commonly used to model the relations between variables in ecological and 
disease studies. Examples of global regression models are: generalised linear 
regression models, Bayesian models for small area studies (Green and Richardson, 
2002), multi-level models and local regression models (McCullagh and Nelder, 
1952; Fotheringham et al., 2002).  
 
2.3.1 Regression models and their use 
In this study, regression modelling was used to explore the relationships between 
the target variables (cervical cancer incidence and Chlamydia incidence) and the 
explanatory variables (measures of deprivation). The outcomes from the models 
provide a summary of the complex relations between variables, and, if spatial 
information is available and included, then it can highlight the geographical 
relations that exist. 
 
2.3.2 Generalised linear regression model (GLM) 
Generalised linear regression modelling (GLM) is a popular statistical modelling 
tool for exploring relationships between target and explanatory variables (Gatrell 
and Bailey, 1996; Elliott et al., 2000). A generalised linear regression model is 
described below: Let  ) ,... , ( 2 1 N i Y Y Y Y   for  i = 1, …, N be the independent 
observed variable, which follows a probability distribution that belongs to the 
exponential family of probability distributions, with mean  i i Y E   ) ( . The linear 
predictor  i Y ˆ  is based on the predictor variables Ti i i v v v ,..., , 2 1  for variables t = 1, 
2, …, T, which are denoted by: 
 
i Ti T i i v v Y          ... ˆ
1 1 0  where  i = 1, …, N         (2.10) 
 
The regression model can be re-written in equation 2.11: 


  
T
t
i ti t i v Y
1
0 ˆ      where  i = 1, …, N and t=1, …, T    (2.11) Chapter 2 Methods 
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 where  0   is the intercept,  t  is the coefficient of variable  ti v  for i = 1, 2,.., N and 
t = 1, 2, …, T, and i   is the error term which is normally distributed with mean 
zero and variance one. 
 
2.3.3 Logistic and Binomial regression model 
Binomial and Logistic regression models are non-linear regression models, within 
the generalised linear regression family, when the observed variable (i.e. the 
response variable) has two possible outcomes (i) 0 or 1, or (ii) true or false. 
Therefore, the outcome can be represented by a binary or logistic indicator 
variable, and the model can be used to predict the chance of an event happening. It 
is particularly useful for modelling an individual patient’s disease result 
(outcomes), for which the test result can be either positive or negative. 
 
The observed variable  i Y   is a Bernoulli random variable; this follows the 
Binomial distribution with two parameters (sample size  i   and probability  i  ): 
) , ( ~ i i i Binomial Y                  ( 2 . 1 2 )  
 
i Y  is considered as a Bernoulli random variable with the following probability 
statement: 
i i
i i
Y P
Y P


  
 
1 ) 0 (
) 1 (
               ( 2 . 1 3 )  
 
where  i Y =1 represents true or positive, and  0  i Y represents false or negative 
outcomes. The linear regression model can be defined as: 
 
i Ti T i i i v v v Y           ... ˆ
2 2 1 1 0            where  1 , 0 ˆ  i Y        (2.14) 


  
T
t
i ti t i v Y
1
0 ˆ                  where i = 1, …, N and t=1, …, T 
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2.3.4 Poisson regression model 
Poisson regression is a non-linear regression model, again part of the generalised 
linear regression family. The outcome is discrete; for example, the number of 
positive incidence cases and, therefore, it is commonly used to model disease 
cases. Usually, the outcomes  N Yi ...   , 2   , 1   , 0  , which are a set of observed counts 
arising from a Poisson process (i.e., the data  N Y Y Y ,..., , 2 1  in regions 1, 2, …, N are 
mutually independent Poisson random variables). In addition, the population 
counts for each region are assumed to be fixed (i.e. non-random variables), 
denoted by  N p p p ,..., , 2 1  (McCullagh and Nelder, 1952). The observed variable is 
assumed to follow a Poisson distribution with mean  i   for i = 1, 2, …, N. 
 
) ( ~ i i Poisson Y        w h e r e   i = 1, 2, …, N     (2.15) 
 
The regression model is given in the following format: 
 
) ... ( ) log( ) ˆ log( 2 2 1 1 0 i Ti T i i i i v v v Y                                 (2.16) 
 
where log is the link function of the Poisson regression model and  i   is the offset, 
which is a variable measuring the units of exposure in region i, for example, 
number of expected cases in region i.  
 
2.3.5 Bayesian hierarchical models  
The Bayesian approach as applied to health studies has been defined as “the 
explicit use of external evidence in the design, monitoring, analysis, interpretation 
and reporting of a health technology assessment” (Spiegelhalter et al., 2004). The 
Bayesian approach is an efficient way to estimate models and predict uncertainty 
with the given available data and prior distributions. Based on the Bayesian 
framework the posterior distribution covers the possible range of uncertainty of 
the estimated parameters. The observed i Y , unobserved data z and unknown 
parameters  can be described in terms of probability statements. The probability 
statements are conditional on the observed values of  i Y , written as: 
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) , | ( z Y p i                  ( 2 . 1 7 )  
 
The idea is to estimate   conditional on  i Y  and z. The prior distribution  ) ( p  is 
a term expressing the uncertainty of the unknown parameter prior to analysis, 
whereas the posterior distribution  ) , | ( z Y p i   is a term expressing the uncertainty 
of    after taking account of the data (Gelman et al., 2003). The posterior is 
defined below: 
 
) | , ( ) (
) | , ( ) (
) | , ( ) (
) , | (  
  
 
 z Y p p
d z Y p p
z Y p p
z Y p i
i
i
i  

 
) ( ) | , ( ) , | (    p z Y p z Y p i i                ( 2 . 1 8 )  
 
where  ) , (  z Y p i  represents the observed data, e.g. disease incidence at region i. A 
range of non-spatial and spatial model structures have been used to estimate the 
posterior mean of the parameters of interest. A Bayesian regression method is 
applied in this study to explore the relationship between the observed disease 
cases and the explanatory variables (a series of social status, family structure 
variables and measures of deprivation). The results provide a summary of 
complex relations between variables. The posterior samples were drawn from 
Gibbs sampling based on Markov chain Monte Carlo (MCMC) methods, until the 
chain and posterior converge to a stationary distribution (Lawson et al., 2003). 
 
In this thesis, two types of Bayesian models are defined: non-spatial and spatial. 
The details of each model are discussed below. 
 
2.3.5.1 Non-spatial model 
Spatial information is not specified in the non-spatial model. Every region is 
assumed to be homogeneous. No neighbourhood information is given in the 
model, such that the model provides only global and average information as 
results. It is also assumed that no effects are contributed from the direct 
neighbourhood; each of the regions is completely independent. Such a model is 
useful only if the underlying model has no spatial variation, because the non-Chapter 2 Methods 
  27
spatial model gives only the average of the estimated parameters, there is no 
difference over space. The non-spatial Bayesian model is defined below: 
 
) ( ~ i i i Poisson Y    
i Ti T i o i i v v            ... log log 1 1               (2.22) 
 
where  i    is the offset (e.g. expected cases), 0     is the intercept,  t   is  the 
coefficient of variable  t v  and  finally,  i    is the unstructured heterogeneity (i.e. 
random effect). 
 
2.3.5.2 Spatial model 
The conditionally autoregressive (CAR) model was introduced by Besag et al., 
(1991). Where spatial information is given in the model (e.g. direct 
neighbourhood), such information can be used to predict the underlying parameter 
of interest, such as incidence rate  i  ˆ . In the CAR model, spatial correlation is 
included; therefore, the estimated parameters in region i depend on the neighbours 
j. There are two model settings, BYM and MIX models, as described below. 
 
(i) Besag, York and Mollie’s (BYM) spatial model 
In the BYM model, area-specific random effects are included, which decompose 
into two components. The first component is  i   the uncorrelated heterogeneity; 
this is the part measuring unstructured variation between areas. The second 
component is  i  ; this is the component that models the structured variation in 
space (i.e. clustering component or correlated heterogeneity). Both  i  and  i  need 
to have a specified prior distribution. The model is defined as: 
 
i
T
t
ti t i i v          
1
0 ) log( log                                   (2.19) 
i i i                      ( 2 . 2 0 )  
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(ii)Bayesian Mixed (MIX) spatial model 
A special type of spatial mixture model (MIX) was introduced by Lawson and 
Clark (2002). This spatial mixture model allows both smoothness and 
discontinuities and admits different forms of spatial variation. The MIX spatial 
model has four components. One of them is i  ; unstructured heterogeneity that 
measures the over-dispersion in an individual region. The other two are  i   , 
representing the spatial correlation component and  i    the component which 
models spatial correlation. The final component is  i  ; it models discrete jumps. If 
all the  i  =1, the MIX model converges back to the BYM model, if all the i  =0 
the model is called pure jump (Lawson et al., 2002; 2003). 
 
The model is defined as below: 
i i i i i
T
t
ti t i i v          ) 1 ( log log
1
0        

                    (2.21) 
All the components  i v ,  i u ,  i   and  i   need to have specified prior distributions.  
 
2.3.5.3 Bayesian model measurement 
For GLMs the p-value can be used to measure the “goodness” of fit of the models, 
but for the Bayesian model it is different. Some kind of model measurement is 
needed to compare candidate models. In most cases concening the use of the 
Bayesian model, the deviance information criterion (DIC) is used to measure how 
well the model is fitted, and the penalty value (pD) is used to measure how 
complex the model is (Spiegelhalter et al., 2002 Gelman et al., 2003). Both DIC 
and pD can be used to compare the candidate models; the smaller the DIC and pD 
the better the model fit. For full details of calculations and explanations please 
refer to Spiegelhalter et al., (2002) and Gelman et al., (2003). The summary of 
DIC and pD are given below in equations 2.22 and 2.23: 
 
) ( D D pD            ( 2 . 2 2 )  
) ( 2         
) (         


D D
D D D
D pD DIC
 
  
 
         ( 2 . 2 3 )  
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where D  is the expectation measuring how well the model is fitted to the data. If 
D  is large it means that the model is fitted poorly to the data. It is defined as: 
 
) | ) , ( ( y y D E D  
 



L
l
l y D
L 1
) , (
1
          ( 2 . 2 4 )  
 
Finally,  ) , (  y D  is deviance and  ) ˆ ( D  evaluates the average of samples  , which 
is defined as: 
 
) ˆ | ( log 2          
)) ( ˆ , ( ) ˆ (

 
y p
y y D D
 

       ( 2 . 2 5 )  
 
2.3.6 Geographically weighted regression (GWR) modelling 
Generally, in global models geographical variation in the relations is ignored and 
the process is assumed to be stationary. Geographically weighted regression 
(GWR) modelling is a type of local regression model. It is a well established 
technique that can be used to examine spatial variation in relations (i.e., local 
analysis rather than global analysis) and explore spatial patterns in parameters 
when spatial variation in parameters (non-stationary) is allowed. Information on 
local variation in parameters can lead to greater understanding of the relations 
between the target and explanatory variables.  
 
2.3.6.1 Model Structure 
In reality, some relations may vary over space, (i.e. a non-stationary model is 
required to describe this variation). The spatial variation in relations is ignored in 
a global regression model. Such local behaviour can be captured through the 
GWR model. If the non-stationary model is appropriate the results from the global 
model can provide misleading interpretations, and the spatial variation is only 
reflected in the residual map from the global model. The true underlying 
geographical pattern is hidden. The use of GWR allows to takes account of the Chapter 2 Methods 
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spatial variation if it does exist, and model the relations using a non-stationary 
process. The GWR model is defined below: 
 
) , ( ) , ( ) , ( ) , ( ) , (
1
0 i i
T
t
i i t i i t i i i i i y x y x v y x y x y x Y       

    (2.26) 
 
where ) , ( i i y x  represents the coordinates of location i, ) , ( i i i y x Y  is the observed 
variable of location i,   ) , ( 0 i i y x   is the intercept for location i, and ) , ( i i t y x   is 
the coefficient of variables t at location i.   ) , ( 0 i i y x   and  ) , ( i i t y x   are assumed 
as a continuous function in the regression model, rather than as constant and fixed 
in the global model. In GWR,  ) , ( i i i y x    represents the error term and it is 
assumed to follow a normal distribution with mean zero and variance 
2  . 
 
) , ( ˆ
i i i y x Y ,  ) , ( ˆ
i i o y x   and  ) , ( ˆ
i i t y x    can be estimated from the maximum 
likelihood approach which is equivalent to using the least squares from the global 
model. However, within GWR, the parameters  ) , ( ˆ y x o   and  ) , ( ˆ
i i t y x   are 
estimated through a local likelihood approach and estimated through an iterative 
process, until the estimates of the parameters converge. The estimation for 
location i is affected by the surrounding locations j. The amount of effect from 
location j is determined by the weighting scheme. For example, if regression point 
) , ( i i y x is closer to data point ) , ( 1 1 y x  than data point  ) , ( 2 2 y x , then  ) , ( 1 1 y x causes 
more effect and more contribution to the estimation to  ) , ( i i y x  than  location 
) , ( 2 2 y x   (see Figure 2.1). The amount of effect depends on the choice of 
weighting scheme and the distance parameter  ij d  between regression point i and 
the neighbouring (data) point j. The closer the data point to the regression point i, 
the greater the contribution to the estimation of the regression point i than the data 
point which is further away from the regression point i.  For full details of the 
calculation and estimation of GWR please refer to Fotheringham et al., (1998; 
2002). 
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Figure 2.1 Regression point i and data point j in GWR model. The closer the data 
point j to regression point i, the greater the contribution to the regression point i 
from j. 
 
2.3.6.2 Weighted Function: Kernel 
Parameter estimation depends on the choice of and type of weighting function and 
kernel, where estimation is highly related to the kernel. Typically, there are two 
types of weighting functions being used in GWR, which are (i) Gaussian kernel 
(fixed kernel) and (ii) bi-square kernel (adaptive kernel); the weighting function is 
conditional on the size of kernel. In theory, the weight should decrease gradually 
as the distance between i and j increases, converging to zero.  
 
(i) The Gaussian kernel function is defined as follows (Fotheringham et al., 2002): 
 
)
2
1
exp(
d
d
w
ij
ij                                (2.27) 
 
Where  ij d   is the distance between point j and regression point i and d is the 
bandwidth. The closer a point j to regression point i, the larger the weight given. 
The weight of  j  will be changed when the location of regression point i is 
changed.  
 
) , ( i i i y x Y  
) , ( j j j y x Y  
) , ( j j j y x Y   ij d  
ij d  Chapter 2 Methods 
  32
(ii) The bi-square kernel utilises an adaptive method to calculate the weight  ij w .  
The size of the adaptive kernel may vary, but it covers the same number of data 
points in each of the kernels. The weighting function  ij w    (where  i is the 
regression point and j is the data point for i =1, …, N and j = 1, …, N) determines 
the weight for each data point. Each data point receives a different weight to the 
adaptive weight, which depends on the distance between i and j.   Any points 
outside the kernel receive zero weight to the regression point and closer to the 
regression point receive more weight than those further away from the regression 
point. The amount of weight is determined by the bandwidth d. The function is 
given as below (Fotheringham et al., 2002); 
 
 



 

otherwise
d d
d
d
w
ij
ij
ij
                                   0
              ] ) ( 1 [
2 2
         ( 2 . 2 9 )  
 
where   ij d  is the distance parameter between regression point i and data point j. 
The choice of bandwidth is very important in terms of estimation of the 
parameters and the amount of smoothing of the parameters. In theory, a larger 
bandwidth can cause over smoothing (i.e. convergence to the global model) and a 
smaller bandwidth can also cause under smoothing (i.e. large spatial variation). 
Therefore, an optimal size of bandwidth is essential. The methods used to select 
the optimal bandwidth are to use some model measurements (e.g. cross-validation 
error, Akaike information criterion (AIC) and (or) correct Akaike information 
criterion (AICc)). The model with a certain kernel size which has the smallest 
measurement (e.g. AICc), is the optimal model with optimal kernel size.  
 
2.3.6.3 Model measurement  
The coefficients vary continuously over space, therefore, it is almost impossible to 
achieve completely unbiased estimation. Models with very few data can cause 
larger variation in local parameter estimation. Therefore the estimation becomes 
less reliable. On the other hand, a model with large number of data points can 
provide more reliable local parameter estimations. However, such models may Chapter 2 Methods 
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contain a large amount of bias as the distances between regression point i and data 
points j increase. Thus, it is important to get a balance between the bias and 
variance of the parameters in estimation. A trade-off is needed between the bias 
and variability of parameters and can be considered by introducing model 
selection indicators. There are many indicators available, such as DIC and BIC. 
For GWR, it is common to use the AIC to measure how well the  model is fitted 
with certain explanatory variables at a given bandwidth size. 
 
AIC was developed by Akaike in 1971 to assess the performance of estimated 
statistical models. The AIC of the model with bandwidth d is given as: 
 
) ( 2 ) ( ) ( d K d D d AIC           ( 2 . 3 0 )  
 
Where D represents the deviance, K represents the effective number of parameters 
in the regression model, and d is the bandwidth in the kernel. The model with the 
smallest AIC value represents the model with the optimal bandwidth. Such a 
method is called minimum AIC estimator (MAICE). In practice, if the difference 
in AIC between two models is less than or equal to two, there is no significant 
difference between the two models, in which case both models are accepted as the 
best fitted model with optimal bandwidth. 
 
AIC can reflect biased measurement (Akaike, 1974; Sugiura, 1978) when there 
are too many parameters and too few sample points (data). In order to avoid 
biased estimation from AIC, Sugiura (1978) derived a second order variant of 
AIC which is called c-AIC, and Hurvich and Tsai (1989) incorporated a small 
sample bias adjustment which led to a criterion called AICc defined below, where 
N is the total number of regions: 
 
1 ) (
) 1 ) ( )( (
2 ) ( 2 ) ( ) (
 

  
d K N
d K d K
d K d D d AICc      ( 2 . 3 1 )        
1 ) (
) 1 ) ( )( (
2 ) (
 

 
d K N
d K d K
d AIC  
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The other bandwidth selection criterion that can be used in GWR is called the 
Bayesian information criterion (BIC), and the calculation is given below: 
 
) ( log ) log( 2 N K L BIC e          ( 2 . 3 2 )  
 
Where L is denoted as the model likelihood. BIC was derived from Bayesian 
theory, where each of the discrete number of candidate models have equal prior 
probabilities; the prior distributions on the model parameters. Again, the model 
with the smallest BIC is the better fitted model compared to the other candidate 
models. Both AICc and BIC can be used as a measurement method to compare 
candidate models; the best fitted model can be identified through comparing the 
AICc or BIC values. 
 
2.3.7 Multilevel regression models 
The term ‘multilevel’ refers to a nested membership relationship among units in a 
system (Centre for Multilevel Modelling, 2008). Multilevel modelling techniques 
allow the combination of different levels of information to explain the relations 
between observed variables and explanatory variables, given that some variables 
are measured at a lower level and some at a higher level. It is an appropriate tool 
for modelling data with complex hierarchical structures. It allows and helps users 
to fit a model when the target or observed outcome and the explanatory variables 
do not appear in the same level but the lower level information does nested within 
the higher level. Nowadays, it has become more common in studies of diseases, to 
understand how the diseases respond when different level information is available; 
for example, higher level socio-economic variables may be associated with an 
observed disease at an individual level. So it is possible to compare the different 
variables between individuals and within groups (Centre for Multilevel Modelling, 
2008). The correlation between observed and explanatory variables might be 
different from individual to individual. For a normal single level model, such 
structural information is ignored, and this may provide misleading results.  
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2.3.7.1 Model structure 
For multilevel regression models, there are few possible model structure (i) simple 
hierarchical model, (ii) random intercepts model, (iii) random coefficients model, 
(iv) Bayesian approach, and (v) conditionally autoregressive (CAR) model. Each 
of such model structure will be described in the following sections. The basic 
model structure is showed below.  
 
) , ( ~ cd cd cd n Binomial y   
)
1
log( ) ( log
cd
cd
cd it




  
  cd d d cd e u v v      2 2 1 1 0     
 
)) ( exp( 1
1
2 2 1 1 0 cd d d cd
cd e u v v      

  
      ( 2 . 3 3 )  
 
Where  cd y  is the observed variable,  0   is the intercept,  t   is the coefficients for t 
= 1, 2, …, T,  d u  is the random effect component at level d (higher level residuals), 
and  cd e  is the random effect component at c level (lower level residuals). Where 
level c is lower than level d (e.g. individual c nested within region d). The first 
few terms in the model are assumed as the fixed part in the model and both  d u and 
cd e  represent the random part in the model. The random effect components are 
Normally distributed with mean zero and variance 
2
u   and 
2
e  . 
 
) , 0 ( ~
2
u d Normal u       ) , 0 ( ~
2
e cd Normal e   
 
(i) Simple hierarchical model 
For the simple hierarchical model, all the parameters are assumed as constant and 
only showed the overall value for the coefficients, the model structure showed 
below, 
 
d cd cd v v it 2 2 1 1 0 ) ( log               ( 2 . 3 4 )  
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(ii) Random intercept model 
Within the simple hierarchical model the intercept is fixed as a constant term over 
space. However, adding the random effect term (random intercept) in the model, 
which allows to account for the probability of  cd y  occur in different d ,  d 0   vary 
across the space at the higher level d, the model is defined below, 
 
d cd d cd v v it 2 2 1 1 0 ) ( log               ( 2 . 3 5 )  
d d u0 0 0      
 
Where  d 0   the random intercept has two components which are the fixed term  0   
and the random effect  od u  it is a higher level specified component (level d) it is 
Normally distributed with mean zero and variance 
2
0d   in equation (). 
 
(iii) Random coefficients model 
The coefficients can be vary , which allows to account for the difference in the 
lower level which nested within the higher level and also vary across the higher 
level. For example, the random coefficient account for the difference between 
explanatory variables (e.g. high socio-economic condition or low socio-economic 
condition) within the same higher level d (e.g. Output Areas) and to vary across in 
the higher study areas (Output Areas), the model structure is defined below, 
 
d cd d d cd v v it 2 1 0 ) ( log               ( 2 . 3 6 )  
d d u0 0 0      
d d u0 1 1      
 
(iv) Bayesian framework 
Bayesian theory can be incorporate within multilevel modelling, which 
combinating the prior information into the model, so that each unknown 
parameters resulting with a posterior distribution represent the possible 
uncertainly range for that parameter. Therefore, each of the parameters in model 
(equations 2.34, 2.35 and 2.36) will be given with a specified prior distribution 
simple to section 2.3.5. 
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(v) CAR model 
The model in (i) to (iv) have not included with spatial information, thus each 
study area is assumed independent to other study areas. However, the neighbours 
normally quite similar to each other and there is certain affect from each other. 
Therefore, the spatial information is very helpful in understanding human 
behaviours. Conditionally autoregressive (CAR) model is commonly applied 
within multilevel regression model. When the areas are next to each other, which 
will received a weighted value one, otherwise the weighted value equal to zero. 
Such idea suggested the direct neighbour’s information is taken into account in 
the prediction. 
 
2.3.7.2 Parameters estimation process 
There are two main approach of fitting multilevel model, which are (i) likelihood-
based and (ii) Bayesian approach. For the likelihood-based included iterative 
generalized least squares estimation (IGLS) and restricted iterative generalized 
least squares (RIGLS), the estimation from both methods are procedure from an 
iterative process. However, when a model is based on Bayesian framework an 
alterative approached Monte Carlo Markov Chain (MCMC) can be used to 
estimate the unknown parameters, where Gibbs sampling will be applied in 
MCMC. 
 
2.3.7.3 Model comparison  
Chi-square goodness of fit test is commonly used to compare between the model, 
when maximum likelihood estimation is used in multilevel model, likelihood 
ration test can be used otherwise pD and DIC values can be used to measure how 
good it the model fitted and to compare between models. Details about pD and 
DIC please reference to section 2.3.5.3. 
 
2.3.8 Available software for regression modelling 
Since computing technology is improving rapidly, there are many software 
packages available for data analysis, and for constructing the regression model. 
Four software packages were used in this study, which are listed below: 
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(i) S-plus 
(ii) WinBUGS, 
(iii) GWR 3.0 
(iv) MLwiN 
 
S-plus was used to fit generalised linear regression models with various 
distributions, all the Bayesian models were fitted using WinBUGS, the local 
regression model was fitted by using GWR 3.0 and finally, MLwiN was used to 
fit multilevel regression models for the Chlamydia study. 
 
 
2.4 Classification and regression trees (CART) analysis 
Classification and regression tree (CART) is a classification method, which was 
developed by Breimen et al., (1984). CART is a data analysis tool for predicting 
the dependent variable based on categorical predictor variables. It works by   
splitting the observed variable (e.g. patients) into groups, by using a binary trees 
method which often provides an illuminating view of the data. CART has been 
applied in many health studies (Chiogna et al., 1996; Harper and Winslett, 2006). 
Particularly, for health studies, it might be interesting to identify the risk groups of 
patients and their common characteristics.  An example is shown in Figure 2.2: 
 
 
Figure 2.2 CART analysis of cardiac patients (Breimen et al., 1984). In the tree, F 
represents low risk group heart attack patients and G represents high risk group 
heart attack patients. 
 
G 
F 
G  F 
no 
no 
no 
yes 
yes
yes
Is the minimum systolic blood pressure 
over the initial 24 hour period > 91? 
Is age > 62.5 
Is sinus tachycardia present?  Chapter 2 Methods 
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Before starting to construct a regression tree it is necessary to define the predicted 
variable (i.e. the variable of interest). Each junction of the tree is called a node, the 
node at the end of a branch is called the terminal node. The parent node is the 
node being split further; thus, child nodes come from the parent node, and each 
parent node has two child nodes. If a variable is ordinal, variance is used to 
measure the purity in the group; if a variable is categorical then deviance is used 
to measure the purity in the group. An algorithm is used to split the data into sub-
populations (child nodes); the sup-populations need to have higher purity 
(decreasing variance or deviance) than the parent node (Breimen et al., 1984). 
Therefore, each of the variables (nodes) will have a best binary split given that it 
produces a node with the smallest variance or deviance. Users need to predefine a 
set of stopping rules to stop branching and stop expanding the tree. Some 
examples are listed below. In addition to the “stop rules”, stop branching occurs 
when the variance or deviance has not significantly reduced. It is necessary to 
define a set of stop rules to stop expanding the tree. Here are some examples of 
stop rules: 
 
(i) stop when nodes contain a certain number of cases, 
(ii) stop when reduction of variance is below a certain threshold, 
(iii) stop when a maximum number of terminal nodes has been produced. 
 
2.4.1 CART algorithm 
Variance is the main element in the CART, which is used to split the data into 
groups (or sub-groups) according to the best independent variable with reduced 
total variance. Firstly, each independent variable value is required to calculate the 
sum of the independent variable in that group (x), the sum of square value 
(
2 x ) and the number of items of data in that group (N). Secondly, sort the 
values of the independent variable into increasing order of the mean value of the 
dependent variable. Thirdly, to design where to split the independent variable, 
look for the sorted mean that produces the minimum variance. It is important to 
split the data based on the best independent variable in order to reduce the total 
variance calculated as following: Chapter 2 Methods 
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Finally, choose a suitable sub-group of the data as the current group, and repeat 
the same process until either the data are split into groups and the size is less than 
the minimum number (stop rule (ii) in section 2.4) or the reduction in variance 
obtained by a split of the data is less than the minimum value (stop rule (iii) in 
section 2.4). 
 
 
2.5 Decision theory 
Everyone needs to make a decision when there is more than one choice; however, 
how can one make the best choice with the best outcome? It is a difficult question 
to answer. Decision analysis can be applied to predict the best choice with the best 
possible outcome. Some mathematical models can be used to make decisions with 
certain objective functions with specific risk (e.g. positive cervical cancer test 
result). The true future outcome cannot be predicted with full certainty, but it is 
possible to estimate the outcome with enough accuracy based on the collected 
data or distribution. It is particularly useful for studying screening systems, as it 
allows an analysis of which screening option provides the best outcome 
(Spiegelhalter et al., 2004). 
 
2.5.1 Decision tree model structure 
The Decision tree can be applied based on decision theory; the tree can be used to 
determine the optimal outcome based on the given risk. Such a model enables a 
decision maker to break down a complex problem into several smaller problems. 
Decision theory has been applied in many health-care studies to evaluate health 
options. Below is one of the examples (Figure 2.3) from Ashby and Smith (2000) 
and Spiegelhalter et al., (2004). It shows how to make a decision based on the 
estimated risk from collected data and also the prior distribution, which allows Chapter 2 Methods 
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one to calculate the cost of the treatment, so that the policy makers can make 
decisions about the patients’ treatments. 
 
 
Figure 2.3 Decision tree for folic acid supplementation decision. The square node 
represents where to make a decision and the circular nodes represent events. The 
values or outcomes at the end of the tree are called utility of consequences. Where 
0 d  and  1 d   represent the decision of taking a supplement or not,  0 p  and  1 p  
represent the probabilities of having an neural tube defect (NTD) based on the 
earlier decision (taking supplement or not),  0 U  and  1 U  represent the utilities of 
taking NTD or not and finally,  0 c  and  1 c  represent the cost. 
 
The decision can be made based on the cost of the outcome (consequences). 
Whichever gives the best cost for the treatment might be considered as the 
optimal decision. The same theory can be used in evaluating cervical cancer and 
Chlamydia screening systems to evaluate the optimal decision, which can increase 
the benefits for the patients and best use of the resource.  
 
  
2.6 Simulation model 
Simulation is a technique that facilitates learning about a disease process while 
observing the patients’ or diseases’ behaviour from a real system. The collected 
data can be used to design the system; and by asking some “what if” questions it 
is possible to identify any bottlenecks within the system and establish what can be 
0 1 c U   
0 0 c U   
1 1 c U   
1 0 c U   
Decision 
NTD
NTD
No NTD
No NTD
0 p  
0 1 p   
1 p  
1 1 p   
0 d  
1 d  
Supplement 
No Supplement 
Utility of consequences  Event?Chapter 2 Methods 
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done to improve the real system and achieve the best possible outcomes (Winston, 
1994; Taha, 1997; Hillier and Lieberman, 2001).  
 
Particularly, for the NHS healthcare system, it might be interesting to know about 
each individual patient passing through the system, and that would provide a 
better opportunity to view the system, and to identify any areas within the current 
system that need improving.  In addition, it is possible to forecast the future 
demand, which allows the NHS to prepare to provide better quality health services 
and better estimate resources. In terms of the patients’ waiting time, it could also 
benefit the patients by reducing waiting times, and as a result, the system would 
operate in a more effective way. Finally, the patients’ life quality (QoL) might be 
improved through such a study. 
 
Simulation is used in this thesis to study both cervical cancer and Chlamydia 
screening systems in order to attain a better understanding of how the screening 
systems run and what activities could be undertaken to improve the detection rates. 
Two possible simulation frameworks are considered – the Markov and Semi-
Markov models. The choice of simulation framework depends on the type of 
information available, as explained below. 
 
2.6.1 Markov and Semi-Markov models 
In some cases, it is of interest to know how a random variable (RV) changes in a 
given process. In particular, it could be of interest in a specific disease process. In 
a situation where a doctor wants to predict the probability of a patient moving 
from one state to another, a stochastic process model is particularly helpful to 
answer such a question. In particular, a type of stochastic process Markov chain 
has been applied in many areas, such as in marketing and finance, and especially 
in healthcare services. Markov chains have the special property that probabilities 
involving how the process will evolve in the future depend only on the present 
state of the process, and so are independent of events in the past. For a disease 
process, the parameter space T is countable (e.g. for cervical cancer these could be 
healthy, CIN 1, CIN 2, CIN 3, cancer and death). 
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Consider a continuous time chain  ) , 0 [ ) (   t t X . It takes a value in a discrete state 
space S (e.g. pre-cervical cancer stages CIN 1, CIN 2 and CIN 3, cancer, death). 
The probability of moving from one state to another is called a transition 
probability  ij   and the time spent in state i before moving to state j is called the 
holding time ij h . The reason a chain is said to be a semi-Markov chain is that each 
transition depends on the previous state or states, which means all transition 
probabilities are denoted as ) | Pr( 1 i X j X n n ij      . It exactly describes the 
pre-cervical cancer disease process, as each disease state is highly dependent on 
the previous state. The Semi-Markov model does not have the memory-less 
property (i.e. the current state is independent of past states) and it can be fitted 
with any distribution (Minh, 2000). 
 
As simulation model can be used to simulate each individual patient’s flow 
through the cervical cancer or Chlamydia infection process (e.g. how long a 
patient may remain in a state and how many patients stay in a state). It allows 
some understanding of the disease process and allows us to ask some “what if” 
questions: for example, what happens if a screening programme becomes 
available with a set of policies etc.. It allows us to examine and understand the 
screening programme without putting anyone (e.g. patients) at risk. Chapter 3 Data 
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Chapter 3 Data 
 
 
3.1 Introduction 
For the study of diseases, there are two types of data available, aggregated and 
individual data, and it is more common to have aggregated data than individual 
data, due to confidentiality restrictions.  As a result, data are often aggregated as 
summary counts rather than being provided as point-level data on individuals. 
Two diseases were studied in this thesis: the cervical cancer study used 
aggregated data and the Chlamydia study used individual data. The cervical 
cancer incidence data were drawn from 2004 statistics, and the Chlamydia data 
from 1999-2000. The Townsend indicator, social grade IV and V, and family 
structure (e.g. marital status and lone parents etc.) variables were downloaded 
from the UK census 2001 at different levels. The shape files for mapping were 
downloaded from Edina UKBorders. 
 
 
3.2 Cervical cancer data 
3.2.1 Cervical cancer national data 2004 
The cervical cancer count data were provided by the Association of Public Health 
Observatories (APHO), which represents the nine Public Health Observatories 
(PHO) in England (Table 3.1). In total, 7179 cervical cancer cases (i.e. current 
cases in 2004, including new diagnosed cases) and 2391 deaths were recorded in 
2004. The data were represented at district and unitary authority levels of the 
Cancer Registries in England. The total female population per age group was 
determined from the 2001 UK Census (between the ages of 0 to 4, 5 to 9, …, 85 
and over). These data were used to calculate the number of expected cases per 
region. The incidence rates were downloaded from the cancer research UK 
website (Cancer Research UK, 2005). 
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Table 3.1. Public Health Observatories (PHO) in England 
Public Health Observatory (PHO)  Number of districts/unitary 
authorities in PHO 
1. South West  45 
2. South of England  67 
3. London  33 
4. East of England  48 
5. East Midlands  40 
6. West Midlands  21 
7. North West  23 
8. Yorkshire and Humber  43 
9. North East  34 
 
 
3.2.2 Townsend indicators, social grade and family structure national data at 
district or unitary authority level in 2001 
The second dataset included in the cervical cancer study was composed of the 
Townsend indicators, social grade and family structure data for 2001, which were 
downloaded from the UK Census of 2001. Since the census is carried out once 
every ten years the closest matched year to 2004 was 2001. All variables were 
included in the analyses, which are listed in Table 3.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 Chapter 3 Data 
  46
Table 3.2 Summary of explanatory variables used as indicators in the regression 
analysis. 
Type of 
variables 
Variables  Description  Table from UK census 
2001 
(i) Unemployment  Employed population   KS009a  Economic 
activity: all persons 
(from the key statistics) 
(ii) Households not 
owned 
All households not owned 
by the tenant 
KS018 Tenure (from 
the key statistics) 
(iii) Car ownership  All households with no cars/ 
vans 
KS017 Cars or vans: all 
households (from the 
key statistics) 
Townsend 
index score 
(iv) Over-crowded 
housing 
Over one person per 
bedroom 
UV 058 Person per 
room (from the census 
area statistics univariate 
tables) 
(v) Female marital 
status  
(for cervical cancer 
study) 
(i) Proportion of single 
(officially single): single 
(never married) + divorced 
+ widowed 
(ii) Proportion of married 
(officially married): married 
+ remarried + separated (but 
still legally married) 
ST002 Age by sex and 
marital status 
(vi) Marital status  
(for Chlamydia 
study) 
(i) Proportion of single 
(officially single): single 
(never married) + divorced 
+ widowed 
(ii) Proportion of married 
(officially married): married 
+ remarried + separated (but 
still legally married) 
KS004 Marital status 
Family 
structure  
(vii) Households 
with lone parent 
(i) All lone parents 
(ii) Female lone parents 
KS022 Lone parent 
households with 
dependent children 
Social grade 
(proportion) 
(viii) Proportion of 
Social grade IV + V 
Grade VI: semi-skilled and 
unskilled manual workers 
Grade V: on state benefit, 
unemployed, lowest grade 
workers 
UV050 Approximated 
social grade VI and V 
(low socio-grade) 
 
Variables (i) to (iv) were used to calculate the Townsend index and other variables 
were used individually in the regression models. Variables (vi) to (viii) were 
expressed as a proportion of the total population.  
 
At the beginning of this study the data were subjected to a Chi-square goodness of 
fit test, which showed that the data approximately followed a Poisson distribution. 
The national incidence rate per age group was provided by Cancer Research UK 
(Cancer Research UK, 2005). The incidence rate was used to calculate the number 
of expected cases. Chapter 3 Data 
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3.2.3 Individual colposcopy clinical data from Portsmouth St Mary’s 
Hospital 1998-2006 
Colposcopy individual test results were provided by St Mary’s Hospital, 
Portsmouth, between 1998 and 2006; these included some of the individual 
patients’ information: (i) date of birth, (ii) date of smear, (iii) date of colposcopy, 
(iv) smear tests result and (v) colposcopy test results. Therefore, the ages of the 
patients and the screening intervals can be estimated based on dates of birth and 
date of tests. The patient’s name was removed before the data became available 
for this PhD study. This was done for ethical issues and to protect the patient’s 
privacy. 
 
 
3.3 Chlamydia data 
3.3.1 Chlamydia individual clinical data 1999 – 2001 
The individual patients’ data were provided by St Mary’s Hospital Portsmouth, 
which came from the second phase of an opportunistic screening trial study. Data 
were collected between October 1999 and September 2000, around the 
Portsmouth area. In total, 25553 tests consisted of 17342 patients, which included 
repeat tests to check that the infection had been cured. All the patients were 
allocated with a new ID number when they had repeat tests. The results and 
patients’ data were provided in Excel format with matching patient IDs. The 
patients’ ID numbers were used to link the tests and patients’ records together as 
shown in Figure 3.1. The patient’s records had patient name fields, but such 
information was removed before the data became available for research study to 
ensure patient anonymity. 
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Figure 3.1 Linking the patient’s details, results and explanatory data together.  
 
Every time when a patient comes for a Chlamydia test, the patient receives a new 
patient’s ID. However, a patient who has taken two Chlamydia tests and who has 
two different IDs, will have matching ID information attached in both of the 
patients’ details and result records. Thus, the matching ID allows linking the same 
patient’s history together in a very easy way. The postcode information is 
available from each individual patient’s records. Therefore, that can be used to 
identify the location and it can be used to create a link to join the individual 
patient and the aggregated socio-economic data together. 
 
The majority of the data were collected from the female population between the 
ages of 16 to 24 (Pimenta et al., 2003 a;b). A list of personal information was 
available, including variables such as (i) patients’ ID, (ii) gender, (iii) date of birth, 
(iv) date of form of the test, (v) the estimated age based on (iii) and (iv); (vi) 
ethnic group, (vii) postcode, and (viii) results, which are either positive or 
negative. Most importantly, the postcode information provided the spatial 
Patients’ details 
Patient ID  25553 
Ethnic group code: 0, 1, 2, 3, 4, 5, 6, 14, 34 
and 99   
Postcode 
DOB 
Date of form 
Result 
Patient ID  17342 
Ethnic group code 
Postcode 
DOB 
Date of form 
Lab Referral group 
Completed data 
Patients 8415 
Result: Positive: 778, Negative: 7637 
Link: ID
Deprivation indicators data 
(i)  Households not owned,  
(ii)  Households with no van/ car,  
(iii)  Over one person per 
bedroom,  
(iv)  Unemployed population. 
Family structure data 
(i)  Marital status, 
(ii)  Households with lone parent, 
Link: PostcodeChapter 3 Data 
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information, which would allow the researcher to apply any spatial modelling 
based on that information. For full details of the trial study of the data please refer 
to Pimenta et al., (2003 a;b)  
 
3.3.2 Townsend indicators, social grade and family structure data at Output 
Area level from the Census 2001 
A Postcode to Output Area (OA) look-up table was used to link the postcode and 
Output Area together. In addition to the non-available individual socio-economic 
data, the lowest available level was used in this study, which was the Output Area 
level. Townsend indicators, social grade and family structure data were collected 
through the UK census 2001; this was the closest year to the second phase of the 
Chlamydia screening trial study and all variables were collected at Output Area 
(OA) level. In total, there are 1365 Output Areas that were included in the trial 
study (Table 3.3). 
 
Table 3.3 Chlamydia study summary at unitary authority level. 
Location No.  of 
Output 
Area 
No. of test No.  of 
positive 
test 
Total 
population 
Positive rate 
per 10000 
people 
Southampton 15 14  2  217,460  0.09197 
Eastleigh 18  21  1  116,176  0.08608 
Winchester 10  129  7  107,303  0.6524 
East 
Hampshire 
111 336  24  109,354  2.1947 
Fareham  344  1,817 151 107,965  13.986 
Gosport 246  1,502 160 76,381  20.9476 
Portsmouth  621  4,595 433 186,717  23.1902 
Total  1,365  8,414 778 921,356  8.4441 
 
3.3.3 Townsend indicators, social grade and family structure data at Census 
area statistics (CAS) ward data   
The purpose of having different levels of data is to examine the disease pattern 
and relation between Chlamydia incidence cases and deprivation indicator, social 
status and family structure factors at different spatial levels. An Output Area-to-
CAS ward look-up table was used to link the Output Areas and wards together. 
All variables were collected through the UK census 2001; the Townsend scores at 
this level are available from the Census Dissemination Unit based on the 2001 Chapter 3 Data 
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census data (Census Dissemination Unit, 2006) and variables were listed in Table 
3.2.  
 
 
3.4 Data problem 
It is common to encounter three data issues (i) aggregated data, (ii) individual data, 
and (iii) missing data. In particular, for the study of disease, most of the data are 
available at aggregated levels because of confidentiality restrictions on patients’ 
personal data. Therefore, it is unlikely to achieve point level data, mostly data are 
only available at aggregated level, and it only provides an average picture of the 
study region. Individual data are often not available. Missing data is another 
common issue in studies of disease; it could be due to unobserved data, or when 
the observed data are too small; for example, for the cervical cancer data, all the 
observed records between zero and five were closed to protect patients’ 
confidentiality. It is possible to model diseases despite a certain proportion of 
missing data; the details of how to deal with missing data are shown in each of the 
analysis chapters four to seven. 
 
 
3.5 Summary 
Two sets of data relating to two different diseases at national and local levels were 
used to study the relationships, if any, with deprivation indicator, social status and 
family structure variables. The missing data were overcome by employing 
different methods; for full details refer to each of the analysis chapters (4-7). Chapter 4 Model for early detection of cervical cancer through cervical 
cancer screening programme 
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Chapter 4 Model for early detection of cervical cancer 
through cervical cancer screening programme 
 
 
4.1 Introduction 
Cancer is one of the most common causes of death; however, it can be prevented 
by early detection through regular screening tests. Most patients remain in an 
asymptomatic state at the early stages of cancer. When a patient becomes aware of 
symptoms, it is likely to be at a more advanced stage of the disease. Pre-cancer 
stages and early cancer stages can be detected through screening (Jonse, 1997). 
An example: in the case of colorectal cancer it was found that a regular screening 
test is essential in preventing cancer and it makes a remarkable difference in 
survival rates (Harper and Winslett, 2006). There are a number of national 
screening programmes available for parts of the general population that satisfy 
some basic requirements for taking the tests (e.g. age). The cervical cancer 
screening programme is one example of a national screening programme that is 
free of charge for every female who falls within a certain age group (Table 1.3). 
Within the cervical cancer screening programme, the smear test is the major test 
for every female patient. Patients who have moderate dyskaryosis, severe 
dyskaryosis or suspected invasive cancer from their smear test results, will need to 
take a further test, called a colposcopy, to investigate the abnormality further. It 
has been argued that, in the past, too many unnecessary colposcopies were 
performed. From a management point of view, it is helpful to reduce the number 
of unnecessary coploscopies as this can reduce the amount of wasted resources. A 
study demonstrated the possibility of removing the low risk population from the 
cervical cancer screening programme, which is also a possible way of increasing 
the efficiency of the current screening programme (Sherlaw-Johnson et al., 1999).  
 
From the patients’ point of view, the waiting time can be reduced if unnecessary 
coploscopies are avoided. Thus, those in greatest need would have the chance to Chapter 4 Model for early detection of cervical cancer through cervical 
cancer screening programme 
  52
detect cancer earlier and receive the appropriate treatment earlier. This chapter 
focuses on evaluating screening options and simulating the natural pre-cervical 
cancer process through a decision tree model and simulation model. Risk 
grouping through Classification and Regression Tree (CART) analysis can 
identify the elements associated with the development of Cervical Intraepithelial 
Neoplasia (CINs) and cervical cancer. Risk grouping will help in targeting 
patients to increase the efficiency of screening services (e.g. different risk groups 
may have different screening intervals and even different screening tests) 
(Breiman et al., 1984; Sherlaw-Johnson et al, 1999). Types of diagnostic tests are 
also important to the level of preventing cancer and cost-effectiveness of the 
screening programmes (Jenkins et al., 1996; Sherlaw-Johnson et al., 1999; 
Sherlaw-Johnson and Phillps, 2004). Other research has demonstrated how the use 
of different types of diagnostic tests (e.g. LBC and HPV tests) may affect the 
chances of detecting abnormal cells and the number of colposcopies required 
(Jenkins  et al., 1996; Sherlaw-Johnson and Philips, 2004). Details of medical 
terms can be found in Appendix A. 
 
 
4.2 Objectives 
This chapter analyses a set of clinical data; the individual colposcopy data from 
the Portsmouth St Mary Hospital between 1998 to June 2006. From the available 
data, the specific objectives are (i) to analyse which type of patients had a higher 
chance of requiring colposcopy than others. Separating the population into risk 
groups is one possible strategy to increase the chance of detecting cervical cancer 
at the early pre-cancer states; (ii) to construct a decision tree model to evaluate the 
effectiveness of each screening option, and (iii) to fit a simulation model, which 
describes the natural history of the pre-cervical cancer process. This model can 
describe a patient’s flow through pre-cervical cancer and cervical cancer in the 
screening system from a normal (healthy) state to a cancer state over a period of 
time. All the analysis in this Chapter is intended primarily as a demonstration of 
what is possible, the regression analyses (Chapter 5) was intended to demonstrate 
that risk is related to known explanatory variables.  Chapter 4 Model for early detection of cervical cancer through cervical 
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When the associated risk factors were identified from the regression models in 
Chapter 5, the general population can be divided into risk group, according to the 
identified associated risk factors in Chapter 5. The probabilities and other required 
parameters can be added into the decision tree and simulation models in this 
Chapter to demonstrate the real use of decision tree and simulation models.  
 
 
 
4.3 Current screening programme 
In the UK, the national cervical cancer screening programme is free of charge for 
every woman from the age of 25 to 64 (Table 1.3).  Cervical cancer screening 
began in Britain in the mid 1960s, but it became an official screening programme 
by 1998 (Patnick, 2004). It was estimated that screening services cost around 
£150 million per year, including treating pre-cancerous lesions annually, equating 
to £37.50 per woman screened (Patnick, 2004). Annually, around 3.5 million 
women attend for cervical cancer screening tests (Patnick, 2005). 
 
Cervical cancer screening tests are used to detect abnormal cells within the cervix, 
but it is not a test for diagnosing cervical cancer. Details about the national 
cervical cancer screening policy are summarised from the national screening 
guidelines (Patnick, 2004), attached in Appendix B. 
 
4.3.1 Potential problems 
No test can provide 100% accurate and effective results. Therefore, a certain 
number of unnecessary colposcopies are performed every year. Such unnecessary 
colposcopies increase the waiting time and waiting lists for other patients who 
may then have to wait longer before they can take the colposcopy. The potential 
problems are explained in Figure 4.1. 
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Figure 4.1. Problems associated with unnecessary colposcopies. The 
corresponding waiting list and waiting time increases at the same time as the 
number of colposcopies increases. Therefore, the time taken to detect abnormal 
cells increases and the chance of detecting abnormal cells at an early stage 
decreases. Finally the number of cervical cancer cases may increase. 
 
 
4.4 Disease states 
Disease states are used to measure patients’ illnesses. Pre-cervical cancer and 
cervical cancer can be diagnosed at different states in their disease development. 
Carcinoma in situ (CIS) is a term used to describe atypical epithelia found in the 
cervix by measuring the full-thickness of the epithelium (Singer and Monaghan, 
2000). The term was introduced by Broders (1932).  
 
Pre-cervical cancer states are called CINs, a term introduced by Richart (1968). 
CINs are used to measure abnormalities within the cervix, and these are measured 
at three levels; CIN1, CIN2 and CIN3. Normally, disease states are expressed 
numerically (e.g CIN1, CIN2, etc). The earlier the disease is detected, the greater 
the chance of survival and the greater the benefit that may be achieved from 
treatment (Jonse, 1997). In this chapter, pre-cervical cancer disease states are 
considered.  
No. of 
Colposcopies 
Size of Waiting 
list 
Waiting time 
Chance of detecting 
abnormal cells at early 
stages 
Time for 
detecting 
abnormal cells 
No. of cervical 
cancer cases 
+ 
+ 
+ 
+ 
- 
+ 
+ Chapter 4 Model for early detection of cervical cancer through cervical 
cancer screening programme 
  55
Human Papilloma virus (HPV) is a type of virus. It is one of the common sexually 
transmitted infectious diseases (STIs). HPV can be detected through a colposcopy 
(Martin, 2000). For women with an abnormal cervical smear, the HPV DNA is 
found to be positive in a much higher percentage and is therefore  a useful 
indicator of a high risk of developing cancer of the cervix. Some forms of HPV 
are especially related to cervical cancer incidence; for example, HPV 16 and HPV 
18 (Goldie et al., 2003; Arias-Pulido et al., 2006). Therefore, the presence of HPV 
might be an indicator, which may be associated to the development of cervical 
cancer in the future. Details of medical terms are attached in Appendix A. 
 
 
4.5 Data analysis 
Patients are assumed as homogeneous under national healthcare policies, but 
individual patients differ from each other in a number of characteristics and 
physical conditions. Those characteristics include (i) sex, (ii) age, and (iii) socio-
economic condition. Further characteristics focusing on physical condition 
include (iv) medical condition, (v) severity of illness, (vi) level of complications 
of disease states, (vii) speed of recovery, and (viii) response to medication. 
Patients with similar characteristics tend to have similar needs. Those patients can 
be considered as a group of patients requiring similar healthcare. In fact, these 
groups are typically heterogeneous and require more detailed modelling for 
classification; it is advantageous to be able to divide this heterogeneous group into 
smaller homogeneous (in terms of a particular measurement, e.g. patients’ age) 
subgroups. Classification and Regression Tree Analysis (CART) is a data analysis 
tool to split patients into groups, by using a binary trees method which often 
provides an illuminating view of the data (Breiman et al., 1984). 
 
4.5.1 CART analysis and Colposcopy risk groupings 
CART is commonly used in healthcare to divide the population into groups 
according to their risk; an example is maternity risk grouping to avoid 
complications and to increase benefits to both the medical teams and the mothers 
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(i.e. collected data and expert opinion) to explore which is the best option for 
diagnosing possible heart disease in new born babies (Chiogna et al., 1996). For 
the cervical cancer study the initial analysis attempted to classify patients into risk 
groups based on colposcopy results from Portsmouth clinical data. The results 
may help to predict which type of patients are likely to have positive colposcopy 
results as well as grouping patients into various groups according to their common 
characteristics.  
 
Firstly, colposcopy results were defined as the predicted (dependent) variable. The 
list of independent variables included date of birth, age at smear test (equation 
4.1), smear results, age at colposcopy (equation 4.2), screening interval (equation 
4.3), and patients’ history.  
 
Age of smear = Date of smear test – Date of birth        (4.1) 
Age of colposcopy = Date of colposcopy – Date of birth      (4.2) 
Screening interval = Date of colposcopy – Date of smear test    (4.3) 
 
The predicted variable was the characteristic predicted by the predictor 
(independent) variables. Thus, the predicted variables were assumed to be 
potentially related to the predictor variable. Once the predicted variable had been 
chosen, an algorithm was used to split the original population into sub-
populations. The first node of the tree was the predicted variable. More details of 
the CART algorithm were discussed in Chapter two. Also within this study the 
CART algorithm was used slightly differently than was described in Chapter two. 
The difference was that each split was done manually. Since the relationship 
between Colposcopy and Human Papilloma Virus (HPV) was of interest, HPV 
absent and HPV present was used to divide individual patients into groups in 
CART analysis. The final CART tree and result summary are given in section 
4.5.3. 
 
4.5.2 CART analysis with PORT 
The software package PORT was developed over a period of time under the 
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came from a company called Practical Insights Ltd and the software can be 
purchased from the GeoData Institute, University of Southampton. The main 
purpose of the software is CART analysis. PORT is a data analysis programme 
which creates classifications and provides a variety of statistical information about 
the elements in the classes. Within the software users can choose the tree-based 
algorithm or manually split the data into groups. Therefore, the data can be 
classified into groups according to certain characters or factors that the users have 
chosen. PORT is a data analysis programme which creates classifications and 
provides a variety of statistical information about the elements in the classes. An 
example is classification of people in various risk groups for a particular 
condition. Another example is the classification of hospital patients from the point 
of view of the length of stay in the hospital. 
 
4.5.3 CART Results 
The classification results can be used to increase knowledge about the predicted 
variable and help to predict an individual patient’s needs and resource utilisation. 
The healthcare needs and corresponding resources vary from group to group. For 
example, given an individual patient, who can be classified into a patient sub-
group based on the past experience and data, and the type of healthcare needs. 
Therefore, the results can be predicted based on the CART results. A more 
suitable healthcare decision can be made based on which group the patient 
belongs to. The CART results are listed in Figure 4.2 and Table 4.1.  
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The coploscopy results (node 1) were divided into two groups, which are 
coploscopy positive (node 2) and coploscopy negative (node 3). Patients in node 2 
were further divided into HPV absent or HPV present from the coploscopy 
results. A similar approach was applied to node 3; patients were divided into 
nodes 18 and 19, who had HPV history absent or HPV history present. Nodes 4 
and 5 were divided further into nodes 6, 7, 8, 9 and there are 8 final nodes (nodes 
10-17). So simply, it is possible to assume that nodes 10, 11, 12 and 13 represent 
one group, patients who had positive coploscopy and HPV absent, nodes 14, 15, 
16 and 17 another group, who had  positive coploscopy but HPV present, and 
nodes 18 and 19 are a final group who had negative colposcopy results. 
 
The probability for each of the nodes was calculated as the percentage of patients 
within that group. Details of the calculation are listed (Table 4.1). For numerically 
independent variables (e.g. age of smear test), the minimum and maximum values 
are presented to indicate classification rules for forming these nodes. The final 
risk groupings were found as terminal nodes (nodes from which there are no 
further binary splits) and the terminal nodes are highlighted in Table 4.1. 
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Table 4.1 CART tree nodes summary for colposcopy results 
Node N  Field  name  (%)  Minimum Maximum  Deviance
1 1,639 All  patients  ---  ---  ---  2.93 
2 1,534 Coploscopy 
positive 
93.594% 
(1534/1639)
--- ---  2.87 
4 1,306 Coploscopy  with 
non HPV 
85.137% 
(1306/1534)
--- ---  2.56 
5 228  Coploscopy  with 
HPV 
14.863% 
(228/1534) 
--- ---  1.81 
6 919  Coploscopy  age   
40 
70.368% 
(919/1306) 
0 40  2.34 
10  882  Smear with non 
HPV 
95.974% 
(882/919) 
--- ---  2.33 
11 35  Smear  with  HPV  3.808% 
(35/919) 
--- ---  1.81 
7 387  Colposcopy  age 
>40 
29.632% 
(387/1306) 
41 73  2.57 
12  377  Smear with non 
HPV 
97.416% 
(377/ 487) 
--- ---  2.57 
13 10  Smear  with  HPV  2.584% 
(10/387) 
--- ---  1.70 
8 174  Coploscopy  age   
33 
76.316% 
(174/228) 
8 33  1.73 
14  136  Smear with non 
HPV 
78.161% 
(136/174) 
--- ---  1.59 
15 38  Smear  with  HPV  21.893% 
(38/174) 
--- ---  1.79 
9  54  Coplscopy age > 
33 
23.684% 
(54/228) 
34 58  1.79 
16  42  Smear with non 
HPV 
77.778% 
(42/54) 
--- ---  1.77 
17 12  Smear  with  HPV  22.222% 
(12/54) 
--- ---  1.36 
3 105  Coploscopy 
negative 
6.406% 
(105/1639) 
--- ---  0.05 
18  104  History with non 
HPV 
99.048% 
(104/105) 
--- ---  0.05 
19 1  History  with  HPV  0.952% 
(1/105) 
--- ---  0.00 
 
From the node tree (Figure 4.2) and node summary table (Table 4.1), it is apparent 
that overall 93.594% of patients had positive colposcopy results and only 6.406% 
of patients had negative results from 1998 to 2006 in Portsmouth.  For the patients 
who had negative colposcopy results only 1% of the patients had a HPV history. 
Most patients had no HPV history (99%). Overall, 15% of patients who had 
positive colposcopy had HPV and 77% of them were below age 33. 85% of 
patients who had a positive colposcopy had no HPV and 70% of them were below 
age 40. Thus, over 66% (1,093/1,639) of positive colposcopy patients were under 
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women (e.g. 44% of cervical cancer patients were below age 45) (Moore-Higgs et 
al., 2000). 
 
The results show that age is one of the key factors associated with the colposcopy 
results. This is in accordance with previous studies which showed clearly that age 
and sexual behaviour are related to cervical cancer development (Moore-Higgs et 
al., 2000 Bosch and Iftner, 2005).  In addition, HPV was associated with the 
development of cervical cancer: HPV DNA was present in up to 99.7 percent of 
all cervical cancer cases, and infection with two common types of HPV (HPV 16 
and HPV 18) accounts for more than 50 percent of all cervical cancer cases 
diagnosed each year (Goldie et al., 2003). 
 
The main interest is to understand how HPV presence or absence is related to 
positive colposcopy results, and to identify which types of patients are likely to 
have positive colposcopy results (e.g. HPV present or absent). Therefore, the 
colposcopy results were subdivided into a few subgroups. In practice, it is 
possible to group patients from nodes 10, 11, 12 and 13 into one group, 
(representing patients with positive colposcopy but HPV absent). Nodes 14, 15, 
16 and 17 can be classified into a second group, (this group of patients had 
positive colposcopy and HPV present). Finally, nodes 18 and 19 can be classified 
into a third group (negative colposcopy and 99% of the patients had no HPV). 
From the CART results, patients from different groups may have different needs 
in terms of screening tests (e.g. screening interval) Different groups of patients 
may be assumed to have different probabilities of developing cervical cancer in 
the future and thus different diagnostic tests should be offered to different groups 
of patients. Such information can be utilised in decision tree and simulation 
models to estimate healthcare capacity and resources.  
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4.6 Decision tree model 
Some studies demonstrated that the type of diagnostic tests (e.g. LBC, HPV) and 
the combinations of tests relate to the effectiveness and the cost of the cervical 
cancer screening programme (Jenkins et al., 1996; Sherlaw-Johnson and Gallivan, 
2000; Sherlaw-Johnson and Philips, 2004). In this section, a decision tree model 
was developed to evaluate screening options for the UK national cervical cancer 
screening programme. Details and definition of each test can be found from 
Chapter 1, section 1.4.2. Various options can be evaluated using a sequence of 
three decisions: 
 
(i)  Current policy: no HPV test at all stages, thus, under the general 
decision tree model, the no HPV test option would be evaluated by 
using zero as the probability of a HPV test. 
(ii)  HPV test for mild, moderate, severe dyskaryosis and severe 
dyskaryosis/ suspected invasive cancer results only. 
(iii)  No colposcopy tests without HPV tests when the initial test results are 
abnormal. 
 
The structure of the necessary decision tree link to current cervical cancer 
screening policy is displayed in Figure 4.3. A decision node, represented by a 
square, indicates that a decision needs to be made at that point in the process. A 
chance node, represented by a circle, indicates that a random event occurs at that 
point. There is a decision node for the i th regular smear test. Other decision nodes 
are for decision, HPV test or an urgent smear test. Before starting to evaluate the 
screening options some information is needed: the number of women and 
probabilities of each possible outcome. The percentage and cohort size used in 
this chapter is a dummy dataset, which is due to lack of available information, but 
it demonstrated the possible use of the decision tree and the potential benefit of 
evaluating screening options.  
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test becoming available for these with mild dyskaryosis results, and the green line represents HPV test becoming available for those who had moderate and suspected 
dyskaryosis results.  
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Having constructed the decision tree, it is now possible to analyse the 
screening options. Firstly, assume that there are 100,000 patients to start 
with. The decision tree model was developed by using Visual Basic 
Application (VBA) within Excel. The analysis processes follow the 
following steps. 
 
1. Start at the left side of the decision tree and move right one column at a 
time. For each column, perform either step 2 or step 3 depending upon 
whether the nodes in that column are chance nodes or decision nodes. 
 
2. For each chance node, calculate the expected values, 
 
Expected value = 
n
i
i ix p        (4.4) 
 
Where  i p is the probability of  i x  and n is the number of possible outcomes. 
The probability can be estimated from data, if data are available. The 
decision with the best outcome (i.e. minimum number of tests) can be 
accepted as the appropriate decision.  
  
3. For each decision node, compare the expected values of its branches and 
choose the alternative whose branch has the largest or smallest expected 
values (it depends on the problem and, specifically whether the users want 
to obtain the maximum or minimum value). 
 
4.6.1 Model for evaluating cervical cancer screening options 
From the model (Figure 4.3), users can evaluate the number of smear tests, 
urgent smear tests, HPV tests and colposcopy tests needed for different 
screening options. Within the decision tree model, three risk groups were 
defined, (i) low risk, (ii) medium risk and (iii) high risk. The risk groups can 
be defined by the users. Three groups of patients (not an individual) were 
followed through the whole screening system. Therefore, patients within the 
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same group was assumed to have the same chance of moving from one node 
to the others. 
 
 The decision tree structure (Figure 4.3), based on VBA, allows users to 
estimate the total number of smear tests, HPV tests and Colposcopy tests 
required for each group, and each option. The basic logic within the 
decision tree model is explained in Figure 4.4. The number of patients in 
each node (Figure 4.3) was equal to the percentage for that node multiplied 
by the number of patients in the previous node. 
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Figure 4.4 Schematic diagram showing the basic calculation within the 
decision tree model. 
 
The user needs to enter the number of women (cohort size), the proportions 
belonging to each risk group from the total population, and the probabilities 
for each of the smear test results (positive, negative and inadequate); 
abnormal results (e.g. mild, moderate, severe dyskaryosis and cancer) and 
HPV test results. Details of the decision tree model within Excel are 
attached in Appendix C. 
  
4.6.2 Decision tree results 
Different events have different percentage values; for example, 80%, 15%, 
and 5% of the initial tests of the cohort of women of medium risk group will 
yield negative, abnormal, and inadequate results. Further, 50%, 35%, 10% 
Input: 
1.  No. of women 
2.  % of women in each risk 
group 
3.  % for each possible test 
result for each risk group 
(e.g. smear positive, 
negative) 
4.  screening option (e.g. i, 
ii, iii) 
Process: 
Calculation 
Output: 
1.  Total no. of 
routine smear 
tests 
2.  Total no. of 
urgent smear tests 
3.  Total no. of 
colposcopies 
4.  Total no. of HPV 
tests 
Calculation: 
Example: Low risk group 
 
1. No. of women in low risk group = No. of women * % of women in low risk group 
2. No. of positive smear tests given for the low risk group = No. of women in low risk 
group * % of positive smear tests from the low risk group 
3. No. of colposcopies for low risk group = 

n
i
results smear positive of no
1
        . , 
where i = 1, 2,… n the number of risk groups 
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and 5% of the women who had abnormal results will have mild dyskaryosis, 
moderate dyskaryosis, severe dyskaryosis, or severe dyskaryosis/suspected 
invasive cancer. At any stage, the various percentages add up to 100%. In 
the decision tree model, “initial smear test” means the first smear test when 
a woman enters the national cervical cancer screening programme. Urgent 
smear test is used to represent a necessary smear test after the initial smear 
test. For example, if a woman has an inadequate smear at the initial test, and 
needs to take another smear test within a short period; this is classified as an 
urgent smear test. Table 4.2 shows the probabilities of each possible smear 
test result of various risk groups and the general population. The detailed 
calculations are attached in appendix C. 
 
Table 4.2 Dummy dataset of risk groups, a set of dummy data were used to 
explain and demonstrate the use of decision tree model, due to the lack of 
available data. 
Risk groups  Negative smear  Abnormal  Inadequate 
Low  90% 5%  5% 
Medium  80% 15% 5% 
High  60% 35% 5% 
General 
population 
77.5% 17.5% 5% 
 
The percentages used in this chapter represent a dummy dataset, since this 
information is not available. However, the dataset demonstrated the possible 
use of the decision tree and potential benefit for evaluating screening 
options. The decision tree model was used to evaluate a variety of options. 
Assume there is a cohort of 100,000 women, with 50%, 25% and 25% of the 
population from low, medium and high risk groups respectively with the 
general population percentage of 77.5%, 17.5 and 5% for negative, 
abnormal and inadequate results at the initial smear test. There were three 
options listed in section 4.6; current policy, HPV test and no HPV test. In 
the general decision tree model, the no HPV test option would be evaluated 
by using zero as the probability of a HPV test.  
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Results are shown in Table 4.3. The various options require different 
numbers of tests (e.g. smear, urgent smear, HPV and colposcopy). Option 1 
(12,966) required the least number of tests and option 2 (132,681) required 
the largest number of tests in total. However, option 3 provided the largest 
percentage of positive colposcopies, where the percentage of positive 
colposcopy tests is equal to the total number of positive colposcopy tests 
divided by the total number of colposcopy tests. In terms of the efficiency of 
positive colposcopy tests, option 3 provides the largest percentage with the 
smallest number of colposcopy tests in total. Therefore, option 3 is the most 
effective option in this situation, given that we want to minimise the number 
of colposcopy tests. When the probabilities change the final option may 
change. 
 
 Table 4.3 Decision tree results for different screening options. 
 
It can be seen that, in this simple example, option 3 is the most effective, 
because it provides the largest percentage of positive colposcopy tests 
(66.4%). 
 
The percentage information can be changed within the built-in interface, 
where users need to enter the percentage into the interface before starting to 
run the model.  
 
Summary Initial 
smear 
test 
Urgent 
smear 
test 
HPV 
test 
Colposcopy Positive 
colposcopy 
Total tests 
(smear, 
HPV and 
colposcopy)
Option 1  100,000 14,000  0  15,663  8,466 
(54%) 
129,663 
Option 2  100,000 7,875  11,900 12,906  6,829 
(52.9%) 
132,681 
Option 3  100,000 7,875  11,900 9,336  6,199 
(66.4%) 
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4.7 Simulation model 
Simulation is a widely used and effective tool for the analysis of complex 
systems, and also to manage the screening system. Examples of simulation 
application include the prevention of and treatment for diabetic retinopathy 
and HIV studies (Harper, 2002; 2003). Some simulation studies have 
demonstrated that human behaviour may affect the healthcare results and a 
simulation can capture and describe such factors as human behaviour in the 
model (Brailsford et al., 2006). Other research has shown that the 
simulation model can provide a way of investigating the needs of NHS 
services at different geographical locations (Harper et al., 2005).  This is 
because of the complexities involved; it is not easy to provide an accurate 
model to capture the real situation. An alternative approach is to use 
simulation. Simulation models can also be used to forecast workforce and 
resource needed (Powell and Harper, 2004; Harper et al., 2005) 
 
Simulation may be defined as a technique that imitates the operation of a 
real world system as it evolves over time. A simulation model usually takes 
the form of a set of assumptions about the operation of the system, 
expressed as mathematical or logical relations between objects of interest in 
the system. In particular, when modelling a patient’s pathway, similar 
patients can be grouped into sub-groups according to their behaviour, so that 
the focus is on individual patients passing through the healthcare system.  
The simulation process involves executing or running models through time 
on a computer, which generates representative samples of the measures of 
performance. In this respect, simulation may be seen as a sampling 
experiment on the real system, with the results being sample points.  
 
In most simulation studies, users are concerned with the simulation of a 
system or a particular part of that system at a particular point in time. Thus, 
in order to model a system, users must understand the concept of a system. 
The patient-flows will be simulated over time, and each of the patients will 
be followed through over the whole simulation period. The simulation 
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within the current system as well as estimate the capacity and resources 
required. 
 
There are two common model frameworks, which are the Markov and 
Semi-Markov models. When time parameters are not available the Markov 
model is suitable to describe patients’ activities; otherwise, the Semi-
Markov model can be used. The Markov and Semi-Markov models are 
discussed in the next two sub-sections. Details of the simulation model are 
attached in Appendix D. 
 
For the pre-cervical cancer process, the parameter space T is countable (e.g. 
healthy, CIN 1, CIN 2, CIN 3, cancer and death). Thus, for the pre-cervical 
cancer process the Markov chain with discrete parameter state is the most 
appropriate. In this section, a Markov chain model will be fitted to describe 
the pre-cervical cancer process. The simulation is shown in Figure 4.5 
(Goldie et al., 2003). 
 
 
Figure 4.5. Cervical cancer disease model, describing how each healthy 
female could flow through the process (e.g. from health to CIN 1). 
 
To model the pre-cervical cancer disease process, the Markov chain may not 
be an ideal choice, because of the memory-less property and the fixed 
distribution assumptions. The disease growth process does depend on the 
Healthy  CIN 1  CIN 2  CIN 3  Death  Invasive 
cancer 
Remaining in the 
current state 
Transiting from one 
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previous states (more specifically, the present disease state depends on the 
previous disease state or states). Therefore, an alterative model needs to be 
introduced, called the semi-Markov chain. If the information on holding 
time is available for the above model (Figure 4.5), it is possible to construct 
a semi-Markov chain model. The model parameters and probabilities 
function applied in this section are a dummy dataset, which is due to lack of 
available information, but again it demonstrated the possible use of the 
simulation models. 
 
4.7.1 Simulation results 
The simulation model was developed in VBA within Excel; it demonstrated 
the possible use of the Semi-Markov model, when transition probabilities 
and holding time are available from clinical data. However, this information 
was not available at the time of writing; therefore, a set of dummy 
distributions were used in the simulation model. 
 
Users are required to enter some information to start simulating a group of 
patients’ flows through the disease system; e.g. simulation period in weeks, 
distribution for describing the chance of developing abnormal cells (e.g. 
Binomial), and distribution of length of stay in each state (e.g. Weibull). A 
set of simulated results is shown in Table 4.4. 
 
Table 4.4 Summary of simulation results. 
Information Simulated  Results 
Simulation period  900 weeks 
Simulated population  90,000 
Number of patients with positive smear results  9,034 
Length of stay in CIN 1  21-33 weeks 
Length of stay in CIN 2  14-21 weeks 
Length of stay in CIN 3  6-11 weeks 
 
 Chapter 4 Model for early detection of cervical cancer through cervical 
cancer screening programme 
  71 
4.8 Summary 
CART was used to divide the population into risk groups of developing 
cervical cancer; each individual person within the same group shares the 
same common characteristics (i.e. personal risk factors). Those 
characteristics determined the chance of developing cervical cancer in the 
patients’ life time. Patients from different risk groups may have different 
probabilities of developing cervical cancer. By identifying the risk factors it 
helps in understanding which factors are related to cervical cancer. 
 
Decision tree models help in evaluating screening options, when the policy 
makers face the situation of selecting the option which can maximize the 
returns (i.e. detecting more cases at the early pre-cervical cancer states) and 
minimize the number of tests. Such a method allows examination of which 
is the best option to increase the efficiency of the programme. Simulation 
allows understanding the natural disease process; it also allows to evaluate 
screening options if transition probabilities and holding times are available. 
 
Therefore, all the above techniques demonstrated the possible way to 
identify the patient’s common risk characters with different probabilities in 
developing cervical cancer in their life time. The combinations of both 
personal and national risk factors provide greater understanding of the 
associated risk factors of cervical cancer development. 
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Chapter 5 Cervical cancer regression study 
 
 
5.1 Introduction 
The cervical cancer screening programme in the UK was set up in 1988; the 
screening programme works effectively to reduce the risk of cervical cancer 
through detection of early pre-cancerous stages. In this context, it would be 
interesting to understand the relations between cervical cancer disease risk, and 
deprivation, social status and family structure factors. Knowledge of such 
relations may be of use in planning screening programmes to reduce risk and to 
target the necessary resources in order to increase the efficiency of the screening 
programme. Within the UK there is marked geographical variation in the cervical 
cancer incidence rate. This chapter demonstrates that individuals may have 
different risks of developing cervical cancer as a function of various personal (e.g. 
age, social status) and family structure variables and also the surrounding 
deprivation conditions. Certain geographically varying deprivation, social grade 
and family structure factors can provide valuable information about human 
behaviour and this behaviour may have implications for the likelihood of 
developing cervical cancer. The cervical cancer data were provided by the UK’s 
Public Health Observatories (PHO). The deprivation, social grade and family 
structure variables were provided by the UK census 2001. Details of the data were 
given in Chapter 3. 
 
The Poisson distribution is the most appropriate distribution to describe the 
underlying disease distribution for rare diseases (Richardson, 2003; 2004). Three 
types of regression model were applied in this chapter; the preliminary stage of 
this chapter used (i) generalised linear modelling to investigate the relationship 
between cervical cancer and indicator of social deprivation, social grade and 
family structure factors across England at the global level; (ii) a Bayesian 
hierarchical model was used to model the relationship between cervical cancer 
incidence and the same variables, and (iii) geographically weighted regression 
(GWR), was used to analyse the locally varying relationship between cervical 
cancer incidence, each variable was modelled as non-stationary. 
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Based on the results, it is possible to see, at least in principle, how the national 
screening programme could be made more efficient and effective by adapting 
deprivation indicator, social grade and family structure factors locally as a 
function of dividing the population into a number of risk groups according to the 
national and (or) personal common characteristics. For example, in Chapter 4, 
CART was used to divide patients into risk groups according to their personal 
characters. Combining both personal and national characters (i.e. risk factors) 
allows an understanding of potential risk factors, which are associated with 
cervical cancer development in a woman’s life time.  
 
The aim of this chapter was to use various regression models to examine the 
relationship between cervical cancer incidence and explanatory variables. The 
specific objectives of this study were (i) to explore geographical variation in 
cervical cancer incidence across England through various regression models at the 
district and unitary authority levels (where a district is smaller than a unitary 
authority) and (ii) attempt to explain the geographical variation through the 
explanatory variables.  
 
 
5.2 Data 
Two sets of data were included for analysis; cervical cancer count data for 2004 
and explanatory data for 2001. The data are represented at district and unitary 
authority levels in England. A total of N regions was considered, where N = 354. 
For each region i = 1,2,…, N cells, let  i Y  be the incidence (i.e., number of cervical 
cancer cases) and  i e  be the expected cases for region i. However, any observed 
data between zero to five cases were closed to protect the patients. Therefore, such 
missing data were treated as truncated missing data between 0 to 5. The methods 
to overcome the missing data are discussed in detail in each of the regression 
sections. The expected number of incidence cases is around 21.56 cases per 
region. At the beginning of this study the data were subjected to a Chi-square 
goodness of fit test, which showed that the data approximately followed a Poisson 
distribution. 
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The expected cases were calculated by using the normalized incidence rate  j r per 
age group from the Cancer Research UK data (Cancer Research UK 2005). This 
rate was normalized by multiplying by the ratio between total cervical cancer 
cases (the data used here) and new diagnosed cases (~2.4) the data used in the 
Cancer Research UK rates. The normalized rate was then multiplied by the female 
population  ji p within that age group in region i, where j is the age group. The 
female population per age group was determined from the 2001 UK Census of 
those aged between 0 and 85 and over. The expected cases were calculated as 
shown in equation 5.1. 
 
 
j
ji j i p r e      where  j =1, .. 85+, i = 1, …, 354      (5.1) 
 
where j is the age group (e.g. age 0 to 4, 5 to 9 … 85 and over) and i is the number 
of study regions. 
 
The Townsend index was constructed using four socio-economic variables: (i) 
unemployed population, (ii) household with no car/van, (iii) households not 
owned, and (iv) over-crowded housing (over one person sharing one room). The 
index was used as an individual variable in the regression models and other 
variables representing family structure and social grade were applied in the 
regression models. Details of data can be found in chapter 3. All explanatory 
variables are represented as proportions of the total population. The maps of each 
Townsend, social grade and family structure variables are displayed in Figure 5.1.  
 
Figures 5.1a and 5.1b show greater percentages of unemployment and households 
without a car in the Midlands and the North of England. Figure 5.1c shows a less 
spatially structured pattern for percentage of households not owned while Figure 
5.1d shows that some of the major cities (e.g. London, Manchester) have a greater 
density of people per room with potential overcrowding problems. Figure 5.1e 
shows a high percentage of lower social grade population in North and Midland 
areas. Figure 5.1f and 5.1g show more single population found in major cities and 
higher percentage of married population found in the rural areas. Figure 5.1h and 
5.1i have very similar patterns, because a large proportion of lone parents are 
female lone parents. Chapter 5 Cervical cancer regression study 
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(a)       (b) 
 
(c)       (d) 
 
(e)       (f) 
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(g)       (h) 
    
      ( i )         
 
Figure 5.1. (a) percentage unemployed, (b) percentage of households with no car, 
(c) percentage of households not owned and (d) percentage of rooms occupied by 
more than one person, (e) percentage of socio-grade VI and V, (f) percentage of 
married female population, (g) percentage of single female population, (h) 
percentage of all lone parents households, and (i) percentage of female lone 
parents households. 
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5.3 Analysis 
5.3.1 Exploratory analysis 
Figure 5.2 show scatter plots between incidence and expected cases. While the 
relations between the observed and expected cases are clearly linear, there is a fair 
degree of scatter indicating that some variables other than expected cases or 
population may be affecting incidence. The two points at the extreme top-right of 
the plots represent Birmingham and Leeds. 
   
 
Figure 5.2 Incidence plotted against the expected cases for England 2004. 
 
It is helpful to estimate the correlations between incidence and explanatory 
variables, which show how all variables are correlated together and whether the 
relationships are positive or negative. Table 5.1 and Figure 5.3 show the 
correlation values between incidence and explanatory variables. Most of the 
variables are positively correlated and proportion of married population is 
negatively correlated to incidence cases, apart from the Townsend index which is 
less correlated to other variables.  
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Table 5.1 Correlations between incidence cases and Townsend index score, low 
socio-grade and family structure proportion variables. 
Correlations 
(p-values) 
Incidence 
cases 
Townsend 
index score 
Proportion 
of female 
married 
population 
Proportion 
of female 
single 
population  
Proportion 
of all lone 
parent 
household  
Proportion 
of female 
lone 
household  
Townsend 
index score 
0.386 
(0.000) 
     
Proportion of 
female 
married 
population 
-0.418 
(0.000) 
-0.841 
(0.000) 
    
Proportion of 
female single 
population 
0.418 
(0.000) 
0.841 
(0.000) 
-1.00 
(0.000) 
   
Proportion of 
all lone parent 
household 
0.523 
(0.000) 
0.639 
(0.000) 
-0.714 
(0.000) 
0.714 
(0.000) 
  
Proportion of 
female lone 
household 
0.523 
(0.000) 
0.646 
(0.000) 
-0.720 
(0.000) 
0.720 
(0.000) 
0.998 
(0.000) 
 
Proportion of 
G4 + G5 
0.401 
(0.000) 
0.331 
(0.000) 
-0.307 
(0.000) 
0.307 
(0.000) 
0.685 
(0.000) 
0.680 
(0.000) 
 
 
 
Figure 5.3 Matrix plot showing the relationships between variables.  
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The box-plots in Figure 5.4 show the variation within and between PHOs in 
incidence and mortality measured at the district or unitary authority level. The 
variables plotted are purely the number of incidence cases and death cases, with 
no information provided on the age structure or population size. Therefore, the 
plots need to be interpreted with care. The number of districts (or unitary 
authorities) per PHO is shown in Table 3.1. From Figure 5.4, it can be seen that 
the Yorkshire and Humber PHO had a large median and inter-quartile range 
compared with other PHOs.  
(a) 
 
(b) 
 
Figure 5.4. Box-plot of cervical cancer (a) incidence and (b) mortality per PHO, 
England 2004. 
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5.3.2 Townsend index 
The Townsend index was applied again in this section and details of  the 
calculation can be found from Chapter 2. Figure 5.5 shows the Townsend index 
for England in 2001. The Townsend index was used directly in all regression 
models as an individual explanatory variable,  
 
However, there are some drawbacks of using Townsend index, as follows:  
 
(i)  It is not possible to distinguish between individuals who are not able to 
buy a car or those who do not need a car. For example, those who live 
in a main city (e.g. London) may not need to have a car, since public 
transportation is more convenient, 
(ii)  It is also not possible to distinguish between individuals who are not 
able to buy a property and those who do not want a property. It is more 
common for people who live in a main city to rent a house than buy a 
house. 
 
 
 
Figure 5.5. Townsend index, England 2001. North of England and Midlands have 
a larger Townsend index than the south. Southern areas in particular have a 
smaller Z. However, the areas near London have higher deprivation which is due 
to the main drawback of using a deprivation index.  
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5.4 Generalised linear regression model (GLM) 
5.4.1 Truncated missing data 
The 21 regions were truncated, which were treated as missing data (i.e. NA). In 
this section, all NA data were excluded from the GLM model. The more technical 
methods to overcome the truncation missing data are described in the next two 
sections of this chapter. 
 
5.4.2 Methods  
Various types of regression techniques are available to model the relations 
between variables.  Generalised linear modelling (GLM) is a popular statistical 
modelling tool for exploring relationships between the observed (cervical cancer 
incidence) and explanatory variables (Gatrell and Bailey, 1996; Elliott et al, 
2000). The outcomes from the models provide a summary of the complex 
geographical relations that may exist. 
 
For the study of cervical cancer, it was assumed that the data (incidence) represent 
a set of observed counts arising from a Poisson process (i.e., the data  N Y Y Y ,..., , 2 1  
in regions 1, 2, …, N are mutually independent Poisson random variables). In 
addition, the population counts for each region are assumed fixed (i.e. non-
random variables), denoted  N p p p ,..., , 2 1 and  i r  denotes the assumed constant risk 
(McCullagh and Nelder., 1952). The relevant simple Poisson regression equation 
with offset variable is given (McCullagh and Nelder, 1952; Nakaya et al., 2005). 
 
) ( ~ i i Poisson Y   
) exp( ˆ
1
0 i
T
t
ti t i i v e Y       

   F o r   i = 1, 2,…, N       (5.2) 
 
where  i Y   is the observed value at location i,  i e   is the expected cases,  o   is  a 
constant term (i.e. intercept),  t   measures the relationship between the observed 
and explanatory variables, the  ti v  are the explanatory variables, and  i   is the error 
term associated with location i, which is independent and normally distributed 
with mean of 0 and variance 
2
i  .  Chapter 5 Cervical cancer regression study 
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The Chi-square test provides a method to test the level of significance between the 
observed cases and the Townsend index and explanatory variables. Hypotheses 
may be set up such as to test the association between the observed and 
explanatory variables. The test statistic is given below:  
 




N
i i i
i i
Y
Y Y
ˆ
) ˆ (
2
2                   ( 5 . 3 )  
Where  i Y ˆ  is the estimated cases per region, i =1, 2, …, N. 
 
The observed variable was:     
1.          Incidence, NA was excluded 
 
The explanatory variables were: 
1.          Townsend index score 
2.  Proportion of female married population 
3.  Proportion of female single population 
4.  Proportion of all households with a lone parent 
5.  Proportion of households with a female lone parent 
6.  Proportion of Social grade IV and V population 
 
Each individual explanatory variable was used in GLMs, to predict observed 
variable. The most significant variable was added into each model at each step, 
until the p-value was larger than the significance level (i.e. 0.05), in which case, 
the last variable was removed and the final model accepted.  
 
5.4.3 Generalised linear modelling 
Incidence cases and observed indirectly standardised incidence ratio (SIR) (with 
excluded missing data) were mapped in Figure 5.6, the cervical cancer incidence 
cases and SIR vary with location. For example, East Lindsey, North East 
Lincolnshire, Hartlepool, Sedgefield and Barrow-in-Furness had the largest 
cervical cancer incidence in 2004. Townsend index and other explanatory 
variables were investigated as explanatory variables within a GLM framework. 
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Firstly, the explanatory variables were treated in isolation, entered as a single 
explanatory variable into the GLM. Ten GLM models involving six explanatory 
variables were fitted (Table 5.3). Secondly, incidence was fitted with a single 
GLM as described in Table 5.3. The results suggest that all single variables were 
significantly related to the observed variables. 
 
(a)       (b) 
 
Figure 5.6. (a) Observed cervical cancer cases per region. The regions highlighted 
in yellow represent regions with missing data, (b) observed SIR per region. A few 
places have large incidence (e.g. West Devon, West Wiltshire, Sedgefield) 
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Table 5.2 (a) Summary of GLM (b) the intercept and coefficient values for each 
explanatory variable, where the regions with missing data were excluded from the 
modelling.  
 
(a) 
Model Variables  Std.Error  t-value  P-value 
1  Townsend index score  0.002285586  2.717489  0.006983208 
2  Proportion of female married population  0.21514951  -3.152812  0.001723092 
3  Proportion of female single population  0.2151495  3.152812  0.001723092 
4  Proportion of household with lone parent  0.61764346  10.248450  0 
5 
 
Proportion of households with female lone 
parent 
0.64785344   10.035571  0 
6  Proportion of low social grade (IV+V) 
population 
0.17947345 15.29755  0 
0.19102757 15.135210  0  7 
 
Proportion of low social grade (IV+V) 
population 
+ Townsend index score 
0.00254778 -2.263933  0.02246866 
0.877438931 10.914176  0  8  Proportion of household with female lone 
parent 
+ Townsend index score 
0.003206611 -5.110045  2.015673e-007 
0.004338032 0.07847839  0.0069832  9 
 
Townsend index score 
+ proportion of female married population  0.407034440 -1.59990279 0.1101383 
0.004338032 0.07847839  0.0069832  10 
 
Townsend index score+ proportion of female 
single population  0.407034440 1.59990279  0.1101383 
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(b) 
Model   Variables 
0    1    2   
1  Townsend index score  0.233497811  0.006211054   
2  Proportion of female married population  0.5236252  -0.6783260   
3  Proportion of female single population  -0.1547008  0.6783260     
4  Proportion of household with lone parent  -0.1713738  6.3298879   
5  Proportion of households with female 
lone parent 
-0.1424144 6.5015793  
6  Proportion of low social grade (IV+V) 
population 
-0.6820043 2.7455034  
7 
 
Proportion of low social grade (IV+V) 
population + Townsend index score 
-0.722888707 2.891242526 -0.005768002 
8 
 
Proportion of household with female lone 
parent + Townsend index score 
-0.30106881 9.57652309 -0.01638593 
9 
 
Townsend index score  
+ proportion of female married 
population 
0.5118985113 0.0003404418 -0.6512155378 
10 
 
Townsend index score  
+ proportion of female single population 
-0.1393170265 0.0003404418 0.6512155378 
 
The final fitted models were models 1 – 6 in Table 5.2 and Figures 5.7 to 5.12. 
Models 7 and 8 in Table 5.2 were not accepted as the best fitted models, because 
some of the coefficients changed from positive to negative. For example in model 
7 the coefficient of Townsend index score changed to negative. However, prior 
expectation would be that the relation with Townsend index to be positive. 
Further, the relationship between observed cases and Townsend index is 
positively related in Table 5.1. For these reasons models 7 and 8 were not 
accepted as the best fitted model. For models 9 and 10 the P-value are larger than 
0.05 (5%). Therefore, the models were not accepted. Figures 5.7 to 5.12 show 
diagnostic statistics for each of the significant GLM models and the maps 
highlight that the North of England, Midlands and West of England had larger 
SIR from the fitted models. Some regions with larger Townsend index scores 
(greater deprivation) also had higher predicted SIR.  
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(b)       (c) 
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Figure 5.7. (a) Predicted SIR from model 1 in Table 5.2, (b) incidence plotted 
against fitted value and (c) normal plot for GLM predicting incidence when the 
missing data are excluded from the modelling. 
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Figure 5.8. (a) Prediction SIR from model 2 in Table 5.2, (b) incidence plotted 
against fitted value and (c) normal plot for GLM predicting incidence when the 
missing data are excluded from the modelling. 
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(a) 
 
  (b)       (c) 
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Figure 5.9. (a) Prediction SIR from model 3 in Table 5.2, (b) incidence plotted 
against fitted value and (c) normal plot for GLM predicting incidence when the 
missing data are excluded from the modelling. 
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Figure 5.10. (a) Prediction SIR from model 4 in Table 5.2, (b) incidence plotted 
against fitted value and (c) normal plot for GLM predicting incidence when the 
missing data are excluded from the modelling. 
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( a )         
 
( b )        ( c )      
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Figure 5.11. (a) Prediction SIR from model 5 in Table 5.2, (b) incidence plotted 
against fitted value and (c) normal plot for GLM predicting incidence when the 
missing data are excluded from the modelling. 
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Figure 5.12 (a) Prediction SIR from model 6 in Table 5.2, (b) incidence plotted 
against fitted value and (c) normal plot for GLM predicting incidence when the 
missing data are excluded from the modelling. 
 
GLM results showed that at the global level there is a significant relation between 
cervical cancer, Townsend index, proportion of social grade IV and V, proportion 
of single female, married female population and proportion of household with 
lone parent. The regions with higher Townsend index, larger proportion of 
population at low social grade, larger population of single female population, and 
also larger proportion of lone parent is likely have higher incidence rate. 
However, for the proportion of female married population is the other way 
around, when the proportion of female married population increase the incidence 
rate decrease. Such summary showed the chance of developing cervical cancer 
related personal marital status It would be more interesting to investigate further if Chapter 5 Cervical cancer regression study 
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spatial information was taken into account, thus, in the next section the Bayesian 
approach is used to predict the incidence rate when the uncertainties are taken care 
of using prior distributions. Spatial information will be adopted in the regression 
models; therefore, it allows the spatial pattern and the spatial variation in cervical 
cancer incidence to be studied. As the literature showed deprivation is highly 
related to chance of developing disease (Rees et al., 2002). 
 
 
5.5 Bayesian regression model 
Bayesian modelling has been demonstrated to be useful for analysing many types 
of complex epidemiological and biomedical data; examples include it being used 
to explore the relation between deprivation and socio-economic status (Abellan et 
al., 2007) and mortality with income (Nakaya and Dorling, 2005), and estimating 
the disease relative risk (Richardson et al., 2004). In this section, the framework 
of Bayesian hierarchical modelling was used to model the relationship between 
cervical cancer incidence rate and a range of deprivation, social grade and family 
structure factors across England. Three types of non-spatial and spatial models 
were used in the Bayesian framework. (i) non-spatial, (ii) BYM spatial, and (iii) 
MIX spatial models (e.g., the influence of the prior structure specified and the 
amount of smoothing of the risks actually performed). Interesting questions 
related to the performance of the models were investigated and discussed in the 
discussion Chapter 9. 
 
5.5.1 Truncated missing data 
On average, there are 21.56 incidence cases per study region. The data were 
represented at the district and unitary authority levels of the Cancer Registries in 
England. Twenty one regions had observed cases between zero to five cases. For 
confidentiality reasons, these 21 (6%) observed data were closed. It is common 
to have closed or missing data in disease studies. In practice, it is possible to 
exclude or remove those 21 disclosed observed data from analysis; however, it 
could cause an amount of information to be discarded. It reduces the prediction 
power and the ability to detect the association or relation between the observed 
and the explanatory variables (Lunn et al., 2006). All these undisclosed data were Chapter 5 Cervical cancer regression study 
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treated as missing data and were computed through the Bayesian modelling by 
borrowing information from the first order neighbours. Prediction for these 21 
regions was restricted to between zero and five cases.  
 
5.5.2 Methods 
A Bayesian regression method was applied in this study to explore the 
relationship between the observed cervical cancer incidence rate and the 
explanatory variables (a series of deprivation, social status and family structure 
variables). The final models provide a summary of the complex geographical 
relations. 
 
A hierarchical framework has been used in many spatial disease studies, 
especially for those diseases that have smaller counts in small study regions. 
Incidence cases and incidence rate were estimated through a Bayesian approach. 
The model is defined below: 
 
) ( ~ i i Poisson Y  ,       where  i = 1, 2, …, N        (5.4) 
 
5.5.3 Model definition 
The study area, England, was defined as D, which was split into 354 study regions 
i d , so  } { D di   for i =1, 2, …, 354. With the Poisson assumption  i Y  is assumed 
to be independently distributed with mean  i  , indirectly standardised incidence 
ratio (SIR)  i  , and expected cases  i e . The model is defined below: 
 
) ( ~ i i Poisson Y       
i  = i i e           
i
i
i e

  ˆ                   ( 5 . 5 )  
 
The closed or unobserved data were treated as a censoring problem, re-computed 
or re-estimated by borrowing information from a prior distribution ) ( p , and also 
the neighbouring data. Lower and upper limits were specified for the closed data. Chapter 5 Cervical cancer regression study 
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5.5.4 Model assumptions 
In the spatial model, incidence i Y  is assumed to be conditionally independently 
distributed with standardised incidence ratio  i  , which is also a positive random 
variable. Townsend index, low social status and the family structure variables 
were taken into account in the models. Each of the variables was tested 
individually in the analysis. The model was defined below: 
 
) ( ~ i i i i e Poisson Y                   ( 5 . 6 )  
 
It is common to use expected cases  i e  to be the offset; Two types of model were 
applied in this study; (i) non-spatial, and (ii) spatial conditionally auto-regressive 
(CAR) models. The structure and the advantages of these two types of models are 
now discussed briefly. 
 
5.5.5 Non-spatial model 
Spatial information is not specified in the non-spatial model. Every region is 
assumed to be the same (i.e. no difference in terms of location). No 
neighbourhood information is available in the model, such that the model provides 
only global and average information to the users. It is also assumed that no effects 
are contributed by the direct neighbourhood; each of the regions is completely 
independent. Such a model is useful only if the underlying model has no spatial 
variation, because the non-spatial model only gives average estimated parameters, 
which do not vary over space. The non-spatial model was defined below: 
 
i
t
ti t i i v e          0 log log  
) exp( 0 i
t
ti t i v                 ( 5 . 7 )  
 
Where  0  is the intercept of the regression model,  t   is the coefficient of the 
explanatory variable  ti v  and  i   is the unstructured heterogeneity (random effect). 
Figure 5.13 shows the linkage between variables and parameters. Chapter 5 Cervical cancer regression study 
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Figure 5.13 The link between variables and parameters in the non-spatial model. 
 
5.5.6 Spatial model 
Spatial models provide an underlying model with given observed spatial data, 
which can be used to predict the underlying incidence rate with the available 
spatial information. The conditionally autoregressive (CAR) model was 
introduced by Besag et al, 1991. CAR models are commonly used by statisticians 
and epidemiologists and it is facilitated within WinBUGS. Information from 
direct neighbours is taken into account. The weighting function  ij w of all the direct 
neighbours has an equal weight of one (Lawson et al., 2003): 
 




otherwise
i of neighbour direct is j
wij            , 0
                       , 1
              (5.8) 
 
Where  ij w   is the weighting function for measuring the association between 
regions i and j. There are two common CAR model settings, which are BYM and 
MIX as described above. 
 
(i) BYM spatial model 
In the BYM model,  BYMi  ˆ  was defined as the indirectly standardised incidence 
ratio.(SIR). Instead of modelling directly the correlation between log incidence 
i Y  
i   
0   
i   
ti v  
t   
i e  
i       
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standardised ratio log BYMi  ˆ  as an independent function and several covariates, an 
alternative approach is to model the conditional independence between incidence 
rates in different areas. Area-specific random effects are decomposed into two 
components. The first component is  i   the uncorrelated heterogeneity; this is the 
part measuring unstructured variation between areas. The second is  i  ; this is the 
component that models the structured variation in space (i.e. clustering component 
or correlated heterogeneity). The model is defined as below and the model 
structure is described in Figure 5.14: 
 
i
t
ti t i i v e          0 log log                         (5.9) 
i i i                    ( 5 . 1 0 )  
) exp( ˆ
0 i
t
ti t i v                     ( 5 . 1 1 )  
 
The prior distributions of uncorrelated and correlated heterogeneity  i  and  i   are 
specified below: 
 
) , 0 ( ~    Normal i              ( 5 . 1 2 )  
) , 0 ( ~    Normal i              ( 5 . 1 3 )  
 
For the clustering component, a spatial correlation structure is used. Estimation of 
the posterior mean of incidence standardised ratio  BYMi  ˆ  in any area depends on 
neighbouring areas. 
 
The parameters     and     control the variability of clustering component  i   and 
correlated heterogeneity i  . The prior distribution of these two parameters can be 
specified, and the Gamma distribution is the most common choice as suggested by 
Bernardinelli et al., (1995).  
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  Figure 5.14 The link between variables and parameters in the BYM model. 
 
(ii) MIX spatial model 
The BYM method is used to analyse the incidence rate in small areas and it is 
considered as a smoothing technique. However, such models could over smooth 
the spatial incidence rate where large discontinuities exist in the risk surfaces. 
Therefore, in both theory and practice, it is important to maintain the 
discontinuities and smoothness within the model and maps. Thus, a special type of 
spatial mixture model (MIX) was introduced by Lawson and Clark (2002). This 
spatial mixture model allows both smoothness and discontinuities and admits 
different forms of spatial variation. 
 
Within the BYM model, the non-spatial model has one random effect component 
and the spatial model has two random effect components. The MIX spatial model 
has four components. One of them is  i  ; unstructured heterogeneity that measures 
the over-dispersion in an individual region. This is assumed to be a fixed 
component. Two of them are  i   and  i    the mixing components. These two 
components represent different aspects of spatial correlation. Figure 5.15 
describes the link between the parameters. The final one  i   models  discrete 
jumps. If all the  i  =1, the MIX model is the same as the standard BYM model. If 
all zeros, the model is called pure jump (Lawson et al., 2002; 2003). 
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Figure 5.15 The link between variables and parameters in the MIX model. 
 
The model is defined as below: 
 
i i i i i
t
ti t i i v e         ) 1 ( log log 0                   (5.14) 
) ) 1 ( exp( ˆ
0 i i i i i
t
ti t MIXi v                         ( 5 . 1 5 )  
 
The jump  i   is given a prior i. It examines the total absolute difference between 
neighbours: 
 
) 5 . 0 , 5 . 0 ( ~ Beta i               ( 5 . 1 6 )  
 
5.5.7 Analysis and results 
In this section, three Bayesian hierarchical models ((i) non-spatial, (ii) BYM 
spatial, and (iii) MIX spatial models) were applied to explore the relation between 
cervical cancer SIR and deprivation, social grade and family structure variables at 
the district or unitary authority level in England in 2004. All the Bayesian models 
are listed in Table 5.3 – Table 5.5 and mapped in Figure 5.16-5.18. 
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Table 5.3 Summary of non-spatial Bayesian Poisson regression models. 
(a) 
Model Variables 
0   (95% CI)  1   (95% CI)  2   (95% CI) 
1  Townsend index score  0.1636 
(0.1234, 0.2025) 
0.01053 
(0.002544, 0.01852) 
 
2  Proportion of female single 
population 
-0.3838 
(-0.8746, -0.01081) 
0.9622 
(0.3185, 1.813) 
 
3 Proportion  of  female  married 
population 
0.6039 
(0.2765, 0.9457) 
-1.023 
(-1.823 ,  -0.2605) 
 
4  Proportion of household with 
lone parent  
-0.3003 
(-0.4389, -0.1673) 
7.724 
(5.672, 9.869) 
 
5  Proportion of household with 
female lone parent 
-0.2644 
(-0.3935, -0.1391) 
7.916 
(5.776, 10.15) 
 
6  Proportion of low social grade 
(IV+V) population 
0.1527 
(0.1143, 0.1897) 
0.08666  
(0.05574, 0.1177) 
 
7  Proportion of household with 
female lone parent + proportion 
of low social grade (IV+V) 
population 
-0.1993 
(-0.3521, -0.04974) 
6.61 
(3.935, 9.324) 
0.03217 
(-0.004757, 0.06884) 
8 
 
Proportion of household with 
female lone parent + Townsend  
index score 
-0.4194 
(-0.5871, -0.2586) 
10.9 
(8.034, 13.86) 
-0.01569 
(-0.02589,-0.005774) 
9  Proportion of household with 
female lone parent proportion + 
proportion of female single 
population 
0.729 
(0.3631, 1.219) 
12.81 
(9.965, 16.13) 
-2.195 
(-3.254 ,  -1.433) 
10  Proportion of households with 
female lone parent + proportion 
of female married population 
-1.42  
(-1.963 ,  -0.8573) 
12.63 
(9.716, 15.59) 
2.108 
(1.092, 3.068) 
 (b) 
Model Models  (variables)  pD  DIC 
1  Townsend index score  103.3577023  974.70254708 
2  Proportion of female single population  103.32035773  975.5729926 
3  Proportion of female married population  102.95395444  976.78772316 
4  Proportion of household with lone parent   93.23612062  969.9301876 
5  Proportion of household with female lone parent  91.12125211  967.19954957 
6  Proportion of low social grade (IV+V) population  97.56668097  973.20375348 
7  Proportion of household with female lone parent + proportion of 
low social grade (IV+V) population 
95.12799991 967.12499188 
8 
 
Proportion of household with female lone parent + Townsend  
index score 
93.12824428 967.83376986 
9 
 
Proportion of household with female lone parent proportion + 
proportion of female single population 
90.51250534 967.09715974 
10 
 
Proportion of households with female lone parent + proportion of 
female married population 
89.52749918 963.62040584 
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Table 5.4 Summary of BYM CAR Bayesian Poisson regression models. 
 (a) 
Model Variables 
0   (95% CI)  1   (95% CI)  2   (95% CI) 
1  Townsend index score  0.1458 
(0.1104, 0.1807) 
0.02306 
(0.01241, 0.03363) 
 
2  Proportion of female single 
population 
-0.7927 
(-1.257 ,  -0.199) 
1.654 
(0.6269, 2.457) 
 
3  Proportion of female married 
population 
0.8681 
(0.4578, 1.215) 
-1.671 
(-2.476 ,  -0.7157) 
 
4  Proportion of household with lone 
parent 
-0.2371 
(-0.3978, -0.08078) 
6.488 
(3.996, 9.063) 
 
5  Proportion of household with 
female lone parent 
-0.227  
(-0.3788, -0.08095) 
7.005 
(4.414, 9.7) 
 
6  Proportion of low social grade 
(IV+V) population 
0.1447 
(0.1086, 0.1804) 
0.05525 
(0.01942, 0.09107) 
 
7 
 
Townsend index score  
+ proportion of female married 
population 
0.2723  
(-0.5423, 0.9069) 
0.02054 
(0.003082, 0.04032) 
-0.2943 
(-1.771 ,  1.593) 
8  Townsend index score  
+ proportion of households with 
female lone parent 
-0.1082  
(-0.3146, 0.09071) 
0.01021 
(-0.004598, 0.02493) 
4.769 
(1.094, 8.565) 
9 
 
Townsend index score  
+ Proportion of  low social grade 
(IV+V) population 
0.1434 
(0.107, 0.1796) 
0.01997 
(0.008008, 0.03197) 
0.02319 
(-0.01761, 
0.06476) 
(b) 
Model Models  (variables)  pD  DIC 
1  Townsend index score  106.02894151  957.99103804 
2  Proportion of female single population  106.80700759  960.27818055 
3  Proportion of female married population  107.46463116  959.94719854 
4  Proportion of household with lone parent  108.81552651  964.28449211 
5  Proportion of household with female lone parent  106.90209847  959.53606315 
6  Proportion of G4 + G5 population  109.7265438  96341250304 
7  Townsend index score  
+ proportion of female married population 
108.74620904 962.51777259 
8  Townsend index score  
+ proportion of households with female lone parent 
105.54561402 955.67957353 
9  Townsend index score  
Proportion of  G4 + G5 population 
105.14123698 958.24877874 
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Table 5.5 Summary of MIX CAR Bayesian Poisson regression models. 
(a) 
Model Models  (variables) 
0   (95% CI)  1   (95% CI)  2   (95% CI) 
1  Townsend index score  0.162 
(0.1312, 0.1918) 
0.02194 
(0.01357, 0.03045) 
 
2  Proportion of female single 
population 
-0.7628 
(-0.8929, -0.6475) 
1.628  
(1.418, 1.832) 
 
3  Proportion of female married 
population 
0.8551  
(0.5591, 1.112) 
-1.604 
(-2.208 ,  -0.9156) 
 
4  Proportion of household with lone 
parent 
-0.2443 
(-0.3771, -0.1133) 
6.891 
(4.814, 8.989) 
 
5  Proportion of household with female 
lone parent 
-0.234 
(-0.3476, -0.1182) 
7.469 
(5.49, 9.452) 
 
6  Proportion of low social grade 
(IV+V) population 
0.1606 
(0.1293, 0.1918) 
0.04438 
(0.01856, 0.07247) 
 
7 
 
Townsend index score  
+ proportion of female married 
population 
0.3893  
(-0.07695, 0.8459) 
0.01695 
(0.003931, 0.03085) 
-0.5275 
(-1.578 ,  0.5523) 
8  Townsend index score  
+ proportion of household with 
female lone parent 
-0.1792 
(-0.3246, -0.02895) 
0.00484 
(-0.005615, 
0.01577) 
6.451 
(3.751, 9.057) 
9  Townsend index score  
+ proportion of low social grade 
()V+V) population 
0.1594 
(0.1289, 0.1898) 
0.01948 
(0.01006, 0.02885) 
0.01481 
(-0.01227, 0.04337) 
(b) 
Model Variables  pD  DIC 
1  Townsend index score  74.48339393  947.00286159 
2  Proportion of female single population  75.56180522  946.91556045 
3  Proportion of female married population  76.78314502  947.73158404 
4  Proportion of household with lone parent  70.3796227  953.56697841 
5  Proportion of household with female lone parent  72.92979225  948.69604725 
6  Proportion of low social grade (IV+V) population  77.21551043  957.22739088 
7  Townsend index score  
+ proportion of female married population 
75.6384955 943.07269939 
8  Townsend index score  
+ proportion of household with female lone parent 
76.41373642 951.03644554 
9  Townsend index score  
+ proportion of low social grade (V+V) population 
81.58074762 949.74908547 
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The best fitted models were: 
(i)  Non-spatial model: 
) exp( ˆ
  1 0 i lonei All i v         
) exp( ˆ
  1 0 i lonei Female i v         
) exp( ˆ
45 2   1 0 i i G lonei Female i v v           
 
(i)  BYM CAR model:  
) exp( ˆ
1 0 i Townsendi i v         
) exp( ˆ
  2 1 0 i lonei Female Townsendi i v v           
) exp( ˆ
45 2 1 0 i i G Townsendi i v v           
 
(ii) MIX CAR model:  
) ) 1 ( exp( ˆ
2 1 0 i i i i i Marriedi Townsendi i u v v                 
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Figure 5.16 The estimated mean indirectly standardised incidence ratio  i  ˆ  for 
different non-spatial models; (a) raw ratio  i  ˆ  , (b)  i  ˆ  from the non-spatial model 
with proportion of household with lone parent, (c) SIR plot against fitted value, 
(d)  i  ˆ   from the non-spatial model with proportion of household with female lone 
parent, (e) SIR plot against fitted value, (f)  i  ˆ   from the non-spatial model with 
proportion of household with female lone parent and lower social grade 
population. 
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(e)      (f) 
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Figure 5.17 The estimated mean indirectly standardised incidence ratio  i  ˆ  for 
different BYM CAR models; (a)  i  ˆ  from the BYM model with Townsend index, 
(b) SIR plot against fitted value, (c)  i  ˆ  from the BYM model with Townsend 
index and proportion of household with female lone parent, (d) SIR plot against 
fitted value, (e)   i  ˆ  from the BYM model with Townsend index and proportion of 
low social grade population and (f) SIR plot against fitted value. 
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Figure 5.18 The estimated mean indirectly standardised incidence ratio  i  ˆ  for 
different MIX CAR models; (a)  i  ˆ  from the MIX model with Townsend index 
and proportion of female married population, (b) SIR plot against fitted value. 
 
Townsend index, proportion of household with lone parent, proportion of 
population with low social grade (IV+V) and proportion of female married 
population are the most significant variables associated to cervical cancer SIR in 
all three types of Bayesian regression models. In simple terms, the analysis 
suggests that on average, as the Townsend index, and proportion of household 
with lone parent, and proportion of population with low social grade increase 
cervical cancer incidence increases, but when the proportion of female married 
populations increase the standardised incidence ratio (SIR) decreases. 
 
Based on prior knowledge, the martial status do affect the incidence rate, for 
example if a woman is single status the chance for her to have more than one 
sexual partner is higher than a married woman, the marital status factor does 
reflect some possible information about personal sexual behaviours, which may 
be related to the chance of cervical cancer development. From the prior 
knowledge, it is expected regions with high deprivation and with a large 
population of single females or female lone parents may have a higher incidence Chapter 5 Cervical cancer regression study 
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rate, where the chance of developing cervical cancer is related to female 
reproductive history and personal sexual behaviour. 
 
The values of  0  ,  1   and  2    are shown in Table 5.3a, 5.4a, and5.5a and the 
model measurements in Table 5.3b, 5.4b,5.5b. The posterior mean of SIR for all 
three models is shown in Figure 5.16, 5.17 and 5.18. Clearly, all final fitted 
models have a very similar posterior mean, but Figure 5.18 has a clear spatial 
pattern compared to the raw data Figure 5.16a. This arises because the spatial 
models have the advantage of spatial smoothing. By comparing the pD and DIC 
values between models, the spatial MIX models have smaller pD and DIC values 
than the BYM spatial and non-spatial models.  
 
Three types of Bayesian regression models were used to examine the relations 
between target and explanatory variables. Tthe link between parameters is shown 
in Figures 5.13-15. The Bayesian regression models highlighted that the 
Townsend index and some of the family structure variables (e.g. female lone 
parent and married population) are significantly related to cervical cancer 
development, which is very similar to the GLM results in the section 5.4. In the 
next section of this chapter, the geographically weighted Poisson regression 
model is used to study the same set of data. However, other methods are provided 
to deal with the missing data issue and an opportunity is provided to model the 
variables as non-stationary. 
 
 
5.6 Geographically weighted Poisson regression model (GWPR) 
Traditionally, global models have been applied in disease studies (Best et al., 
2000). In such studies, it is assumed that the disease can be modelled adequately 
by a geographically invariant process. Simply, the disease model and, specifically, 
its parameters are spatially stationary or spatially constant. Possible spatial 
variation in the parameters in such models is neglected. Such missing information 
can be very important and also meaningful in disease analysis. Since some of the 
relations between the target variable and some explanatory factors may not be Chapter 5 Cervical cancer regression study 
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spatially constant, the covariance may vary spatially (Nakaya and Dorling, 2005). 
In these circumstances, local regression modelling is a viable alternative approach 
for exploring the relationship between the target and explanatory variables at the 
local level, taking into account spatial variation in parameters and allowing the 
covariance to vary locally based on geographical context. 
 
Many studies show that ill health issues are related to socio-economic status (e.g. 
Green and Richardson, 2002; Jarup et al., 2002; Lawson and Clark, 2002; 
Richardson and Best, 2003; Richardson et al., 2004). Other studies show that such 
relations may also vary between regions and such variation should be taken into 
account in modelling (Pascutto et al., 2000). 
 
GWR is well developed for different modelling frameworks (e.g., Gaussian and 
Poisson). For example, Gaussian GWR was applied to long-term limiting illness 
in the Northeast of England, and the results showed complex regional variation in 
regression parameters (Fotheringham et al., 1998). Technically, geographically 
weighted Poisson regression (GWPR) can be applied where proportions are 
predicted (e.g. in many disease studies). 
 
The global regression models described early in section 5.4.3 showed significant 
relationships between cervical cancer incidence and Townsend index, proportion 
of low social grade population, proportion of single population and proportion of 
married population (i.e. representing the family structure and also reflecting some 
of the information about the possible sexual behaviour of the general population 
and households with lone parent). This section demonstrates a statistical tool, 
geographically weighted Poisson regression (GWPR), for analysing the relation 
between cervical cancer disease incidence and the same set of explanatory factors 
in England. A kernel was used as a spatial weighting function to estimate spatial 
variation in the Poisson regression parameters. Local parameters were estimated 
which describe the spatial variation in the relationships between incidence and 
deprivation, social grade and family structure characteristics. Within the GWPR 
model, the spatial data were modelled as the result of non-stationary processes 
over space. Chapter 5 Cervical cancer regression study 
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5.6.1 Truncated missing data 
One way of dealing with this truncation is to estimate the basic true mean from 
the data, including the missing data, accepting the estimated mean to be true; then 
a random number can be drawn for each of the regions based on the estimated true 
mean. So in practice, for each region, we drew a large number 6000000 of random 
values based on the true mean, and the first 100 random numbers between zero 
and five were used to replace the missing data. The set of 100 samples is 
sufficiently large enough to represent the probabilities of the missing data. 
Finally, 100 sets of 21 data, were imputed in place of the missing data from the 
original dataset and applied the GWPR models 100 times.  
 
5.6.2 Prediction mean 
100 different sets of realisations were drawn to replace the missing data for the 21 
regions. Thus, the GWPR models were run 100 times and the average predictions 
were estimated from the outcomes from the 100 GWPR models. The average 
prediction was represented by  ) ( i Y E and defined below: 
 
100
ˆ
) ˆ (
100
1 
 
n
n
i
i
Y
Y E             ( 5 . 1 7 )  
 
Where n is the number of GWPR models; in this case, n is equal to 100, 
n
i Y ˆ  is the 
prediction outcome from the nth model from region i, where i = 1,2 , …, N and 
) ˆ ( i Y E  is the overall average prediction from the 100 GWPR models. It is also 
important to examine the variation from the 100 GWPR predictions. Such 
information explains how much variation there is within the prediction when the 
missing data vary between zero to five cases. 
 
5.6.3 Prediction variance 
It is useful to calculate the overall variance for the 100 predictions; it shows the 
overall variation resulting as a function of the uncertainty due to the truncation of 
the distribution. The variance provides information on prediction uncertainty and Chapter 5 Cervical cancer regression study 
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parameter estimation uncertainty; therefore, it allows for comparison of the 
variation within the prediction between the observed and missing data. It 
summarises the prediction variation due to the truncation. The variance is denoted 
as  ) ˆ var( i Y , which is the overall variance out of the n model predictions, and was 
calculated as: 
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5.6.4 Analysis and results 
When GWR was first developed, the Gaussian model was commonly used in 
disease studies (Fotheringham et al., 1998; Nakaya et al., 2005). For disease 
counted cases and rare diseases with small numbers of cases, the Poisson model is 
a more appropriate framework to describe the underlying distribution (Lawson et 
al., 2003; Gelman et al, 2003). Many disease analysis studies for small areas 
applied the Poisson model to describe the disease distribution (e.g. Green and 
Richardson, 2002; Lawson and Clark, 2002; 2003).  
 
5.6.5 Variable definition 
Thus, estimated incidence ratio (SIR)  i  ˆ  is equal to: 
i
i
i e

  ˆ               ( 5 . 1 9 )  
 
Therefore, a GWPR cervical cancer incidence model can be defined as below: 
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Where the link function for the Poisson model is log and  i e log  represents the 
expected cases for exposure to cervical cancer, also called the “offset”, which is a Chapter 5 Cervical cancer regression study 
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measurement unit of exposure for region i. Most disease studies based on the 
Poisson distribution framework used the expected cases  i e   as the offset. Both 
global Poisson and GWPR models were preformed, and summarised in the next 
two sections. 
 
5.6.6 Global Poisson regression model 
To examine possible determinants of the geographical patterns in the cervical 
cancer incidence, a traditional global Poisson regression model with offset 
expected cases was fitted, which is based on the demographic composition of each 
region. Deprivation, social grade and family structure variables were tested; the 
variables were described in Chapter 3. All explanatory variables were significant 
to the observed incidence. For full details of measurements of all 100 candidate 
models please refer to Appendix E. Table 5.6 shows the results from one of the 
random models with different variables. The final fitted global Poisson regression 
model is defined as: 
 
) 832 . 2 718 . 0 exp( ˆ
45i G i i v e Y           ( 5 . 2 0 )  
 
Where  i G v 45  represents the proportion of low social grade population, which is 
significant at the global level. Equation 5.20 is one of the 100 models. 
 
5.6.7 GWPR results 
The GWPR method applied within this study was described in Chapter 2. The 
overall prediction means and variances of  ) , ( ˆ
i i y x Y are displayed in Figures 5.19 
and estimated parameters mapped in Figure 5.20. The final fitted model is given 
as (model 6 in Table 5.6); 
 
) , ( ) , ( ) , ( exp( ) , ( ˆ
45 1 0 i i i G i i i i i i i i y x v y x y x e y x Y          ( 5 . 2 1 )  
 
The proportion of low social grade population is significant to incidence rate. The 
estimated predicted mean, variance, and residual values are displayed in Figure 
5.19. The overall estimated  ) , ( ˆ
0 i i y x   and  ) , ( ˆ
i i t y x   out of the 100 samples are Chapter 5 Cervical cancer regression study 
  113
displayed in Figure 5.20. As summarised in this study, the use of an adaptive 
weighted function and the optimal bandwidth were selected based on the smallest 
AICc in Table 5.6; therefore the optimal kernel size was 91 regions. It is clear that 
the contribution of the explanatory variables varies over space (Figure 5.20). 
Results of the 100 models can be found in Appendix E. 
 
 
(a) 
 
(b)       (c) 
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(d)       (e) 
 
(f)       (g) 
 
Figure 5.19. (a) Raw SIR, (b) the prediction mean of SIR out of the 100 models, 
(c) the variance of the predictions of SIR, (d) the mean of residual values between 
the observed and predicted cases and (e) the residual variance, (f) the mean of R-
square value and (g) variance of R-square value. 
 
Figure 5.19 a and b have a similar pattern and the variance of the 100 models in 
5.19c showed very small variation between the 100 models. Residual value (d) 
showed spatial correlation and also small variation in (e). The R-square values of 
local models (f) are generally high between 78 to 98% and again the variation of 
the R-square value from the 100 model is relatively small in (g).  
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(a)       (b) 
 
(c)       (d) 
 
Figure 5.20. Estimated parameters (a) mean oi  ˆ  , (b) variance  oi  ˆ , (c) mean  i 1 ˆ  , 
(d) variance i 1 ˆ   from model 6 in Table 5.6. 
 
Figure 5.20 shows the spatial variation of the local parameter estimates from 
model 6 (covariate is proportion of low social grade population). The local 
estimates of  i 1 ˆ   are positive in all areas (Figure 5.20c). Areas with high estimated 
coefficient are the South, Midlands, and North of England. The West of England 
(e.g. Cornwell) has a lower incidence rate and also low estimated coefficient. It 
could be related to the population structure; the proportion of elderly population is 
higher in the West of England than the South of England. It is clearly shown that Chapter 5 Cervical cancer regression study 
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the contribution of the explanatory variable proportion of low social status in the 
final fitted model, and the relationship varies over space. Therefore, global models 
are not suitable to describe behaviour of the explanatory variables. 
 
As described in section 5.5.7, the models were compared using the local AICc. 
The smallest AICc values were assumed to provide the best fitted model out of the 
candidate models. From Table 5.6, it can be concluded that the best fitted model is 
model 6, which is the GWPR model with the smallest AICc and kernel size with 
91 regions. 
 
Table 5.6 Summary statistics of model comparisons.  
Model Variables  Kernel  AICc 
(global) 
BIC 
(global) 
AICc 
(local) 
BIC 
(local) 
1 Townsend  index 
score 
91 853.023703  860.728109  640.3845  709.916097 
2 Female  single 
proportion 
91  849.382834  857.08724 651.31749 725.374232 
3 Female  married 
proportion 
91  849.382834  857.08724 651.31749 725.374232 
4 All  lone  parent 
proportion 
91  750.371283 858.075689 594.871272 666.851433 
5  Female lone parent 
proportion 
91 754.678029  762.32435  597.276846  669.281713 
6  G4 + G5 
proportion 
91  612.968809 620.673215 539.322475 610.348925 
7  G4 +G5 + Female 
lone parent 
proportion 
91  614.875115 626.414434 539.797014 641.997312 
8  G4 + G5 + 
Townsend index 
score 
91  612.221974 623.761293 538.485982 637.542841 
9  G4 + G5 + Female 
married proportion 
91  613.471141 625.010511 539.672056 642.525934 
10  G4 + G5 + All lone 
parent proportion 
91  614.963647 626.502967 539.207776 641.453094 
 
 
Kernel size is very important to the prediction. In theory, the kernel size should 
vary between different models; however, unexpectedly all the models in Table 5.6 
have the same kernel size. It could due to the fact that all the variables exhibit 
similar spatial patterns, such that all models had similar bandwidth values.  
 
Figure 5.21 shows the optimal size of bandwidth is 91 regions. The size is 
relatively large, which may be due to the sample size being small in most of the 
regions; therefore, it is necessary to have a larger kernel to cover sufficient data in 
order to predict reliably. Different sizes of kernel were tested; the optimal Chapter 5 Cervical cancer regression study 
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bandwidth provides the smallest AICc value. When the AICc converges at a 
certain size of kernel, that is the optimal kernel size. 
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Figure 5.21 Kernel bandwidth and the corresponding AICc values. 
 
It is interesting to examine which exploratory variables are fitted adequately by 
stationary parameters, and which variables required a non-stationary process. If 
the inter-quartile range at local level is greater than twice the standard error at 
global level, this would indicate that variable requires a non-stationary process 
(Table 5.7). 
 
Table 5.7 Test for indicating non-stationary variables. 
Parameters  2* S.E. (Global)  Inter-quartile 
range (Local) 
Stationary or 
non-stationary 
variable 
Intercept  0.062 0.458604  Non-stationary 
Proportion of low 
social grade 
(IV+V) 
population 
0.178 1.045168  Non-stationary 
 
Table 5.7 shows that the explanatory variable (low social status population) has a 
larger inter-quartile range than twice the global standard error. This indicates that 
cervical cancer incidence (or incidence rate) is related to the proportion of low 
social grade population and is better fitted by a non-stationary model in GWPR 
rather than using a global regression model. Thus, the local model provides a 
more meaningful model of the relationships between incidence rate and Chapter 5 Cervical cancer regression study 
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proportion of low social status. This allows the non-stationary process within 
models to increase the prediction power, and as a result, lead to a better 
understanding of the relationship between incidence cases (and/or incidence rate) 
and low social grade population. Figure 5.20 shows that the proportion of low 
social status population does affect the incidence rate spatially over England. The 
contribution is greater in the south and north of England than the west, which 
might be related to the population structure, (high percentage of elderly in west 
compared to the rest of England).  
 
The Bayesian CAR and GWPR models showed there was spatial pattern. Some of 
the regions had higher incidence rates e.g. Midlands. Thus, a national fixed 
screening programme may not be suitable and work effectively over the whole 
country.  
 
 
5.7 What does this mean for the design of screening programmes? 
Based on the regression results in this chapter, some of the personal variables (e.g. 
being single or married) and the social status level are associated with cervical 
cancer incidence. Therefore, it should be possible to divide the general female 
population into risk groups according to (i) their deprivation condition, social 
status and family structure variables or (ii) geographical regions. Each risk group 
can have a different screening policy and screening interval. By dividing the 
population into groups, it allows use of the decision tree and simulation models in 
Chapter 4 to evaluate the screening options such that each group may be assigned 
a different screening interval given different probabilities of developing cervical 
cancer.  
 
In reality, the health department (e.g. NHS) has only limited resources. Therefore, 
the use of decision tree and simulation models based on the regression results 
would allow policy makers to evaluate each potential policy based on the risk 
categories, and to evaluate which is the best combination of screening policies 
given limited resources. The optimal policy can provide the best use of resources 
and increase the efficiency of the overall screening programme compared to the 
current national fixed programme.     Chapter 5 Cervical cancer regression study 
  119
5.7.1 CART analysis based on regression results 
There is a missing link between chapters 4 and 5. Therefore, a possible method to 
fill in the gap between chapters, is to create a simple decision tree model based on 
the results from the regression models from chapter 5 as follows:, 
 
1.  Use regression to predict incidence 
2.  Divide the population into groups according to their deprivation condition 
characteristics (e.g., high deprivation index score vs. low deprivation 
index score etc.) 
3.  Create a decision tree model for the population based on the overall 
incidence rate. 
4.  Create a new decision tree model for the groups based on the set of 
incidence rates 
5.  Explore the effect of different screening intervals for the whole population 
(it would depend highly on the availability of transition probabilities) 
6.  Explore the effect of different sets of screening intervals for the groups (it 
would depend highly on the availability of transition probabilities) 
 
In reality, the transition probabilities and transition times for different screening 
intervals for the general population (or for groups) is not available. Only if 
continuous clinical data (or follow up data) are available (i.e. follow each 
individual patient for many years) can the transition probabilities be estimated. 
Otherwise, it is not possible to compare the screening options with various 
screening intervals because of the lack of information about transition 
probabilities (or knowledge).  
 
The transition probability describes how a patient might be expected to develop 
cervical cancer from a particular group. It is possible to estimate the incidence rate 
per group, but it is not possible to know the time interval and the related 
probabilities over which a patient might be expected to develop cervical cancer. 
But the incidence rate per group may be enough for a simple analysis. 
 
The original pre-cervical cancer and cancer disease process should follow the 
structure in Figure 5.22. However, the transition probabilities and transition time 
parameters are required to be estimated from any possible continuous clinical Chapter 5 Cervical cancer regression study 
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data, such data are rarely available. Thus, the following section demonstrated a 
possible simple analysis with risk grouping. 
 
 
Figure 5.22 Pre-cervical cancer and cervical cancer disease process, showing 
summarised probabilities from Jenkins., et al 1996 and the positive and negative 
probabilities were recommended by Dr Harindra from Portsmouth St Mary 
hospital.  
 
The overall idea is that if an individual is tested, that will reveal a realisation of 
the disease (or not) based on the incidence rate per group and can treat the disease 
for that individual. This tells the policy makers in the long run the number of 
cases that they have revealed (removed) and the number that they have missed. 
This simple analysis may be enough to reveal that a selective screening policy 
would be more efficient than a global one. Figure 5.23 demonstrates the use of 
decision tree model to estimate the number of expected cervical cancer cases from 
a general female population, Table 5.8 showed the result based on the model in 
Figure 5.24. The probabilities in Figure 5.24 were estimated from the national 
cervical cancer data. 
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Figure 5.23 Decision tree model. 
 
In Figure 5.23 Two probabilities are needed, which can be estimated from the 
national cervical cancer data. The calculation is listed below; 
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Where  )   ( cancer cervical p  represents the probability of cervical cancer presence, 
and  )   ( cancer cervical p    represents the probability of cervical cancer absence. 
Figure 5.23 shows both cervical cancer probabilities, which were estimated from 
the national cervical cancer data. 
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Figure 5.24 Decision tree model based on the observed national cervical cancer 
data. 
 
Assume there are 20,000,000 females at risk. The positive and negative 
probabilities were listed in Figure 5.24. The expected number of positive cervical 
cancer cases and negative cervical cancer cases can be calculated in the following 
two equations (5.24 and 5.24). Table 5.8 shows the results. 
 
)   (  x              cancer cervical p population risk at total cases cancer cervical positive  (5.2
4) 
) (  x              ncer cervicalca p population risk at total cases cancer cervical negative   
(5.25) 
 
Table 5.8 Decision tree outcome based on the information from Figure 5.24. 
Group Total  patients 
General female population  20,000,000 
Cervical cancer cases  9,020 
No cervical cancer  19,990,980 
 
Figure 5.25 demonstrates the use of a CART tree, which is a potential method of 
splitting the population into risk groups according to certain characteristics. 
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Figure 5.25 Decision tree with the best split from CART, that allows splitting the 
general female population into two risk groups (i.e. high or low risk),  
 
The national cervical cancer count data can be used to estimate the probabilities 
between states and groups. Those probabilities are needed for decision tree 
models. The probabilities in Figure 5.25 can be calculated as below, 
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In this section, CART tree was used to split the population into two risk groups 
with the best split. The whole population can be divided into two groups 
according to the Townsend index score (i.e. high or low). Low risk regions 
represent a low Townsend index score (low deprivation regions) (i.e. below the 
best split point) and high risk regions represent a high Townsend index score (i.e. 
above the best split point). For details about the best split in CART please refer to 
Chapter 2. 
 
5.7.2 Risk grouping 
CART techniques can be used to divide the whole population into groups; Chapter 
2 explained the CART theory and decision tree theory and section 5.7.1 
demonstrated how to split the population into groups according to the deprivation 
indicator. Such techniques show that the chance of developing cervical cancer 
varies between groups, which means that some groups with certain characters 
(e.g. low deprivation condition) may have higher chance of developing cervical 
cancer in their life time compared to other risk groups.  
 
5.7.2.1 CART based on the Townsend index score 
Townsend index score was identified as a significant factor to the cervical cancer 
development. Therefore, Townsend index was chosen as a factor to divide the 
population into risk groups. By applying CART methods the population was 
divided into two risk groups according to the Townsend index score (e.g. high or 
low deprivation). The probabilities of developing cervical cancer were estimated 
per group.  
 
Data: cervical cancer data (observed national counts) 
Missing data: excluded from analysis (in total there are 354 regions, 21 with NA 
counts) 
Average (overall) incidence rate: 0.00045 
Predicted variable: incidence rate per 10000 women per region Chapter 5 Cervical cancer regression study 
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Independent variable: Townsend index score  
Best split: <1.45  
 
The best split is Townsend index equal to 1.45, which suggests that any regions 
with an index less than 1.45 are identified as the low risk group and any regions 
with index above 1.45 are identified as the high risk group. Figure 5.26 shows the 
decision tree model. The probabilities were estimated from the national cervical 
cancer count data. Table 5.9 shows the number of expected cervical cancer cases 
per group. 
 
 
Figure 5.26 Decision tree model with two risk groups. The low risk group has a 
low Townsend index score and the high risk group has a high Townsend index 
score. The probabilities were estimated from the observed national data. 
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Table 5.9 Potential decision tree (Figure 5.26), based on the national observed 
data. Population was split into two risk groups. 
Group Total  patients 
General female population  20,000,000 
Low risk group  15,254,000 
Cervical cancer  6,102 
No cervical cancer  15,247,898 
High risk group  4,746,000 
Cervical cancer  1,424 
No cervical cancer  4,744,576 
Total cervical cancer  7,579 
 
 
Figure 5.27 Risk grouping by the Townsend index score. the black areas represent 
the high risk group and the white areas represent the low risk group. 
 
 
5.8 Summary 
In this chapter, various regression models were used to explore the relations 
between cervical cancer incidence and Townsend index as well as other variables. 
The results summarised that the Townsend index, personal marital status and Chapter 5 Cervical cancer regression study 
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social grade were significant to cervical cancer incidence. Particularly, the GWPR 
results showed that the significant variable proportion of low social grade 
population was fitted best by non-stationary models, which means the 
contribution from the same variable might vary over space. The non-stationary 
process can increase the prediction power and increase understanding of the 
relationship between cervical cancer incidence and explanatory variables over 
space. If the non-stationary assumption and spatial information were ignored it 
could lead to misleading explanation of the results. It demonstrated that not 
everyone has the same chance of developing cervical cancer; some patients with 
certain characteristics (e.g. high or low social status) have a different chance of 
developing cervical cancer. Therefore, the lower risk patients may not need to be 
screened as often as the high risk patients. The maps (Figures 5.27) showed the 
risk grouping according to the Townsend index. In practice, it is possible to screen 
the high risk population in the black areas in the map more often than the white 
areas. This could reduce the amount of wasted resources. The exact resources can 
be added into the high risk groups. That may help to detect the higher risk patients 
at any early pre-cervical cancer states.  
 
However, something is missing. That is the time parameters and transition 
probabilities. If the transition time and probabilities were available between states, 
it would allow estimation of number of patients in each state for a long run. The 
result in section 5.7.2.1 allows evaluation of the effectiveness of the screening 
options and it also allows comparison of different options. 
 
Both Chapter 4 and this chapter demonstrated the use of different mathematical 
models, which allows identifying the personal and other factors that are associated 
with cervical cancer incidence (e.g. age). The simple analysis in section 5.7 
showed that the chance of developing cervical cancer does vary between risk 
groups. Surely, including both personal and general associated risk factors may 
increase the screening efficiency. The efficiency of the national cervical cancer 
screening policy at local and (or) national levels is discussed in Chapter 8. 
 
 Chapter 6 Chlamydia study 
  128
Chapter 6 Chlamydia study 
 
 
6.1 Introduction 
On average there is a 10% positive rate of Chlamydia within the entire UK 
population most commonly under the age of 25 (Primarolo, 2006). The numbers 
of new Chlamydia cases has increased annually from the mid-1990s; the 
confirmed cases rose by 5% between 2004 and 2005. It has become the most 
common sexually transmitted infectious disease (STD/ SDI) in the UK and it is 
also one of the sexual health issues causing most concern worldwide. The UK 
Department of Health carried out an opportunistic screening trial study in 10 
centres to collect data between 1999 to 2000, which will be used to inform an 
extension of the screening programme to the whole country in the future as part of 
the National Chlamydia Screening Programme (NCSP). Portsmouth was one of 
the chosen sites for the opportunistic screening trial of Chlamydia. The target 
population was estimated at 30,000 (Evenden et al., 2006). If it were necessary to 
set up an official national screening programme as has been done for other 
diseases such as cervical cancer, it would be interesting to consider what type of 
screening system should be adopted. If a fixed screening programme with fixed 
screening interval was implemented (e.g. cancer screening programme) to cover 
the whole population, this may increase work pressures and overstretch healthcare 
resources. 
 
This chapter demonstrates (i) how to model individual patients’ age, which will be 
used in the regression model in chapter 7, (ii) how to use the decision tree model 
to examine what is the benefit of setting up a screening programme and what is 
the best possible screening option, and (iii) how to use simulation to understand 
the screening systems and to predict the necessary resources. All the techniques 
used in this chapter are mainly used to demonstrate the analysis that would be 
possible if data were available. Real data were used where available, but where 
data were missing, (e.g. the transition time and some transition probabilities) 
dummy datasets were used to demonstrate the use of the methods.   
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The associated risk factors can be identified through the regression models in 
Chapter 7, those risk factors can be used to divide population into groups, 
according to the identified associated risk factors in Chapter 7. The probabilities 
and other required parameters of each risk group can be added into the decision 
tree and simulation models in this Chapter to demonstrate the potential use of 
decision tree and simulation models to evaluate the screening options, thus, the 
optional screening policy can be achieved through such a process.  
 
 
6.2 Data 
The individual Chlamydia data collected between 1999 and 2000 in Portsmouth 
were used in this chapter and some of the probabilities from NHS reports 
(Primarolo, 2006) are used in the decision tree model and simulation models 
(Pimenta et al., 2003 a, b; Health Protection Agency, 2006). For details of the 
Chlamydia data please refer to chapter 3. 
 
 
6.3 Age 
It is common to have aggregated data in most disease studies; for example in 
Chapters 4 and 5, national cervical cancer data were used. Information on an 
individual patient’s age is not usually available, but it provides rich information 
for understanding how a disease relates to patients within the given age range, and 
which age groups have a higher chance of developing certain types of disease. 
Such information helps to identify the high risk populations, to target the high risk 
populations and to run the screening programme in a more efficient way.  
 
6.3.1 Age category 
It is common to model the individual patient’s age as a categorical variable 
(Clayton and Hills, 1993; Evenden et al., 2006), that is, split the patients into two 
groups or a few groups based on the risk (e.g. low or high risk). In the Chlamydia 
study, the age group 16 to 24 was classified as high risk group; the rest of the ages 
were classified as the low risk group. However, this strategy causes some loss of 
information.  In practice, it is possible to include the individual age in regression, Chapter 6 Chlamydia study 
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but it causes complications in modelling (Jackson et al., 2008); it is not easy to 
model the age (Jackson et al., 2006). It is helpful to estimate the age distribution, 
which is a possible method to overcome the use of age categories (lost 
information).  
 
6.3.2 Age distribution  
Kolmogorov-Smirnov is a test used to examine the underlying distribution, which 
is similar to Chi-square goodness of fit test. The main application of this test was 
to test the age distribution. Firstly, the positive risk  i z  and the normalised positive 
risk  i w  are defined below. The reason to normalise the risk i z  is because the risk 
i z  is always assumed the same (equal risk rate) with different data size; therefore, 


41
12 i
i w =1 for i = 12, 13,…, 41 in total 28 age classes were recorded from ages 12 
to 41, there were no cases recorded between ages 0 to 11 due to the sample 
collection. The basic distribution  ) (x F  is tested in the following section (DeGroot 
and Schervish, 2002). 
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Where  i y  is the number of tests,  i x  is the number of positive incidences (positive 
cases), i is the patient’s age i =  12, …, 41; the test statistic is given below, 
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variance  xi  ˆ  given sample size n equal to 28, since the recorded ages started from 
age 12 to 41, so in total there were 28 age classes.  
 
In this section, the age distribution is tested; the potential distributions were 
considered (i) Normal or (ii) Log-Normal distribution. The Kolmogorov-Smirnov 
test is set up as following, 
 
The hypothesis test is given below,  
) ( ) ( ,   )   (           :
) ( ) ( ,             :
*
1
*
0
x F x F on distributi LogNormal or Normal not is on distributi basic the H
x F x F on distributi mal) (or LogNor Normal is on distributi basic the H


 
Level of significance: 95% 
p-value: 1.36 
 
Table 6.1 Kolmogrov-Smirnov test results from both Normal and Log-Normal 
distributions. 
  Test 1  Test 2 
Distribution   Normal Log-Normal 
) ( i x E   6.259 2.941 
xi  ˆ   6.259 0.298 
*
n D   0.118 0.0972 
* 2 / 1
n D n   0.635921684 0.523484 
P-value 1.36  1.36 
  
Since both 
* 2 / 1
n D n  values (0.636 and 0.523) are less than 1.36,  0 H  is accepted. 
The basic distribution can be Normal and Log-Normal. Using a QQ-plot to 
compare the fitted distribution (Figure 6.1), showed that both Normal and Log-
Normal distributions were fitted well, but it does not show which is better. Log-
Normal had a smaller 
* 2 / 1
n D n  value than Normal. Therefore, it is possible to 
accept a Log-Normal distribution as the underlying distribution. The final fitted 
observed and expected distributions are shown in Figures 6.2 and 6.3. Chapter 6 Chlamydia study 
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Figure 6.1 Q-Q plot, to compare the goodness of fit between the observed risk and 
expected risk with two distributions. The Log Normal distribution is fitted better 
than the Normal distribution, thus, the basic distribution is Log-Normal. 
 
 
Figure 6.2 The cumulative distribution function (CDF) curve of observed and 
expected distributions. The line with dots represents the observed CDF and the 
line with squares represents the experimental CDF. 
 
Normal Observed 
Log-Normal Observed 
Normal 
Expected 
Log-
Normal 
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Figure 6.3 The observed and expected probability per age classes, the line with 
squares represents the observed probability, the line with dots represents the 
experimental distribution.  
 
In theory, age and sex are treated as extra information, which contribute to the risk 
of developing disease at the individual level. However, such data can over-
complicated the model in practice. Thus, it was suggested to estimate the age by 
indirect standardization by Jackson et al., (2006; 2008) and the best choice for 
modelling age in a Poisson model is the logit function. Therefore, in practice it is 
required to define the baseline risk of disease per age. Thus for the Chlamydia 
study, the expected probabilities approximately followed the Log-Normal 
distribution, but that only represents the expected probabilities per age. However, 
the risk of developing Chlamydia is the parameter of interest in the model. The 
expected probabilities from the Log-Normal distribution are not used in the 
regression model directly (in Chapter 7). Rather, the expected probabilities from 
the Log-Normal distribution were transformed into the logit scale and finally 
multiplied by the scale factor 1.6843 (Table 6.2 and Figure 6.4). The final 
outcome represents the risk of developing Chlamydia infection rather than the 
probability of developing Chlamydia infection per age.  
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Figure 6.4 Logit of the expected risk per age group 
 
 
6.4 Decision tree model 
Decision theory became more popular in evaluating healthcare options, 
particularly with in the NHS, where it has been applied in many NHS health 
studies; for example, assessing cost-effectiveness of chest physiotherapy, 
screening and also treatments (Claxton et al., 2004) and there is some evaluation 
of examples of healthcare technologies (Claxton, 1996; Claxton et al., 1999; 
2000; Claxton and Thompson, 2001;  Sculpher et al., 1997)  Decision theory was 
used to evaluate the screening options; a decision tree model was constructed in 
this section based on the Chlamydia disease states described in Figure 6.5 and the 
simple version of disease states in Figure 6.6. Based on the tree structure, it allows 
us to evaluate each of the possible screening options, which might provide better 
opportunities to detect more positive Chlamydia cases. The Chlamydia tree 
structure in Figure 6.7 is based on Figure 6.6. 
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Figure 6.5 Chlamydia disease states. 
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Figure 6.6 Simple version of Chlamydia disease states. 
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6.4.1 Decision tree structure 
A decision tree model was constructed to evaluate the best option for Chlamydia 
screening, which would achieve the best payout (i.e. more detected cases and a 
reduction in the number of cases of PID, complications and infertility). The model 
structure is shown in Figure 6.7; the circle represents the points at which decisions 
should be made and the square box represents the final output from that route. The 
aim is to make a decision which can maximise the payout, which is to decrease 
the number of undetected cases through screening. 
    
 
Figure 6.7 Chlamydia decision tree model. 
 
An example was utilised to explain the use of decision theory, to identify the best 
option and to identify what might be possible to improve with the given best 
screening option. The result of the example is shown in Table 6.2.  The results in 
Table 6.2   show that if policy makers only concentrate on improving the 
detection rate for the positive number of Chlamydia tests, this is not enough. In 
practice, it is necessary to adopt a combination of improving screening to avoid 
undetected cases and also to increase the quality of treatment services to take care 
of those patients who remain in undetected states (i.e. patients transmit to further 
Positive Negative 
Treated Untreated 
PID 
Remain in 
complication  Recorded  PID 
Infertility  Recorded 
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damage stages e.g. infertility), otherwise the number of cases of infertility would 
increase despite the screening becoming more effective and the number of 
undetected cases decreasing. The details of the decision tree model are given in 
Appendix F. Based on the lack of probability information, the probabilities used 
in this section are dummy data, which can demonstrate the use of a decision tree 
model to evaluate screening options. 
 
Table 6.2 Examples of screening options for Chlamydia 
Option Treated 
% 
Untreated 
% 
Recorded PID Infertility  Remain in 
complication 
No 
screening 
option 
0.3 0.7  2910  1750  90  5250 
Option 1  0.5  0.5  4850  1250  150  3750 
Option 2  0.7  0.3  6790  750  210  2250 
Option 3  0.8  0.2  7760  500  240  1500 
  
The probabilities in Figure 6.6 and Table 6.2 were collected from a list of reports 
from the NHS and HPA (Health Protection Agency, 2006; Primarolo, 2006). In 
Table 6.2 there were four options, the first option is no screening, which reflects 
the current situation, when no official screening is available for anyone at regular 
periods. Options 1 to 3 represent the official screening becoming available with 
different levels of efficiency of screening policies. For example, Option 1 had less 
efficiency compared to Options 2 and 3. Therefore, more patients had PID and 
remained in complication, whereas Option 3 was more effective and it detected 
more Chlamydia patients, so fewer patients had PID and remained in 
complication. The treatment efficiency is needed to increase to match with the 
screening efficiency; otherwise more patients will become infertile. The use of the 
decision tree model helps in evaluating the screening options, it clearly shows that 
more patients with Chlamydia are recorded if there is a screening system 
available; however, it is noticeable that the number of infertility patients will 
increase if the treatment for PID does not improve when Chlamydia screening 
becomes available. Therefore, the decision tree model allows the identification of 
possible bottle necks. On the other hand it is necessary to improve the treatment 
for the subsequent illness.  Chapter 6 Chlamydia study 
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In section 6.5, a simulation model is used to demonstrate what is possible in terms 
of improving the screening system and predicting the possible demand in the 
future. 
 
 
6.5 Simulation  
Simulation modelling allows those concerned to simulate disease behaviours and 
the patients’ response to treatments; therefore, decision makers can create a 
simulation model to model and analyse a life threatening condition when applying 
the new system. Two key characteristics are needed to describe the patients’ 
behaviours and response to treatments. Such characteristics can be described by 
the transition probabilities and holding times, which describe how likely a patient 
is to move to further disease states and how long it takes a patient to transfer to 
other states from his or her current state. Both transition probabilities and time 
parameters are described in the next two sections. Parameters and probabilities in 
the simulation model are dummy datasets due to lack of information.  
 
6.5.1 Simulation model structure 
A simulation model describes a disease system; it describes the process of each 
individual transforming through the system, which has a finite number of disease 
states. The period of staying in a disease state is called Length of Stay (LoS) and 
the chances or probabilities of transforming to other states (Figure 6.8) are 
described by the holding time  ij t  and transition probabilities  ij p .  
 
 
Figure 6.8. Transition time and probability from state i to state j 
 
To simulate the passage through the system, data such as holding time and 
transition probabilities within each state are required. Two types of models are 
State i  State j 
ij t  
ij p  Chapter 6 Chlamydia study 
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suitable for the model structure, Markov and Semi-Markov models, and use of 
one or the other depends on what types of information are available. For the 
Markov model the transition probabilities are required, but not the holding times, 
whereas the Semi-Markov model requires both transition probabilities and times. 
A variety of distributions can be used - for example, Weibull, Normal and Log-
Normal.  The Weibull distribution is commonly used to describe the holding time 
if data are not available (Harper, 2002).  
 
Patients may stay healthy for a certain time before moving to the next state (e.g. 
Chlamydia positive, PID etc). Such a study allows understanding of the natural 
disease process and it is also possible to ask some “what if” questions, which help 
to evaluate and improve the screening options. 
 
The simulation model was developed by using Visual Basic for Applications 
(VBA) within Excel and details were attached in Appendix G. Users are allowed 
to change the probabilities between stages and the parameters of the transition 
distribution. The length of the simulation period and numbers of patients to start 
with are decided by the users, and the simulated period is measured by month. In 
theory, it allows changes to the types of the distribution to be made. Each 
individual patient was followed through the tree (Figure 6.9 and 6.10) and the 
results were stored in an Excel worksheet. An example was used to demonstrate 
how to use this simulation model and the results. A uniform distribution was used 
to describe the transition probability and the holding time was described by the 
Weibull distribution, which is one of the common choices when the transition 
time distribution is unknown, or it is not possible to estimate from the data, or 
there are no data available. The transition probabilities shown in Figure 6.9 were 
collected from a list of reports and literature (Health Protection Agency, 2006; 
Primarolo, 2006). There is no national screening programme available in England. 
Therefore, the results were compared between (i) no screening programme is 
available and (ii) screening programme is available. Chapter 6 Chlamydia study 
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Figure 6.9. Chlamydia disease system 
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Figure 6.10 Chlamydia simulation model. 
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6.5.2 Simulation results 
A set of dummy holding time and transition distribution and summary transition 
probabilities (Health Protection Agency, 2006; Primarolo, 2006) were adopted to 
demonstrate the use of simulation in a Chlamydia screening programme, and 
when individual patient data become available, the distribution and parameters 
can be estimated from the available data. Users are allowed to change the 
distribution within the built-in model to adapt it to the purpose required. 
 
To start simulation, users need to enter the simulation period in months (i.e. start 
and end dates are needed and the simulation period can be estimated from the 
given dates), and the number of patients go into the simulation system per month 
as listed below: 
 
Table 6.3 Simulation results from a simple Chlamydia simulation model 
Information Result 
Transition distribution between states  Uniform 
Holding time between states  Weibull 
Simulation period (months)  10 
No of patients per month  1,000 
Final positive patients  1,040 
No. of patients in complication state  449 
No. of patients in PID state (some of them will be recorded after 
receiving treatment) 
330 
No. of patients in infertility state  64 
No. of patients recorded at the final state (from PID or 
complication after receiving treatment) 
527 
 
The simulation with dummy datasets was used to demonstrate what might be 
possible. It summarised the natural Chlamydia process, if the required data (e.g. 
transition time) are available. Table 6.3 showed an example of how many patients 
were in each state. Users can change the distributions and full details of the 
simulation model can be found from Appendix G. 
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6.6 Summary 
The results from decision tree and simulation models show a possible method to 
evaluate the screening option and to understand the Chlamydia disease process 
when required data become available. In particular, Section 6.3 demonstrated how 
to model the individual patients’ age, which had been commonly modelled as 
categorical (e.g. low or high risk categories) (Clayton and Hills, 1993; Jackson et 
al., 2006; 2008), causes a loss of information. Ideally, keeping the age of 
individual patients may increase the prediction power, and at least will not lose 
any information. Thus, modelling age distribution is a possible way forward. Such 
distributional information will be used in Chapter 7 in some of the regression 
models.  
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Chapter 7 Chlamydia regression models 
 
 
7.1 Introduction 
Nationally, the Chlamydia infection rate is 1 in 10 (Primarolo, 2006), and 70% of 
female and 50% of male patients remain asymptomatic at the early disease stages 
(Health Protection Agency, 2006); however, the consequences of undiagnosed 
and untreated Chlamydia can lead to complications. A significant proportion of 
female patients (10-40%) develop Pelvic Inflammatory Disease (PID) (Health 
Protection Agency, 2006), the acute Chlamydia infection including salpingitis. If 
this condition remains untreated it can cause serious damage, such as chronic 
pain, ectopic pregnancy and even infertility. These complications and damage 
only occur in female patients. The male will commonly experience a urethral 
discharge from the penis, and further complications and damage include 
inflammation and fertility problems. There is approximately a one in two chance 
of a man experiencing impaired fertility or epididymitis (Health Protection 
Agency, 2006).  
 
This chapter demonstrates the use of the generalised linear regression model, 
multilevel Bayesian regression model and geographically weighted regression 
(GWR) model to explore the relationship between positive Chlamydia results and 
the deprivation indicator (Townsend index), social status and family structure 
variables at different regional levels. The multilevel regression model is a well 
known type of statistical tool for exploring the relationship between target and 
explanatory variables when the target and explanatory variables are observed at 
different levels; (i.e. multilevel). The GWR allows local variation in relations (i.e. 
non-stationary model). Ignoring the spatial variation could cause misleading 
interpretations of the relations between target and explanatory variables. In order 
to identify the linkage between positive Chlamydia cases and deprivation 
condition, social status and family structure variables, which would provide a 
better understanding of Chlamydia and enable policy makers to view the current 
healthcare problems from a more informed position, more valuable information 
can be added into the screening policy. Chapter 7 Chlamydia regression models 
  146
The objectives of the study were (i) to explore the relationship between positive 
Chlamydia incidence and deprivation indicator, social grade and family structure 
factors, (ii) to identify risk factors that are associated with positive Chlamydia 
infection, (iii) to display the Chlamydia incidence pattern in the Portsmouth area 
between 1999 and 2000, (iv) to divide the population into sub-groups, and (v) to 
target the high risk sub groups and to suggest possible screening strategies. The 
area covered by this Chlamydia study is showing in Figure 7.1. However, some of 
the Output Areas (OAs) do not contain any observed data. Therefore, there are 
many disconnected Output Areas in the mapping. Thus, the study area was 
reconsidered in the data section. 
 
 
Figure 7.1 Study area at CAS Ward level 2001, the basic shape file is available 
from Edina. 
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Figure 7.2 STD clinics in the Portsmouth area; A represents the St. Marys 
hospital, B represents the family planning clinic, C represents the X-Perience 
young persons centre, D represents the social services in Fareham, E represents 
the family planning in Gosport, F represents the Brune park youth centre, G 
represents the Lee on the Solent focus youth club. 
 
Patients are free to choose where to take their Chlamydia test. Therefore, it is 
possible to believe that where the test is taken depends highly on the location of 
the clinics. This explains why very few cases came from Fareham, Southampton 
etc., there are other clinics available and closer to Fareham and Southampton. For 
this reason, regions not close enough to the clinics and disconnected regions were 
not included in this Chlamydia study.  
 
 
7.2 Data 
The data were described fully in Chapter 3; since every Output Area contains 
observed cases, the overall study area was reconsidered in this section as shown in 
Figure 7.2 and 7.3 to avoid disconnected areas. The individual data on the 
occurrence of Chlamydia in Portsmouth between 1999 and 2000 were used. The Chapter 7 Chlamydia regression models 
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individual deprivation indicator, social grade and family structure variables were 
not available; the lowest available level is Output Area (OA) and the second 
lowest level is CAS Ward levels. Therefore the chosen levels for the explanatory 
variables were OA and CAS Ward levels. The explanatory variables were 
downloaded from the UK censes 2001. For full details of the data please refer to 
Chapter 3. The explanatory variables were mapped at OA and CAS Ward levels 
and displayed in Figures 7.3 to 7.4. 
 
(a)  
 
 
(b)  
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(c)  
 
 
(d)  
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(e)  
 
 
 
(f)  
 
Figure 7.3 (a) Townsend index, (b) percentage of socio-grade IV+V, (c) 
households with all lone parents, (d) households with female lone parents, (e) 
single population and (f) married population at Output Area level. 
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(a)        (b) 
 
(c)      (d) 
 
(e)      (f) 
 
Figure 7.4 (a) Townsend index, (b) percentage of socio-grade IV+V, (c) 
households with all lone parents, (d) households with female lone parents, (e) 
single population and (f) married population at CAS ward level. 
 
In addition, the missing test results (or incomplete records) and the repeated test 
records (i.e. a patient had a repeat test to check for the current stage) were 
removed from the analysis and modelling work, since interest is in the first test 
result only. 
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7.3 Exploratory analysis 
7.3.1 Age 
The age probabilities were calculated (equation 7.1); it is clearly shown that the 
peak age is around 20 (Figure 7.5). Most of the research showed that the peak age 
group is under age 25 (Pimenta et al., 2003b; Health Protection Agency, 2006). A 
number of research studies and literature described the at-risk age as being under 
25 years for both females and males; age is one of the important factors which can 
be used to target the high risk population (Pimenta et al., 2003 a, b). 
 
 


 K
k
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x age in cases positive of No
x age result positive P
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            .
)   |   (           (7.1) 
Where K is the total number of positive cases 
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Figure 7.5 Probabilities of positive test results plotted against age. 
 
7.3.2 Ethnic origin 
Data on ethnic origin were available from the patient’s information; Table 7.1 
shows the number of positive cases per ethnic group. It is clearly shown that 93% 
of the positive cases came from the white ethnic origin group and the remaining 
7% of the information came from the unknown group. The sample size from non-
white ethnic groups was relatively small compared to the white ethnic group. 
Therefore, this information is not particularly useful for further analysis. 
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Table 7.1 Positive cases by ethnic origin group. 
Ethnic Group  Ethnic Code  No. of Positive Cases 
White 0  712 
Black Caribbean  1  1 
Black Other  2  2 
Indian 3  1 
Bangladeshi 5  1 
Chinese 6  2 
Black African  14  2 
Other 34  5 
Unknown 99  55 
 
7.3.3 Location 
Figures 7.6, 7.7 and 7.8 show the positive rate patterns in postcode sectors, in the 
CAS Wards and local authority. Table 7.2 shows the number of positive tests per 
CAS Ward. It seems that some of the postcode sectors and CAS Wards had more 
positive cases than the others; for example, SO14 and SO15 (but those postcode 
sectors had very few observed cases), PO2 and PO4 and an Output Area Charles 
Dickens (00MRMR) had much larger number of observed cases and also had 
relatively high positive rates. It is interesting to identify particular disease 
patterns, if any, and disease trends by location, and this will be commented on in 
the regression model section.  
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Table 7.2 Positive rate by CAS Ward. 
CAS Ward  No. of positive  No. of test  positive rate 
00MRMP 24  216  0.1111 
00MRMQ 36  544  0.0662 
00MRMR 51  382  0.1335 
00MRMS 19  242  0.0785 
00MRMT 26  275  0.0945 
00MRMU 8  203  0.0394 
00MRMW 33  354  0.0932 
00MRMX 27  303  0.0891 
00MRMY 22  257  0.0856 
00MRMZ 26  292  0.0890 
00MRNA 47  399  0.1178 
00MRNB 30  257  0.1167 
00MRNC 32  419  0.0764 
00MRND 55  455  0.1209 
24UEFT 13  150  0.0867 
24UEFU 8  128  0.0625 
24UEFW 7  91  0.0769 
24UEFZ 17  168  0.1012 
24UEGA 8  127  0.0630 
24UEGC 3  90  0.0333 
24UEGD 9  124  0.0726 
24UFFL 7  86  0.0814 
24UFFM 15  108  0.1389 
24UFFN 5  74  0.0676 
24UFFP 6  61  0.0984 
24UFFQ 12  91  0.1319 
24UFFR 10  102  0.0980 
24UFFS 13  84  0.1548 
24UFFT 5  82  0.0610 
24UFFU 22  182  0.1209 
24UFFW 11  92  0.1196 
24UFFX 3  29  0.1034 
24UFFY 2  34  0.0588 
24UFFZ 14 124  0.1129 
24UFGA 13  72  0.1806 
24UFGB 3  67  0.0448 
24UFGC 6  96  0.0625 
24UFGD 13  118  0.1102 
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Figure 7.6 Positive rates per postcode sector. 
 
0
0.2
0.4
0.6
0.8
1
1.2
0
0
M
R
M
P
0
0
M
R
M
T
0
0
M
R
M
Y
0
0
M
R
N
C
0
0
M
S
M
T
0
0
M
S
M
Z
2
4
U
C
G
U
2
4
U
C
H
H
2
4
U
C
H
M
2
4
U
C
H
T
2
4
U
C
H
Y
2
4
U
D
F
Y
2
4
U
D
G
F
2
4
U
E
F
R
2
4
U
E
F
W
2
4
U
E
G
A
2
4
U
E
G
E
2
4
U
F
F
N
2
4
U
F
F
S
2
4
U
F
F
X
2
4
U
F
G
B
2
4
U
P
G
L
2
4
U
P
H
E
2
4
U
P
H
L
CAS ward
P
o
s
i
t
i
v
e
 
r
a
t
e
 
Figure 7.7 Positive rates per CAS Ward.  
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Figure 7.8 Positive rates per local authority. 
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7.3.4 Townsend index 
Again the Townsend variables were used to measure the relative deprivation in 
Portsmouth (Townsend et al., 1989). Townsend index variables were used to 
measure the deprivation at both Output Area and CAS Ward levels, as shown in 
Figure 7.3a and Figure 7.4a. The greater the Z value the greater the deprivation, 
which is depicted by the darker colour on the maps. The calculation of the 
Townsend index was explained in Chapter 2. 
 
Figure 7.3a shows a random spatial pattern but Figure 7.4a shows the southern 
part of the study area, which is near the sea, has higher levels of deprivation than 
other areas.  
 
 
7.4 Generalised linear regression model 
For the study of Chlamydia, the data at Output Area level represents a set of 
observed counts  ) ,..., , ( 2 1 N i Y Y Y Y  , where N is the total number of study regions 
(N = 1030 Output Areas as the final study areas), which arise from a Poisson 
process. The expected case was pre-defined. The regression equation is given by:  
 
) ( ~ i i Poisson Y   
) exp( ˆ
1
0 i
T
t
ti t i i v e Y       

 For  i = 1, 2,…, N and t = 1, 2,…,T         (7.2) 
Where 0   is the intercept and the  t   represent the coefficients of the explanatory 
variables  ti v  and  i e  is the expected cases in region i.  
 
7.4.1 Generalised linear regression model at Output Area level 
The explanatory variables were added into the GLM model as single explanatory 
variables. In total, there are five models with single explanatory variables; the 
coefficient value of each model is shown in Table 7.3 and other summary 
information is shown in Table 7.4. 
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Table 7.3 The intercept and coefficient value for each explanatory variable at 
Output Area level. 
 
Table 7.4 Summary of GLM applied with explanatory variable at Output Area 
level. 
Model No  Variables  Std.Error  t-value  P-value 
1  Proportion of low social grade population (IV+V)  0.2738327  5.400888 
 
1.366698e-007 
 
2  Proportion of households with lone parents  0.47552288  6.974013 
 
2.818639e-010 
 
3  Proportion of single population  0.2598869  6.446763 
 
1.410082e-010 
4  Proportion of married population  0.2598869  -6.446757 
 
1.410136e-010 
 
5  Townsend index score  0.01258824  6.300476  7.189273e-010 
0.01632178 2.823691  0.0000000007  6  Townsend index score + proportion of single 
population  0.33245393 3.325408  0.0009316457 
0.01632178 0.04608775  0.0000000007  7  Townsend index score + proportion of married 
population  0.33245395 -1.10554223 0.0009316714 
0.01938381 0.06509723  0.0000000  8  Townsend index score 
+ proportion of low social grade (IV+V) population  0.42073842 0.40669120  0.3337915 
0.01596642 2.982280  0.000000001  9  Townsend index score 
+ proportion of households with lone parents  0.63345241 3.375545  0.001134184 
0.01987323 0.1272617  0.000000001 
 
0.63137369 4.0133095  0.001134184 
10  Townsend index score 
+ proportion of households with lone parents 
+ proportion of single population 
0.34359939 3.8961652  0.000102843 
0.01987323 0.1272668  0.000000001 
0.63137371 4.0133074  0.001134184 
11  Townsend index score 
+ proportion of households with lone parents 
+ proportion of married population  0.34359939 -3.8961566  0.000102847 
Model No 
0    1    2    3   
1. -0.9928989  1.4789398     
2. -0.7393471  3.3163026     
3. -1.367185  1.675429     
4. 0.3082438  -1.6754278     
5. -0.49734973  0.07931188     
6.  -1.07497365  0.04608768 1.10554479  
7.  0.03056997 0.04608775 -1.10554223   
8  -0.63490962  0.06509723 0.40669120  
9  -0.65679942  0.04761635 2.13824715  
10  -1.386411429  0.002529101 2.533898005 1.338719986 
11  -0.047692691  0.002529202 2.533896734 -1.338717048 Chapter 7 Chlamydia regression models 
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At the single variable level, all variables were significantly related to Chlamydia 
incidence (Table 7.4). The final fitted models are shown in Table 7.4. Models 10 
and 11 were significantly related to the positive incidence of Chlamydia at Output 
Area level. In summary, Townsend index, proportion of households with lone 
parents and proportion of single population are related positively with Chlamydia 
incidence rate. When the proportion of married population increases the incidence 
rate decreases. The raw and predicted SIR from model 11 are mapped in Figure 
7.9. 
 
 (a) 
 
( b )        ( c )    
 
Figure 7.9 (a) Map of raw SIR, (b) estimated SIR from model 11 in Table 7.4, (c) 
Residual value between the observed and predicted cases per region. 
 
7.4.2 Generalised linear regression model at CAS Ward level 
In this section, the same model structure was applied at the CAS ward level. The 
coefficient value of each model is shown in Table 7.6 and other summary 
information is shown in Table 7.5. 
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Table 7.5 Summary of GLM of each explanatory variable at Ward level. 
Model Variables  Std.Error  t-value  P-value 
1  Townsend index score  0.01172566  3.638591  0.0003733398 
2  Proportion of single population  0.3491374  1.685270  0.09161565 
3  Proportion of married population  0.3491374  -1.685270  0.09161565 
4  Proportion of households with 
lone parents 
0.95495019 3.677735 0.0004041337 
5  Proportion of low social grade 
(IV+V) population 
0.4134746 4.311681  0.00003131768 
0.02408778 -0.1029605  0.00037334  6  Townsend index score 
+ proportion of low social grade 
population 
0.86808570 2.1441704  0.03041612 
0.01670212 1.512871 0.0003733  7  Townsend index score + 
proportion of households with 
lone parents 
1.38446298 1.486249 0.1447018 
 
Table 7.6 The intercept and coefficient value for each explanatory variable at 
Ward level. 
Model Variables 
0 ˆ    1 ˆ    2 ˆ   
1  Townsend index score  -0.05024602  0.04266487   
2  Proportion of single population  -0.3140181  0.5883909   
3  Proportion of married population  0.2743728  -0.5883909   
4  Proportion of households with lone 
parents 
-0.2633694 3.5120536   
5  Proportion of low social grade 
(G4+G5) population 
-0.6040492 1.7827703   
6  Townsend index score 
+ proportion of low social grade 
population 
-0.627799980 -0.002480091 1.861323662 
7  Townsend index score + 
proportion of households with lone 
parents 
-0.18355514 0.02526815  2.05765660 
 
At the ward level, only the Townsend index (model 1), proportion of households 
with lone parents (model 4), and proportion of low social grade population (model 
5) were significant. Models 2, 3 and 7 in Table 7.5 showed large P-values (> 
0.05). Therefore, those variables were not significant at Output Area level. Model 
6 was not accepted as the best fitted model because the coefficient of Townsend 
index changed to negative, but the relation between incidence and Townsend Chapter 7 Chlamydia regression models 
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index is expressed to be positive. GLM summary and coefficients are shown in 
Tables 7.5 and 7.6. The observed SIR and predicted SIR from models 1, 4 and 5 
are mapped in Figure 7.10.  
(a) 
 
(b)       (c) 
 
(d)       (e) 
 
(f)       (g) 
 
Figure 7.10 (a) raw SIR, (b) predicted SIR from model 1, (c) the residual from the 
observed and predicted cases from model 1, (d) predicted SIR from model 4, (e) 
residual from the observed and predicted cases from model 4, (f) predicted SIR 
from model 5 and (g) residual from the observed and predicted cases from model 
5. Chapter 7 Chlamydia regression models 
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7.5 Multilevel regression model 
A multilevel model was used to model the relation between individual Chlamydia 
results (for example, positive or negative) and explanatory variables at the Output 
Area level. When the size of the study region is small and the relative population 
is also small, the Binomial distribution is suitable to model the counted data 
(Rasbash et al., 2005). Binomial multilevel regression can be used to model the 
outcome with positive or negative results,  ) , ( ~ ij ij ij inomial B Y    with a 
hierarchical model structure. The Chlamydia multilevel hierarchical Bayesian 
regression model was based on Bayesian estimation by using MCMC. So a set of 
prior distributions were given in the model. 
 
For the Chlamydia study, individual test records were observed from the clinical 
study from Portsmouth 1999-2000. The multilevel model was used to model the 
test results (i.e. positive or negative) for each individual patient in the Portsmouth 
area within a one year period given that the explanatory variables are available at 
Output Area level; this is because social status, family structure as well as other 
information is not available from the individual. Therefore, each individual is 
nested in the Output Area level. 
 
7.5.1 Multilevel regression model structure 
A multilevel regression model is often used with the observed and explanatory 
variables appearing or measured at different levels. With particular relation to the 
Chlamydia study, the observed test results was recorded per patient but the 
deprivation, social status and family structure variables were not available at the 
individual level, but at national level only. Therefore, the multilevel regression 
model is a suitable choice to explore the relation between observed and 
explanatory variables when they appear in different levels. In particular, in this 
study patients (i) are nested within Output Area (j). The model structure is 
described in Table 7.7 and Figure 7.11. 
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Table 7.7 This table summarises the model structure. The detailed structure is 
displayed in Figure 7.11. 
Levels Levels  Description 
2 (j)  Output Area  Explanatory variables are available at this level.  
1 (i)  Patients  Test result: positive or negative and patients’ 
personal information is available at this level. 
 
 
Figure 7.11 Unit diagrams, individual patients and each of the test results were 
measured at different times (months) within the study period. 
 
In this study, the test results were analysed. Some of the variables within the 
model are described in Table 7.8. 
 
Table 7.8 Data used in the model. 
Variables Description 
Test  result  Identifying code for each test (level 1 
unit) 
Patient  Identifying code for each  
Postcode  Identifying code for each Postcode  
Output Areas  Identifying code for each Output Area 
(level 2 unit) 
Population (within Postcode)  Population at Postcode level, but age 
information is not available 
Results Positive,  negative 
Age  Patient’s age at the time of test 
Result time  Month at the time of test 
Ethnic  0, 1, 3, 4, 5, 6, 14, 34, 99 
Sex F,  M 
Explanatory variables at Output Areas  (i)  Townsend index score, 
(ii)  Social status variables, 
(iii)  Family structure variables. 
  
OA 1  OA 2  OA 3 
T1  T2  T3  T4  T5  T6  T7 
Level 2 (j) 
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7.5.2 Model 
Let  ij Y be the positive result,  ij   be the chance of having a positive result, and  ij   
be the fixed variable at Output Area level, where i represents patient level (level 
1) and j represents Output Area level (level 2). The at-risk population is defined as 
female population of age 16 to 24 (Pimenta et al., 2003 a; b).  
 
) , ( ~ ij ij ij Binomial Y   , the simple two level regression model is defined below:  
logit j ij ij v v 2 1 0 ) (                        ( 7 . 4 )  
 
In practice, it is possible to have a (i) random intercept or (ii) random coefficient 
models it allows to measure the different between Output Areas. 
 
(i) Random intercept model 
j ij j ij v v it 2 2 1 1 0 ) ( log         
j j u0 0 0      
 
Where  j 0   the random intercept has two components which are the fixed term  0   
and the random effect  oj u  it is a higher level specified component (level j) it is 
Normally distributed with mean zero and variance 
2
0 j   details about the theory 
can be found in Chapter 2. 
 
(ii) Random coefficients model 
j ij j j ij v v it 2 1 0 ) ( log         
j j u0 0 0      
j j u0 1 1      
 
The coefficients can be vary , which allows to account for the difference in the 
lower level which nested within the higher level and also vary across the higher 
level. For example, the random coefficient account for the difference between 
explanatory variables  within the same higher level j (e.g. Output Areas) and to 
vary across in the higher study areas (Output Areas). 
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7.5.3 Analysis 
In this section, two models ((i) global non-spatial model and (ii) CAR model) 
were used and the ages were modelled in two different methods (i) age categories 
and (ii) logit of the risk within the given age. For the age categories there are only 
two categories based on the age groups, which are the higher risk group (category 
1) and the lower risk group (category 0). Different age ranges of the categories 
were examined; results are summarised in Tables 7.9-7.10, models 2 and 3. Age 
was also modelled as function of logit of risk per age (Figure 7.12): results are 
summarised in Tables 7.19-7.12. Finally, Table 7.11 to 7.12 showed the results 
based on simple two levels multilevel models and Table 7.13 and 7.14 showed the 
CAR model random intercept results. Details about the CAR model please refer to 
Chapter 2 in section 2.3.7.1.  
 
 
Figure 7.12 Age can be modelled as a function of logit of risk per age. 
 
In this study all simple (global) hierarchical regression models, random intercept, 
random coefficients and CAR models were applied. Each model was run for 
500000 times. However, only the simple hierarchical models are the best fitted 
models all other models were too complex and received higher penalty values but 
not obvious improvement in the model fitting. Therefore, of the simple 
hierarchical and CAR models results were displayed in the following. Details 
about the model structures please reference to Chapter 2. 
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Table 7.9 Global regression model with age categories, model 2: category 0 is the 
age group between 0 to 12 and 27 to 41; category 1 is between ages 13 to 26. 
Model 3: category 0 is the age group between 0 to 15 and 25 to 41; category 1 is 
between ages 16 to 24 
No Model 
1  -2.245(0.041)cons  
2  -2.553(0.44)cons +0.31(0.441) ij age 1 _ 
3  -2.302(0.191) cons +0.059(0.196)  ij age 2 _ 
4  -2.263(0.042) cons -0.042(0.014) j Townsend  
5  -2.362(0.157) cons +0.214(0.277) j Single  
6  -2.150(0.128) cons -0.209(0.266)  j Married  
7  -2.428(0.061) cons +2.213(0.529)  j parent lone All     
8  -2.644(0.116) cons +1.156(0.309)  j G 5 4  
 
Table 7.10 Global regression model measurement based on the models in Table 
7.9. 
No  D   ) ( D   pD DIC 
1 4272 4270.97  1.03 4273.03 
2  4272.86 4270.96 1.90  4274.76 
3  4272.93 4270.94 1.99  4274.92 
4  4263.98 4261.99 1.99  4265.97 
5  4272.43 4270.41 2.02  4274.46 
6  4272.35 4270.41 1.94  4274.29 
7  4257.06 4255.09 1.97  4259.04 
8  4259.98 4258.03 1.95  4261.93 
 
Table 7.11 Global regression model with logit of risk per age. 
No Models 
1  -2.245(0.041)cons  
2  -1.216(0.348)cons -0.485(0.164)  ) ( log ij age it  
3  -1.380(0.369) cons -0.494(0.172)  ) ( log ij age it  
+2.214(0.54)  j parent lone All     
4  -1.661(0.352) cons -0.460(0.156) ) ( log ij age it  
+1.132(0.316)  j G 5 4  
5  -1.255(0.339) cons -0.489(0.160) ) ( log ij age it  
+0.042(0.014)  j Townsend  
6  -1.559(0.367) cons -0.485(0.160)  ) ( log ij age it  
+1.662(0.644)  j parent lone All    +0.596(0.376)  j G 5 4  
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Table 7.12 Global regression model measurement based on the models in Table 
7.11. 
No  D   ) ( D   pD DIC 
1 4272  4270.97  1.03  4273.03 
2 4263.8  4261.76  2.04  4265.83 
3 4248.97  4245.77  3.21  4252.18 
4 4252.39  4249.43  2.96  4255.34 
5 4255.86  4252.84  3.03  4258.89 
6 4246.99  4242.97  4.03  4251.02 
 
Table 7.13 CAR regression model with logit of risk per age. 
No. Model  u   
1  -0.531(0.197) ij age it _ log + cons u j 0   442.782(166.218) 
2  0.173(0.12)  j Townsend + cons u j 0   451.594(156.302) 
3  22.828(14.28)  j Single + cons u j 0   1638.514(1112.166)
4  0.392(1.673)  j Married + cons u j 0   432.200(149.404) 
5  29.537(8.553) j parent lone All      + cons u j 0   878.224(372.696) 
6  5.989(1.894) j G 5 4  + cons u j 0   469.841(164.489) 
7  -0.500(0.172)  ij age it _ log  
+27.377(6.851)  j parent lone All      +  cons u j 0  
755.135(270.258) 
8  -0.548(0.177)  ij age it _ log  
+5.94(1.985)  j G 5 4 + cons u j 0  
481.839(169.511) 
9  -0.46(0.168)  ij age it _ log  
+19.967(5.468)  j parent lone All     
+3.292(2.429)  j G 5 4 + cons u j 0  
642.273(210.944) 
 
Table 7.14 CAR regression model measurement based on the models in Table 
7.13. 
No.  D  ) ( D   pD DIC 
1 3632  3155.12  476.88  4108.88 
2 3639.64  3164.92  474.73  4114.37 
3 3609.62  3153.86  455.77  4065.39 
4 3639.87  3164.64  475.23  4115.1 
5 3616.76  3156  460.76  4077.52 
6 3637.66  3163.89  473.77  4111.43 
7 3612.11  3148.46  463.65  4075.77 
8 3629.02  3154.34  474.68  4103.7 
9 36170.6  3150.96  466.64  4084.24 
 
The best fitted model is model 6 in Table 7.11 and 7.12. It suggests that the choice 
of age range within the age category did not have much effect in modelling. In Chapter 7 Chlamydia regression models 
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this section, the patients’ age was modelled as (i) categorical variable and (ii) 
function of logit(risk|age=x), to examine which is the best method to model age. 
It was required to compare the DIC values between Tables 7.10, 7.12 and 7.14. 
The results show that it is better to model the age as a function of 
logit(risk|age=x), because such a model (model 6 in Table 7.11) had a  smaller 
DIC value (4251.02) compared to the other models with age categorical 
information in Table 7.9 and 7.10.  
 
Finally, to summarise the results from applying the global regression models, 
overall, the global model 6 in Table 7.11 and 7.12 with smallest DIC value in 
Table 7.12 (4251.02) showed a better fit than the CAR model in Table 7.13 and 
7.14.  The CAR regression model had larger pD (penalty) value, although the 
CAR model had smaller DIC value. The final fitted model reveal that when the 
patient’s age decreases, the proportion of households with lone parents increases 
and the proportion of low social grade population increases then the Chlamydia 
positive rate is predicted to increase. 
 
 
7.6 Geographically weighted regression model 
The basic GWR theory was described and explained in detail in Chapter 2; a 
summary is given below.  
 
Assuming that the underlying distribution is Poisson (e.g the underlying 
distribution is allowed to change according to the dataset), and  i   is the mean 
value: 
 
) ( ~ i i Poisson Y                              (7.5) 
The geographically weighted regression model is given below: 
  
t
ti i i t i i i v y x y x Y ) , ( ) , ( ˆ
0                  (7.6) 
In the following analysis section, GWR models were constructed at different 
levels (i) individual, (ii) Output Area level and (iii) CAS Ward levels. Chapter 7 Chlamydia regression models 
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7.6.1 Output Area Level 
In this section, all variables were measured at the same Output Aarea level. The 
optimal kernel size was 848 (model 4 and 5) regions out of 1030 regions in total 
(Table 7.15). The kernel size is relatively large, the original data had 90% zero 
positive cases; therefore it is necessary to have a larger kernel to include more 
information. Results are shown in Table 7.15. The observed cases and prediction 
parameters are mapped in Figures 7.13 and 7.14. 
 
Offset variable: No. of expected positive cases at ward level 
i i test Total rate Positive cases positive ected of No   *       exp     .  , i = 1, …, N. 



  N
i
i
N
i
i
test Total
cases positive Total
rate Positive
1
1
 
   
        ( 7 . 7 )  
6972
665
 te Positivera  
         = 0.095381526 (~9%) 
 
Table 7.15 GWPR results at Output Area levels. 
Models Variables  Kernel 
size 
AICc 
(Global) 
AICc 
(Local) 
1  Townsend index score  848  1130.682391  416.927276 
2  Proportion of married population  974  1127.501404  426.68265 
3  Proportion of single population  974  1127.501328  426.68261 
4  Proportion of households with 
lone parents 
848 1128.85458  412.854978 
5  Proportion of low social grade 
(IV+V) population 
848 1140.881568  411.380884 
6  Proportion of low social grade 
(IV+V) population + proportion 
of households with lone parents 
869 1123.729741  415.899557 
7  Townsend index score  
+ proportional of households 
with lone parents 
917 1122.099498  418.185964 
8  Proportion of low social grade 
(IV+V) population + proportion 
of single population 
939 1122.404625  425.477156 
9  Proportion of low social grade 
(IV+V) population + Townsend 
index score 
939 1122.404625  425.477156 
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(a) 
 
  (b)       (c) 
 
(d)       (e) 
 
Figure 7.13 (a) Predicted SIR of model 4 in Table 7.15, (b)  i 0 ˆ  , (c)  i 1 ˆ  with all 
lone parents proportion, (d) residual value between observed and predicted cases, 
and (e) 
2 R  value of model 4. 
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(a)       (b) 
 
  (c)       (d) 
 
      (e) 
 
Figure 7.14 (a) Predicted SIR of model 5 in Table 7.15, (b)  i 0 ˆ  , (c)  i 1 ˆ  with all 
lone parents proportion, (d) residual values between observed and predicted cases, 
and (e) 
2 R  value of model 5. 
 
The proportion of low social status population and the proportion of households 
with lone parents are positively related to the incidence rate at Output Area level. 
It suggests that when the proportion of low social status population and/or the 
proportion of households with lone parents increase, the incidence rate increases. 
The results show that the models lack prediction power; the power was not 
enough to explain the observed variable. This may relate to the sampling issue, 
since the data were only collected between 1999 and 2000 around the Portsmouth 
area and for the female population between the ages of 16 to 24. The cases outside Chapter 7 Chlamydia regression models 
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this age range were not available for this study. Thus, it is possible to study the 
same data set a higher level, that is, examine the incidence pattern at a more 
aggregated level. 
 
7.6.2 CAS Ward level 
Output Area is the lowest available level in the UK census; the second lowest 
level is called CAS Ward. By using the Output Area-to-CAS Ward look-up table, 
which was provided by the UK census, it allowed linkage of Output Area and 
CAS Wards together. The look-up table lists which Output Areas were covered by 
which CAS Wards. In total there are 93 Wards under study. The same type of 
regression models were used, and the results are shown in Table 7.16 and Figure 
7.15. The optimal kernel size was 36 regions from model 5. 
 
Offset variable: No. of expected positive cases at ward level 
i i test Total rate Positive cases positive ected of No   *       exp     .  , i = 1, …, N. 



 
N
i
i
N
i
i
test Total
cases positive Total
rate Positive
1
1
 
   
        ( 7 . 8 )  
6978
661
 te Positivera  
         = 0.094726283 (~9%) 
 
The final fitted global model is model 5 in Table 7.16, which has the smaller 
AICc at both global and local level and the model is listed below, 
 
) 45 783 . 1 604 . 0 exp( ˆ
i i i G e Y           ( 7 . 9 )  
 
Where  i Y ˆ  is the predicted cervical cancer cases,  i e  is the expected cases and  i G45  
represents the proportion of low social grade (IV+V) population in region i. The 
local models with different explanatory variables are listed in Table 7.16. 
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Table 7.16 Summary results at CAS Ward level 
Models  Variables  Kernel size  AICc (Global)  AICc (Local) 
1  Townsend index score  36  48.525901  48.642314 
2  Proportion of single population  31  58.341262  55.810529 
3  Proportion of married population  31  58.341262  55.810529 
4  Proportion of households with lone 
parents 
33 48.674031  47.131103 
5  Proportion of low social grade (IV+V) 
population 
36 43.850892  44.591749 
6  Proportion of low social grade (IV+V) 
population + proportion of households 
with lone parents 
36 45.56487  47.283182 
7  Proportion of low social grade (IV+V) 
population + Townsend index score 
36 46.203309  48.697664 
8  Proportion of low social grade (IV+V) 
population + proportion of single 
population  
36 46.153311  47.784771 
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(a)       (b) 
 
(c)       (d) 
 
(e)       (f) 
 
Figure 7.15 (a) Observed SIR, (b) predicted SIR from model 5, (c)  i 0 ˆ   , (d) i 1 ˆ  , 
(e) residual values between observed and predicted cases, and (f) 
2 R  values at 
CAS Ward level. 
 
The results shown in Table 7.16 showed that there is only small difference 
between the global and local models since both of the AICc values are so similar 
(i.e. difference is less than 2). Therefore, in the CAS Ward level the global model 
is good enough to provide reliable estimation for parameters e.g.  ti  ˆ . It is useful 
to examine the global and local models by comparing the global standard error 
and the local inter-quartile range. If twice the global standard error is larger than 
the inter-quartile range then it could indicate that the variable is under a stationary 
process (Table 7.17). Therefore, the global model with proportion of low social Chapter 7 Chlamydia regression models 
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grade population is better then the local model of the Chlamydia incidence rate at 
CAS Ward level.  
  
Table 7.17 Test for indicating stationary variables. 
Parameters  2* S.E. (Global)  Inter-quartile 
range (Local) 
Stationary or 
non-stationary 
variable 
Intercept  0.296 0.201607  Stationary 
Proportion of 
lower social grade 
(G4 + G5) 
population 
0.826 0.430932  Stationary 
 
At the individual level, the model showed that age is related to positive incidence 
of Chlamydia, at both of the Output Area and CAS Ward levels, the proportion of 
households with lone parents, proportion of low social status population are both 
significant to the positive incidence. The coefficients vary spatially at OA level, it 
suggests that the associated factors affecting or contributing to the positive 
incidence vary spatially. It provides information to understand how human 
behaviour and the surrounding deprivation condition or personal social and 
martial status might contribute to the chance of developing Chlamydia. 
 
 
7.7 What does this mean for the design of screening programmes? 
Based on the regression results in this chapter, age and some of the personal 
variables are associated with Chlamydia incidence at different levels. Therefore, 
potentially the general population can be divided into risk groups according to (i) 
the associated factors (e.g. family structure, deprivation and social grade) or (ii) 
geographical regions. Each risk group can have a different screening policy and 
screening interval. The advantage of dividing the population into groups and 
allocating different screening policies and screening intervals to risk groups, is 
that the screening programme can be made more efficient. Decision trees and 
simulation models in Chapter 6 can be used to evaluate the screening options. 
When health resources are limited, but the aim is to reduce the number of 
undetected Chlamydia cases optimal screening options are needed to run the 
programme in an efficient way.   
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Different risk groups may have different probabilities of developing chlamydia. 
By adding this information into the decision tree and simulation models, it allows 
us to answer some questions (e.g. what is the optimal combination of screening 
interval for each risk groups). At the same time, the limited resources can be well 
used and the number of undetected cases can be reduced through regular 
screening.  
 
CART techniques can be used to split the population into risk groups according to 
their deprivation condition. The positive rate and negative rate per group can be 
estimated from the observed data at Output Area level. Decision tree model can be 
used to estimate the expected number of positive and negative cases per group, 
which showed it is a possible method to evaluate screening policy. The total study 
regions can be divided into two groups (i.e. low or high risk regions). In practice, 
the population within the high risk regions can be considered as the higher risk 
population, who may need to take Chlamydia screening test more often than the 
low risk population in the low risk regions. Such study demonstrated the real use 
of decision tree model and risk groups. It could prevent Chlamydia cases 
remaining undetected. 
 
7.7.1 CART analysis 
There is a missing link between chapters 6 and 7 which is similar to that for 
chapter 4 and 5. Therefore, a possible method to fill in the gap between Chapters, 
is to create a simple decision tree model based on the results from the Chlamydia 
GWPR regression models at Output Area level from Chapter 7, 
 
1.  Use regression to predict incidence 
2.  Divide the population into groups according to their deprivation condition 
or other characteristics (e.g., low Townsend index score vs. high 
Townsend index score) 
3.  Create a decision tree model for the population based on the overall 
incidence rate. 
4.  Create a new decision tree model for the groups based on the set of 
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5.  Explore the effect of different screening intervals for the whole population 
(it would depend highly on the availability of transition probabilities) 
6.  Explore the effect of different sets of screening intervals for the groups (it 
would depend highly on the availability of transition probabilities) 
 
In fact, the transition probabilities for different screening intervals are not 
available. Only if continuous clinical data (or follow up data) are available (i.e. 
follow a group of patients for many years) can the transition probabilities be 
estimated. Otherwise, it is not possible to compare the screening options based on 
different screening intervals, because of lack of information about transition 
probabilities.  
 
7.7.2. Risk grouping 
CART techniques can be used to divide the population into groups. Each group is 
assumed to have different probabilities of developing the disease. Section 7.7.2.1 
demonstrated how to split the population into groups according to the Townsend 
index score at OA level. Such techniques show that the chance of developing 
Chlamydia varies between groups, which means some groups with certain 
characters may have higher chance of developing Chlamydia in the patients’ life 
time.  
 
The Chlamydia screening process should follow the structure in Figure 7.16. 
However, the transition probabilities were required to be estimated from any 
possible continuous clinical data. Such data are rarely available. 
 
 
 
 
 
 
 
 
 
 Chapter 7 Chlamydia regression models 
  177
 
 
Figure 7.16 Chlamydia disease process, disease status with the transition 
probabilities (e.g. P1, P2,…, P4%) and the positive and negative probabilities 
were provided from Primarolo (2006). Further damage status include damage to 
the fallopian tubes, damage to the uterus, damage to the surrounding tissues, and 
chronic pelvic pain.  
 
7.7.2.1 CART based on the observed Chlamydia data 
Transition probabilities and transition time are missing in the decision tree and 
simulation models in Chapter 6, which describe how a patient from a particular 
risk group might be expected to get the disease. It is possible to estimate the 
incidence rate per group, but the transition time parameter and the related 
transition probabilities over which a patient might be expected to get Chlamydia 
infection are not known. But the incidence rate per group is enough for a simple 
analysis. 
 
The overall idea assumes that if an individual is tested, that reveals a realisation of 
the disease (or not) (based on the incidence rate per group) and the individual can 
be treated for the disease. This tells the policy makers in the long run the number 
of cases that they have revealed (removed) and the number that they have missed. 
This simple analysis may be enough to reveal that a selective screening policy 
would be more efficient than a national fixed policy. Figure 7.17 demonstrates the 
use of a decision tree model to estimate how many Chlamydia cases arise from a 
general female population. The probabilities in Figure 7.16 and 7.20 were 
estimated from the observed Chlamydia data and the expected Chlamydia cases 
are listed in Table 7.19. 
Female 
population 
Negative 
Positive  PIC 
Further 
damages 
Ectopic 
pregnancy 
Infertility 
Chlamydia test results  Further disease status 
90% 
10% 
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Figure 7.17 Decision tree model. 
 
Assume there are 20000000 population at risk. The positive and negative 
probabilities are listed in Figure 7.18. The expected Chlamydia positive cases and 
expected Chlamydia negative cases can be calculated in the following two 
equations (7.7 and 7.8). Table 7.18 showed the results. 
 
) (  x          Chlamydia p population risk at total cases positive Chlamydia       (7.7) 
) (  x          Chlamydia p population risk at total cases negative Chlamydia    (7.8) 
 
 
Figure 7.18 Decision tree model based on the Chlamydia data. Both the positive 
and negative probabilities were estimated from the available Chlamydia data at 
OA level described in Chapter 3. 
 
 
 
 
General 
female 
population 
Chlamydia 
positive 
Chlamydia 
negative 
0.0229 
0.9771 
General female population 
Chlamydia positive 
Chlamydia negative 
) (Chlamydia p  
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Table 7.18 Decision tree outcome based on the information from Figure 7.18. 
Group Total  patients 
General female population  20000000 
Chlamydia positive  458000 
Chlamydia negative  19542000 
 
Figure 7.19 demonstrates the use of the CART technique to split the population 
into risk groups according to their characters, people in the same group are 
assumed to have the same probability of developing Chlamydia in their life time. 
However, patients from different groups are assumed to have different 
probabilities of developing Chlamydia. 
 
 
Figure 7.19 Potential decision tree with best split from CART analysis, which 
splits the general female population into two risk groups. The Chlamydia count 
data can be used to estimate the probabilities between status and groups. 
 
 
In Figure 7.19 Six probabilities are needed, which can be calculated as below, 
 
regions Total
risk low at regions
group risk low p
i
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1 
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high 
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Chlamydia 
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risk high at regions
group risk high p
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Where low risk regions have lower deprivation condition (i.e. low Townsend 
index score) and the high risk regions have high deprivation condition. For details 
about the best split point please refer to Chapter 2. 
 
7.7.2.2 CART based on the Townsend index score 
In this section, the observed Chlamydia data and Townsend index were used to 
divide the population into groups, where the probabilities of developing 
Chlamydia vary between groups. 
 
Data: Chlamydia data (observed individual counts) summarised at OA level 
Average (overall) incidence rate: 0.02 
Predicted variable: incidence rate per 100 women per region 
Independent variable: Townsend index score  
Best split: Townsend index score <0.5 
 
The analysis shows that the best split is Townsend index equal to 0.5, Figure 7.20 
shows the decision tree model, the low risk regions representing the regions with 
index score less then 0.5. Otherwise, regions are identified as high risk regions. 
Table 7.19 shows the expected number of Chlamydia cases per group. Chapter 7 Chlamydia regression models 
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Figure 7.20 Decision tree model with two risk groups. The low risk group has a 
low Townsend index score and the high risk group has a high Townsend index 
score. The probabilities were estimated from the observed data. 
 
Table 7.19 Potential decision tree, based on the observed data. Population was 
split into two risk groups. 
Group Total  patients 
General female population  20000000 
Chlamydia positive  325254 
Chlamydia negative  19674676 
 
 
 
 
 
 
 
 
 
 
 
General 
female 
population 
Low 
High 
Chlamydia 
negative 
Chlamydia 
negative 
Chlamydia 
positive 
Chlamydia 
positive 
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Figure 7.21 Risk grouping by the Townsend index score, the black represents the 
high risk group with high deprivation condition and the white represents the low 
risk group, with low deprivation condition. 
 
 
7.8 Summary 
The main task of this chapter was to explore the relationship between positive 
Chlamydia infections and some personal variables or deprivation condition, or 
social grade (status) at different regional scales. Obviously, different regional 
scales reflected different disease patterns. The lowest level (i.e. individual) did not 
show any interesting pattern. The results in section 7.5.3 showed the global model 
was better fitted than the CAR models. However, the prediction at individual level 
was inaccurate. This could be due to sampling issues, and will be discussed in 
detail in Chapter 8. At the CAS Ward level, the model showed a greater strength 
of prediction. The south of the study area had a higher Chlamydia incidence 
which could be due to a greater proportion of young population. The results from 
a various regression models showed there is a relationship between Chlamydia 
infection and low social grade (or status). The simple analysis showed that the 
chance of developing Chlamydia does vary between risk groups. The decision tree 
model demonstrated that not everyone has the same chance of developing 
Chlamydia. Some patients with certain characteristics (e.g. high or low socio-Chapter 7 Chlamydia regression models 
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economic status) have different chances of developing Chlamydia. Therefore, the 
lower risk patients may not need to be screened as often as the high risk patients. 
The maps (Figure 7.21) showed the risk grouping according to the Townsend 
index score. In practice, it is possible to screen the high risk population in the 
black areas in the maps more often than the white areas in the maps. Such a 
strategy can reduce the amount of wasted resources, the exact resources can be 
provided to the high risk groups, which may help to increase the detection rate 
and also reduce the number of undetected asymptomatic cases. 
 
The observed data included only female patients between the ages of 16 to 24. 
Therefore, all the cases beyond such groups were excluded from the data, and it 
could cause a sampling issue. The sampling issue could explain why the 
predictions from GWPR were not close to the observed counts. Therefore, the 
expected positive Chlamydia cases were much smaller in Table 7.19, because the 
predicted positive cases were much smaller than the observed data due to the 
sampling issue. However, something is missing. That is the time parameters and 
transition probabilities. If the transition time and probabilities were available 
between status, it would allow estimation of the number of patients in each state 
for a long run. The result in section Table 7.19 allows to evaluate the effectiveness 
of the screening options and it also allows to compare different options. 
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Chapter 8 Discussion 
 
 
8.1 Introduction 
It is important to understand the aim of screening for cervical cancer and 
Chlamydia, which is to prevent the development of invasive cervical cancer by 
detecting and treating precancerous lesions at an early stage (i.e. before the 
abnormal cells change to cancer cells), and to avoid the undetected asymptomatic 
cases of Chlamydia, which in turn will avoid further complications or forward 
infected new cases. There are three stages: (i) prevention, (ii) treatment and (iii) 
follow-up. In practice, stages one and two can be treated as separate stages. If both 
screening programmes are available and useful at the first stage, then cervical 
cancer abnormalities can be detected within this stage and the second and third 
stages may not be necessary or may become less important in practice, whereas 
for Chlamydia cases can be detected early enough and treated, thus avoiding 
further damage and need for further treatments. Therefore, in terms of cost 
effectiveness, screening can prevent resources being overstretched and reduce     
unnecessary pressure on NHS services. 
 
Consider the question: “Does location affect the likelihood of incidence, death or 
survival?” If the chances of developing cervical cancer and/or becoming infected 
by Chlamydia, and the level of response to treatments are associated with 
surrounding environmental variables and personal factors (e.g. age, diet, smoking 
etc.), then local variation in policy may be considered as an effective way of 
improving healthcare services at the national level (Rogerson  et al., 2006). If the 
risks of developing cervical cancer and Chlamydia vary geographically, local 
policies and local screening programmes could be introduced which might result 
in a reduction in the risk of developing cervical cancer and undetected Chlamydia 
cases.  
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8.2 Cervical cancer 
The overall aims of the National Cervical Cancer Screening Programme are to 
reduce the risk of cervical cancer development in the female population. One of 
the objectives of this PhD study was to identity the associated risk factors which 
can in turn increase knowledge of cervical cancer, and it may also allow for the   
improvement of the effectiveness of the screening programmes. In this study, the 
relationships between the incidence of cervical cancer and, deprivation, social 
status, and family structure variables were investigated by applying regression 
models. It was shown that Townsend index, proportion of households with female 
lone parent, proportion of married female population and low social status are 
associated with the cervical cancer incidence. It follows that these known and 
widely available spatially varying factors could be taken into account when 
considering modifying healthcare services locally to increase the efficiency and 
effectiveness of screening programmes.  
 
Survival has a subtly different interpretation to incidence and mortality. Survival 
rate may be related positively, at least in principle, to the effectiveness of the 
healthcare programme locally. That a factor such as proportion of married female 
population is negatively significant in GLMs, implies that personal marital status 
is related to the chance of developing cervical cancer in a woman’s life time. Such 
a variable may reflect some information about personal sexual behaviour. For 
example, a married woman is less likely to have more than one sexual partner, and 
sexual behaviour is highly related to cervical cancer development. 
  
The maps of the residuals from the fitted GWPR models illustrate clearly that the 
residuals are spatially autocorrelated. This points to the need for an alternative 
modelling approach (e.g., spatially auto-regressive modelling), but also highlights 
that these personal factors explain only a part of the variation in cervical cancer 
counts. Other variables are missing from the models. While speculative at this 
stage, it is interesting to argue that a missing variable may be current local spatial 
variation in the effectiveness of the healthcare programme. Of course, several 
alternative interpretations are possible. 
 
Three main points of technical discussion are of interest; (i) the benefits of using 
different regression models, (ii) missing data, and (iii) cervical cancer mapping. Chapter 8 Discussion 
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The important aspect of hierarchical models, which has been discussed widely in 
many studies, is that such models allow borrowing of strength between different 
data sets. Therefore, this leads to improved and more stable estimates of the 
parameters. With different model structures, the level of flexibility of modelling 
random effects is different. So the advantage of the Bayesian method is that it 
provides spatial smoothing that can reduce the chance of obtaining extremely high 
or low estimated rates that may falsely indicate disease clustering. Of course, it 
could also over-smooth in some cases, but a different model setting allows for 
different amounts of smoothing (e.g. BYM and MIX models: Jarup et al., 2002). 
Therefore, it is also useful to compare the spatial pattern within a few different 
methods. Three Bayesian models were utilised to estimate incidence rate with 
different levels of flexibility of random effects. The BYM model produced a 
better fitted model.  
 
The posterior mean of incidence rates exhibited spatial variation. In particular, the 
Midlands and the North of England had relatively high incidence rates. These 
high rates could be related to deprivation, personal marital status and social status. 
It is common to have missing or un-observed data. In the present study, it was 
necessary to apply an appropriate method to take care of the missing data. The 
advantage of the Bayesian model is that it allows for the borrowing of information 
from the available data, prior distribution and direct neighbours (if spatial 
information is available), so that the missing data can be handled appropriately 
and do not cause extreme estimation. 
 
Nationally, the cervical cancer screening programme is free of charge for every 
woman between the ages of 25 to 64. However, there could be local variation in 
the efficiency and the accuracy of the test results. A patient’s attributes, response 
to the test and the treatment are crucial to cervical cancer development, as the 
objective of the screening programme is to prevent cervical cancer development.  
 
Both Bayesian and GWPR results indicated all variables are significant to the 
cervical cancer incidence rate, but the Townsend deprivation, proportion of lone 
parent population, proportion of low social status population and proportion of 
marital status population are the most important variables within the Bayesian 
regression models. Every human is unique, and as a result, a fixed screening Chapter 8 Discussion 
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system might not be flexible enough to cover different requirements of different 
types of patients. The national screening policy uses age to divide target patients 
into groups (young or mature groups). Such a policy ignores the variation between 
patients and their backgrounds (e.g. family history, personal behaviours). It is 
possible to target patients in two ways: (i) divide the population into risk groups 
according to their age and socio status (e.g. low, medium and high), or (ii) divide 
the study area (England) into a few regions and give each region a different 
screening policy or screening interval. 
 
From the GWPR results it is clear that the relationship between incidence rate and 
proportional of low social status population varies spatially. Specifically, the local 
parameters mapped in Figure 5.20 in Chapter 5 varied spatially. The residual map 
(Figure 5.19) seems to exhibit some autocorrelation, which suggests that social 
status, cannot explain spatially correlated variation in incidence rates completely. 
Some other possible variables may be missing from the model (e.g., sexual 
behaviour, personal HPV history, family history etc.). 
 
There are two types of regression models of interest here; local and global. A 
global model describes only the average type of behaviour which is of limited use 
if behaviour varies over space. However, local models provide information about 
the spatial patterns of relationships. An advantage of using local spatial analysis is 
that it is possible to link the outputs of spatial techniques to the powerful visual 
display capabilities of geographical information systems. Practically, the global 
model gives only an average value for each estimated parameter across all study 
areas, which means it assumes that every study region within the study area is the 
same. This may not be true in some cases. The local model allows spatial 
variation in parameters. If no spatial variation is expected, then the global model 
may provide useful and meaningful outputs. 
  
Within a geographical information systems environment, the GWPR method can 
be used as a visualisation and exploratory spatial analysis tool. If users are also 
interested in seeking those variables that can be described adequately by a 
stationary process and which are best fitted by non-stationary models, then it is 
possible to apply a mixed GWPR. A mixed GWPR is a semi-parametric GWPR 
model; it allows some variables to vary spatially and others to remain constant.  Chapter 8 Discussion 
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In terms of prediction, some of the regions face the situation of under-prediction 
or over-prediction. There are two important cases (i) those regions that are 
relatively large (i.e. the size of the cell is large), and (ii) those regions that include 
extreme cases. For the first case, when the regions are relatively large then the 
distance between the regions (point i and j) is larger, so that the accuracy of the 
prediction may be reduced by the distance. In the second case, the prediction can 
be underestimated or overestimated, because of the moderating influence of the 
neighbours. 
 
Many studies (Richardson et al., 2004) have suggested that poor health outcomes 
often appear in the most deprived areas. So it seems that some relationships 
between health outcomes and low social status variables exist in the present study. 
The strength of the relationship between health and low social status should be a 
concern to all governments that espouse ideals of equality. 
 
In the GWPR analysis, one hundred random numbers were drawn from a Poisson 
distribution to replace the missing data. Although this simple method was used to 
deal with the missing data in this study, the results showed very limited variance 
and the predictions for those areas with missing data were very similar, which 
suggests that the results are not affected greatly by replacing the missing data. 
Further research is needed to explore other possible methods to solve the missing 
data problem. For example, it is very common to have missing data in clinical 
trials. Lavori et al., (1995) demonstrated an approximate Bayesian bootstrap 
method to solve the truncation problem at unit-level. Lai and Ying (1994) also 
demonstrated the general principle of constructing M-estimators of regression 
parameters to deal with censored data. 
 
In general, it is possible to assume that in a particular population a group of 
women may behave differently compared to others, which may be related to the 
given geographical location, Townsend deprivation condition , and personal 
conditions (e.g. age). In practice, healthcare planners can identify those related 
factors to divide a general population into varying risk groups (e.g., low, medium 
and high), since different risk groups may have different chances of developing 
cervical cancer in their lifetimes. As well as in terms of considering the screening 
options, it is possible to have more than three options: for example, it is possible Chapter 8 Discussion 
  189
to consider whether or not to provide HPV tests for the low risk cohort, instead 
only providing the HPV test for those women from medium and high risk cohorts. 
Such an approach can increase the accuracy of estimating better screening options 
for different risk groups. A clinical study in the UK demonstrated that up to 25% 
of the available resources can be saved if the low risk group women (i.e. from the 
age of 50 upwards) withdraw from the national screening programme (Sherlaw-
Johnson et al., 1999).  
 
Implementation of a locally adaptive screening policy is likely to be extremely 
difficult to achieve in practice for a variety of reasons. A more feasible alternative 
is to divide the population into spatially varying risk groups, each of which may 
have a different screening frequency. This may increase the chances of detecting 
abnormal cells at a timely stage such that certain activities could be applied to 
control disease incidence. However, it is acknowledged that it is never an easy 
task to improve NHS services, since the healthcare system is extremely complex.  
 
In addition to the complexity of the screening programme system, it is possible to 
consider other details within the screening programme, e.g. diagnostic tests. The 
use of diagnostic tests is highly related to the accuracy of detection rate; for 
example, some studies showed that by accepting the HPV test in the cervical 
cancer screening programme, the detection rate at which the pre-cancer states are 
identified can be increased (Sherlaw-Johnson et al., 1997; Sherlaw-Johnson and 
Gallivan, 2000). Another study shows the use of LBC and the combination of 
Liquid Based Cytology (LBC) and HPV tests in the screening programme in the 
UK; however, the combination of both tests does not increase the cost-
effectiveness of the screening programme, which causes a higher chance of an 
inappropriate colposcopy being administered during a patient’s life time 
(Sherlaw-Johnson and Philips, 2004). HPV and LBC tests may be considered for 
introduction into the screening programme and by 2000 both tests were piloted in 
the screening programme (Patnick, 2008). Finally, the HPV vaccine is available, 
and some clinical studies in Italy and Germany showed that the use of the vaccine 
significantly reduces the incidence of cervical cancer,  and it might be considered 
as a means of achieving increased cost-effectiveness in screening programmes 
(Ferko et al., 2007; Hammerschmidt et al., 2007). Chapter 8 Discussion 
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8.3 Chlamydia 
The aim of Chlamydia screening is to (i) prevent undetected positive Chlamydia 
cases, (ii) provide treatments to positive patients, and (iii) to prevent and avoid 
further complications or forward transmission. Chlamydia screening provides an 
opportunity to identify more asymptomatic cases. Treatments can be provided at 
the right timing for patients and, thus, result in the prevention of forward 
transmission. Thus, in practice, it is necessary to have an effectively operating 
system. At the moment, there is not an official screening period: if a person 
suspects they might be infected with Chlamydia, then they can be tested, unlike 
the cervical cancer screening programme. It might be that there is a need for a 
recommended screening period particularly for high risk patients who could get 
regular and more timely check-ups.  This is one possible way to reduce the 
number of undetected cases and to prevent forward transmission.  
 
One of the key elements is to identify the high risk group from the general 
population, which is one of the objectives within this PhD study. Various 
regression models were used to study the relationship between Chlamydia 
incidence cases and deprivation, social status, lone parents and marital status 
variables. 
 
The U.S. Preventive Services Task Force (USPSTF) reported that women, 
pregnant women, and men should be screened, especially if aged under the age of 
25, which carries a higher risk than other age groups. The USPSTF listed the risk 
factors which feature in the personal histories of those with Chlamydia and other 
STIs, including number of sexual partners and sexual behaviours (e.g. use of 
condom) (USPSTF, 2007; Meyers et al., 2008). Thus, an official screening 
programme should screen those high risk populations regularly. If and when the 
Chlamydia screening programmes become available for high risk groups this 
could be a way of alleviating overstretched NHS resources.  
 
No matter which type of regression models is used, multilevel, aggregated level, 
global and local level models showed that there is a relationship between 
incidence of disease and age of the patients and some of the deprivation, social 
status and family structure variables: particularly larger proportion of households 
with lone parent, and larger proportion of low social grade population may Chapter 8 Discussion 
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increase Chlamydia incidence rates, at OA level, and the proportion of low social 
grade was also positively related to positive Chlamydia cases at CAS ward level. 
However, the predicted patterns at other lower level (e.g. individual levels) were 
not similar to the observed patterns. One possible reason for the inaccurate 
prediction is missing data (e.g. on sexual behaviour). Some of the personal 
information may not exist such as numbers of sexual partners, or STI history, as 
well as the explanatory variables not being available at the personal level. Such 
information would increase the prediction power. 
 
A second possible reason is a sampling problem, since the data were collected 
between 1999 and 2000 and for those female patients between ages 16 to 24; 
which means the proportion above the age of 24 was not recorded. Those 
unobserved data could lead to a major loss of data, which may lead to inaccurate 
prediction power. 
 
A third reason is a typical data issue, which may cause ecological bias. Individual 
level survey data have insufficient power to study small-area variations in health. 
The best way to overcome such an issue concerning data is to combine both 
individual and aggregated data in modelling; such a technique is called 
“Hierarchical related regression for combining aggregate and individual data” 
(Jackson  et al.,  2006; 2008). However, it is not possible to collect any possible 
variables at the personal level for the Chlamydia study. Thus, it is not possible to 
apply the hierarchical related regression model in the Chlamydia study. 
 
The incidence pattern shown in Chapter 7 appears random and also the 
deprivation, low social status and family structure variable patterns do not appear 
similar to the incidence pattern at OA level, which explains why the prediction is 
inaccurate, possibly related to the second and third reasons above. In principle, if 
it is possible to divide a population into groups according to the related risk at a 
certain scale (e.g. CAS Wards), for example, high and low risk groups, each of the 
groups at CAS ward level may have different probabilities of developing 
Chlamydia or becoming infected. Then each of the risk groups can attend 
screening tests at different, but regular intervals; such as once every six months 
for the high risk group at ward level. This could be a possible way to improve the 
chances to detect more cases, as it becomes possible to assume that a particular Chapter 8 Discussion 
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population group may have a higher chance of infection and/ or of transmitting 
Chlamydia than the others at a certain scale (e.g. Ward level). If risk varies 
spatially, then a population can be divided into spatially varying risk groups, 
where each of the risk groups in the different locations should have different 
screening intervals. However, this may not be possible in practice, as this will 
cause over-complications for general practice. Therefore, a possible solution 
might be segmentation, to divide England into broad geographical parts based on 
some variables (e.g. deprivation condition, social status and also family structure), 
where each part can have a different screening interval. Most important is to 
screen those members of the high risk groups. Since the high risk groups might be 
relatively small, it may be easier and more feasible to set up a screening 
programme to incorporate the entire high risk population. However, it is not 
possible to screen the entire population including both low risk and high risk 
population, as this would overstretch the NHS. Particularly, the overall incidence 
rate is 10%, but 75% of the incidence cases come from the age group between the 
ages of 16 to 24 (Health Protection Agency, 2006).  
 
 
8.4 Summary 
Mostly people understand how personal ill-health conditions, family history and 
personal sexual behaviour are directly associated with the development of some 
long-term and infectious (i.e. short-term) diseases. However, the various types of 
regression models indicated that some of the social status, deprivation and marital 
status variables were significantly correlated with cervical cancer and Chlamydia 
broadly; this suggests that deprivation condition, social and marital status 
variables are associated with human health. Such information may be useful for 
policy makers. For example, it might be helpful to divide a population into groups 
according to their personal deprivation condition and social status or the socio-
economic status of the region within which they live. Alternatively, it might be 
possible to consider segmentation based on deprivation condition to divide 
England into a few parts according to other possible variables (e.g. social status) 
geographically. Each of the groups might then be allocated a different screening 
policy; e.g. a different screening test or screening interval. From a financial point 
of view, this may save resources or make better use of limited resources. From the Chapter 8 Discussion 
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patient’s point of view it may increase the chances of detecting and preventing 
long-term disease. 
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Chapter 9 Conclusion 
 
 
9.1 Introduction 
In reality, people are not homogeneous; every human is unique. Individual 
characteristics and behaviours contribute to subsequent disease experience, some 
of the main factors being age, sex and genetic make-up; but also lifestyle factors 
and social background. Social and lifestyle factors are important, some of which 
are strongly associated with cervical cancer development (e.g. the female and their 
partners’ sexual activity, smoking, diet and job etc.) and some of which may be 
associated with Chlamydia (e.g. sexual behaviour, age, socio-grade, culture and 
sexual partners’ behaviour). The preliminary results presented here suggest that 
cervical cancer screening intervals and frequency should vary with deprivation 
condition, social status and family structure factors which themselves can be 
mapped from the UK 2001 Census of Population.  
 
Generally, regression models are used to explore the relations between observed 
health outcomes and explanatory variables. By using GLMs, a simple picture is 
provided of the linkage between the observed and explanatory variables. By using 
Bayesian methods, the posterior distributions describe the uncertainty of the 
parameters, and the local regression can provide more information on the local 
variation in relationships. 
 
 
9.2 Cervical cancer 
The GLM results showed that all of the explanatory variables (Townsend index, 
low social status and marital status) were associated with cervical cancer 
incidence. The Bayesian results showed that Townsend index score, proportion of 
households with lone parent, and also proportion of low social grade population 
were positively associated with cervical cancer incidence rate. It highlighted that 
the Midlands and the West of England had greater incidence rates than the rest of 
England. It is important to understand that such associated variables may be Chapter 9 Conclusion 
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insufficient alone to explain the geographical patterns evident in incidence rates 
since the significant variables are associated to incidence, but not the main cause 
of the development of cancer. The main causes of cervical cancer can be 
attributed to family history and patients’ sexual behaviours as well as their 
partners’ sexual behaviour.  
 
In addition to human behaviour (e.g. family history, personal history and personal 
sexual behaviour), individuals may have different chances of developing cervical 
cancer and also show different responses to the pre-cancerous treatments. The 
detection rate of cervical cancer as well as the mortality and survival rates can 
vary spatially across the UK. Nevertheless, identifying the associated factors does 
provide information that may be useful in planning screening programmes. 
 
Traditionally, global regression models have been used to explore the 
relationships between health outcomes and explanatory variables. However, such 
techniques do not take account of spatial variations in the relationships. This study 
demonstrated the use of GWPR to examine the relations between cervical cancer 
incidence rates and Townsend index score, proportion of households with lone 
parents, and also proportion of low social grade population across England, and 
also demonstrated how the use of local modelling provides a great deal more 
information for health analysis than traditional global modelling. However, the 
GWPR indicated that proportion of low social status population was the most 
significant variable correlated with cervical cancer broadly. This suggests that 
social status is associated to human health. The relation between low social status 
and the incidence rate varies spatially: it has more contribution in the south and 
north of England than west of England, which may related to the population 
structure (e.g. larger proportion of elderly population). Such information may be 
useful for policy makers. It is possible to target patients in two ways: (i) divide the 
population into risk groups according to their age and social status (e.g. low, 
medium and high), or (ii) divide the study area (England) into a few regions and 
give each region a different screening policy or screening interval. Each of the 
groups might then be allocated a different screening policy, (e.g. a different 
screening test or screening interval). Form the financial point of view this may 
save resources or make better use of limited resources. From the patient’s point of 
view it may increase the chances of detecting and preventing long-term disease. Chapter 9 Conclusion 
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Two healthcare studies from the NHS (Herbert and Smith, 2007) showed that 
changes in policy regarding only age and frequency make poor use of resources 
(Raffle., 2004). The results from this study demonstrated that incidence rates vary 
spatially across England. So the ideal way to improve the use of resources may 
not be to adopt a fixed screening interval for different age groups, but to consider 
a more adaptive programme for different parts of England or alternatively, divide 
the population into different deprivation condition, social state and family 
structure risk groups. A NHS study from Herbert and Smith (2007) showed that 
the number of cases with Cervical Intra-epithelial Neoplasia (CIN3) has increased 
for women between age 20-24 because of trends in sexual behaviours, where 
increasing numbers of young people become more active sexually when they are 
still in their mid-teens (Herbert and Smith, 2007). The change in sexual behaviour 
arises in part because of socio-economic changes from time to time and from 
place to place. If that is true, then recognising the associated factors may be useful 
for long-term prevention. For example, it is possible to improve sex education in 
local schools by teaching mid-teen pupils about protective sex. Such an approach 
can be valuable as an intervention factor for long-term prevention.  
 
Further research is required to investigate the link between more specific 
probabilities of transition between pre-cancerous and cancerous status (e.g., CIN1, 
CIN2, and CIN3).  
 
 
9.3 Chlamydia 
GLM, Bayesian multilevel regression and GWR regression models were used in 
the Chlamydia study, and the results showed that some of the variables (e.g. 
deprivation condition, low social status and marital status variables) were 
associated with the development of Chlamydia and or chance of being infected at 
different spatial levels. However, the variable maps and the observed incidence 
maps did not show similar patterns except at Ward level and, thus, the predictions 
were inaccurate. This might be related to sampling problems, and in addition, the 
individual data collected from the surveys usually cause problems such as lack of 
prediction power.  Similarly, aggregated data might also cause problems, such as 
loss of information. The ideal way to overcome such bias issues is to combine Chapter 9 Conclusion 
  197
both individual and aggregated data in the model. In reality, it is not possible to 
collect any variables at an individual level, and the total number of Chlamydia 
cases may not be available at the national level either. Without such data the 
predictive power cannot be increased easily. It is important to understand that the 
deprivation condition, social status and family structure variables may not be 
sufficient to explain the geographical patterns evident in the Chlamydia incidence 
rate. This is most likely because the chance of developing or becoming infected 
by Chlamydia is highly related to personal sexual behaviour, the number of sexual 
partners, and the patients’ partners’ sexual behaviour.  
 
Individuals may have very different behaviours and, thus, varying chances of 
developing Chlamydia; however, information on such behaviour (e.g. family 
history, personal history and personal sexual behaviour) is not available. In terms 
of the disease modelling, the responses to treatments also vary from person to 
person; thus the chance of developing Chlamydia and the level of suffering can 
differ from one individual to the next.  However, the detection rate of Chlamydia 
could be quite different across England. Nevertheless, identifying the associated 
factors does provide information that may be useful in planning programmes. 
 
Further research is required to investigate the link between more specific 
probabilities of transition between Chlamydia and other further damaging stages 
(e.g., PID) and socio-economic variables at the local scale. 
 
 
9.4 Summary 
A better understanding of disease development, disease spatial patterns and the 
contributing factors (i.e. causes and associated factors) are very important in 
healthcare planning. This research demonstrated the use of various mathematical 
models to examine the relationship between cervical cancer incidence and 
deprivation condition, social status and family structure variables and Chlamydia 
infection.  
 
Cervical cancer is related to two sets of factors (i) personal and (ii) socio-
economic factors. In Chapter 4, the CART results showed that the age and if a Chapter 9 Conclusion 
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patient had positive HPV history, who is likely to require a colposcopy in her life 
time. In Chapter 5, the regression results identified that cervical cancer incidence 
is related to age, deprivation condition (Townsend index score), social status (low 
status) and family structure (single or married female population) at the national 
level. 
 
Chlamydia infection is inaccurately related to age and deprivation condition, 
social status and family structure variables at individual level, but it is positively 
related to the proportion of low social grade population at CAS ward level. 
 
To operate a screening system, it is necessary to estimate and allocate resources 
efficiently; however, it is the most difficult task faced by the healthcare industries 
and limited resources can easily be overstretched. Where relationships (i.e. 
between disease incidence and deprivation condition, low social status and family 
structure variables) exist they can be used to inform the optimisation of screening 
programmes. 
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Appendix A 
 Medical Terms Explanation 
 
 
Cancer    “It arises from the abnormal and uncontrolled division of cells that 
then invade and destroy the surrounding tissues” (Martin, 2000). 
  
Cervical cancer  “Cancer of the neck (cervix) of the uterus” (Martin, 2000). 
 
Chlamydia    “Chlamydia is a genus of virus-like bacteria that cause 
disease in man and birds” (Martin, 2000).  
 
Colposcopy    Colposcopy is a type of diagnosis test to diagnose cervical 
precancer, which is available in NHS cervical cancer screening programme 
(Singer and Monaghan, 2000). 
 
Carcinoma in situ (CIS)    “Cancer that arises in epithelium, the tissue 
that lines that skin and internal organs of the body. It may occur in any tissue 
containing epithelial cells. In many cases that site of origin of the tumour may be 
identified by the nature of the cells it contains” (Martin 2000). CIS is a term used 
to measure the thickness of the epithelium that is covered by undifferentiated 
neoplastic cells (Singer and Monagham, 2000).  
 
Cervical Intraepithelial Neoplasia (CIN)    CIN is a term measuring the 
amount of cells changed to abnormal cells in the cervix; the abnormal cells may 
become the invasive cervical cancer cells. It can be measured in three grade levels 
(e.g. CIN 1, CIN 2 and CIN 3) according to the amount of abnormal cells (Martin, 
2000).  
 
Human Papilloma Virus (HPV)    “HPV is a member of the 
papovavirus group that causes warts, including genital warts. There are over 50 
strains of HPV: certain strains are considered to be causative factors in the 
development of anal and genital cancers, especially cervical cancer, but additional Appendix A 
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factors are necessary before the cells become malignant. HPV is one of the most 
common sexually transmitted infections.” (Martin, 2000). 
 
Pelvic Inflammation Disease (PID)    “PID is an acute or chronic condition 
in which the uterus, Fallopian tubes, and ovaries are infected. The inflammation is 
the result of infection spreading from an adjacent infected organ or ascending 
from the vagina; it may also result from a blood-borne infection, such as 
tuberculosis” (Martin, 2000). 
 
Ectopic pregnancy    “The pregnancy development of a fetus at a site 
other than in the uterus. The may happen if the fertilized egg cell remains in the 
ovary to the uterus (the Fallopian tube) or if it lodges in the free abdominal 
cavity” (Martin, 2000). 
 
Infertility    “Inability in a woman to conceive or in a man to induce 
conception” (Martin, 2000). 
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Appendix B 
Cervical Cancer National Screening Guidelines 
 
 
Grade Explanation  Action 
NEGATIVE  No abnormalities 
detected 
Routine recall after three to five 
years 
ABNORMAL  Cellular appearances 
which cannot be 
described as normal 
Refer for colposcopy after one 
borderline change or three abnormal 
tests at any grade in a ten year 
period 
Borderline 
changes 
Endocervical cell 
changes 
 
Squarnous cell changes 
 
Refer for colposcopy after one test 
is reported as borderline 
 
Refer for colposcopy after three 
tests in a series are reported as 
borderline 
Mild 
dyskaryosis 
Cellular appearances 
consistent with CIN 1 
Ideally refer for colposcopy but it 
remains acceptable to recommend a 
repeat test after one test reported as 
mild dyskaryosis. If two tests are 
reported as mild dyskaryosis refer 
for colposcopy 
Moderate 
dyskaryosis 
Cellular appearances 
consistent with CIN 2 
Refer for colposcopy 
Severe 
dyskaryosis 
Cellular appearances 
consistent with CIN 3 
Refer for colposcopy 
Suspected 
invasive cancer 
Possibility of invasive 
cancer 
Refer for colposcopy. Women 
should be seen urgently within two 
weeks of referral 
INADEQUATE  The test cannot be 
interpreted. It may be 
too thick or too thin, 
obscured by 
inflammatory cells, 
blood, incorrectly 
labelled or does not 
contain the right type of 
cells 
Repeat the test. Refer for 
colposcopy after three consecutive 
inadequate samples 
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Appendix C 
Model for Evaluating Cervical Cancer Screening Options 
 
 
A decision tree model for the cervical cancer screening programme is illustrated 
in Figure C1. The model was designed to compare three pre-cervical cancer 
screening options, which were (i) current screening programme, (ii) provide HPV 
test to patients, who had mild dyskaryosis, moderate, severe dyskaryosis and 
devere dyskaryosis/ suspected invasive cancer result and (iii) provide colposcopy 
to patients, only if patients had HPV positive. 
 
The aims of comparing these options were to evaluate the effectiveness of each 
option and find the best option, which can reduce the number of unnecessary 
colposcopy tests. The healthcare providers can consider changing the screening 
policies, having HPV tests instead of repeat smear test and not having colposcopy 
immediately. 
 
Just before starting to evaluate each option, the user needs to select an option first, 
and then click the “Confirm” button and finally the “Evaluation” button, if the 
user wants to clear all the information in the main screen, then press the “Clean” 
button.  
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Figure C1. The main screen for the decision tree model. 
The summary results are displayed in Figure C2. If any needed information 
was missing in Figure C1, an error message appears to remind the users which 
particular information is needed. 
 
 
Figure C2. Result summary for the selected screening option.                                                    
  
 
 
Enter population size 
Select an 
option 
Start evaluating 
for the selected 
option 
Confirm the 
option and the 
information Appendix C 
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Abnormal 
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6125 
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0 
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0 
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0 
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Summary Initial  smear 
test 
Urgent smear 
test 
Total colposcopy  Total positive 
colposcopy 
Total HPV test  Total tests (smear, 
colposcopy and HPV) 
Option 1  100000  14000 15662.5 8465.625  (54%)  0  12966.25 
Option 2  100000 7875  12906.25 6828.9375  (52.9%)  11900  119775 
Option 3  100000 7875  9336.25  6198.9375  (66.4%)  11900  129111.25 
Therefore option 3 is the most effective, because it provides the largest percentage of positive colposcopy (66.4%). 
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Appendix D 
Cervical Cancer Simulation Model 
 
 
A simulation model was developed to simulate the pre-cervical cancer disease 
process when data are available for estimating the simulation parameters e.g. 
distributions parameters. However, such data are not available, thus dummy 
distributions and parameters were used to demonstrate the use of the simulation 
model. The simulation model requires a random number generator, which is 
called “ITVCMath.dll”. Please follow the following instructions in order to link 
the generator and the model together. 
 
Instruction 
Step 1: Go to Tool within Excel 
Setp 2: Select Macro from Tool 
Setp 3: Select Visual Basic Editor 
Setp 4: Go to Tool within the Visual Basic Editor 
Setp 5: Go to references 
Setp 6: Browse the random number generator and click “OK” 
 
Total number of positive smear patients per month were produced by clicking the 
“Binomial” button in Figure D1.  
 
 
Figure D1 Step one to produce simulated patients, who had positive smear result. 
 
The lengths of times of stay in each of the disease states were estimated by the 
Weibull distribution. The user is allowed to change the distribution and the 
parameters inside the code. An example is shown in Figure D2. A summary of 
total patients in each state is given in Figure D3 per month.  Appendix D 
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Figure D2 An example showing the times of stay in each possible disease state for 
each individual patient. 
 
 
Figure D3 Total patients in each state per month. 
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Appendix E 
Cervical cancer GWPR results 
 
Model  Variables  Kernel size  AICc (global)  BIC (global)  AICc (local)  BIC (local) 
 
Random 1  ) 45 exp( 1 0 i i i i G e      91 612.968809  620.673215  539.322475  610.348925 
Random 2  ) 45 exp( 1 0 i i i i G e      91 610.313424  618.017830  536.064037  607.092674 
Random 3  ) 45 exp( 1 0 i i i i G e      91 619.199152  626.903558  544.085911  615.101333 
Random 4  ) 45 exp( 1 0 i i i i G e      91 604.149583  611.853989  530.546542  601.566662 
Random 5  ) 45 exp( 1 0 i i i i G e      91 605.868535  613.572941  532.851371  603.883733 
Random 6  ) 45 exp( 1 0 i i i i G e      91 600.748651  608.453057  528.786566  599.814494 
Random 7  ) 45 exp( 1 0 i i i i G e      91 604.846257  612.550663  531.596209  602.616981 
Random 8  ) 45 exp( 1 0 i i i i G e      91 610.850499  618.554905  537.414116  608.441280 
Random 9  ) 45 exp( 1 0 i i i i G e      91 604.146856  611.851262  531.225499  602.248834 
Random 10  ) 45 exp( 1 0 i i i i G e      91 608.709612  616.414018  535.416812  606.431451 
Random 11  ) 45 exp( 1 0 i i i i G e      91 597.383411  605.087817  524.371359  595.393448 
Random 12  ) 45 exp( 1 0 i i i i G e      91 602.653705  610.358111  529.750664  600.768160 
Random 13  ) 45 exp( 1 0 i i i i G e      91 741.235997  748.940403  585.806422  657.800429 
Random 14  ) 45 exp( 1 0 i i i i G e      91 609.471271  617.175677  535.833222  606.860776 
Random 15  ) 45 exp( 1 0 i i i i G e      91 608.248842  615.953248  534.331422  605.349351 
Random 16  ) 45 exp( 1 0 i i i i G e      91 608.816634  616.521040  535.524496  606.541333 
Random 17  ) 45 exp( 1 0 i i i i G e      91 612.846426  620.550832  539.018499  610.052060 
Random 18  ) 45 exp( 1 0 i i i i G e      91 600.259876  607.964282  526.309510  597.333755 
Random 19  ) 45 exp( 1 0 i i i i G e      91 604.301925  612.006331  530.885972  601.911188 
Random 20  ) 45 exp( 1 0 i i i i G e      91 606.614449  614.318855  533.076753  604.095948 
Random 21  ) 45 exp( 1 0 i i i i G e      91  605.922535           613.626941  533.345661  604.368320 
Random 22  ) 45 exp( 1 0 i i i i G e      91 609.650209  617.354615  536.328890  607.347887 
Random 23  ) 45 exp( 1 0 i i i i G e      91 610.594769  618.299175  537.798756  608.823638 
Random 24  ) 45 exp( 1 0 i i i i G e      91 610.093808  617.798214  537.263698  608.278534 
Random 25  ) 45 exp( 1 0 i i i i G e      91 614.182364  621.886770  540.076933  611.094551 
Random 26  ) 45 exp( 1 0 i i i i G e      91 607.638178  615.342584  533.908497  604.936805 
Random 27  ) 45 exp( 1 0 i i i i G e      91 603.108900  610.813306  530.272566  601.294785 
Random 28  ) 45 exp( 1 0 i i i i G e      91 614.339132  622.043538  540.154719  611.173890 
Random 29  ) 45 exp( 1 0 i i i i G e      91 612.652290  620.356696  538.290571  609.312235 
Random 30  ) 45 exp( 1 0 i i i i G e      91 605.900160  613.604566  533.095988  604.119520 
Random 31  ) 45 exp( 1 0 i i i i G e      91 600.332028  608.036435  527.029383  598.060495 
Random 32  ) 45 exp( 1 0 i i i i G e      91 612.416391  620.120797  538.370861  609.387097 
Random 33  ) 45 exp( 1 0 i i i i G e      91 601.903725  609.608131  529.182309  600.208612 
Random 34  ) 45 exp( 1 0 i i i i G e      91 596.394304  604.098710  523.614381  594.645127 
Random 35  ) 45 exp( 1 0 i i i i G e      91 604.303897  612.008303  531.252234  602.275586 Appendix E 
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Random 36  ) 45 exp( 1 0 i i i i G e      91 598.294507  605.998913  526.515442  597.541765 
Random 37  ) 45 exp( 1 0 i i i i G e      91 602.315367  610.019773  527.825936  598.853810 
Random 38  ) 45 exp( 1 0 i i i i G e      91 609.290608  616.995014  535.762959  606.776912 
Random 39  ) 45 exp( 1 0 i i i i G e      91 598.216931  605.921337  525.067194  596.093567 
Random 40  ) 45 exp( 1 0 i i i i G e      91 607.871200  615.575606  533.923007  604.944259 
Random 41  ) 45 exp( 1 0 i i i i G e      91 608.355362  616.059768  534.759057  605.796040 
Random 42  ) 45 exp( 1 0 i i i i G e      91 615.813697  623.518103  541.428419  612.453023 
Random 43  ) 45 exp( 1 0 i i i i G e      91 2947.626977  2955.331383  2445.934700  2518.35681
9 
Random 44  ) 45 exp( 1 0 i i i i G e      91 609.052703  616.757109  535.343087  606.375374 
Random 45  ) 45 exp( 1 0 i i i i G e      91 610.505383  618.209789  536.896840  607.911584 
Random 46  ) 45 exp( 1 0 i i i i G e      91 608.438809  616.143215  535.152370  606.174284 
Random 47  ) 45 exp( 1 0 i i i i G e      91 604.622725  612.327131  531.500426  602.519560 
Random 48  ) 45 exp( 1 0 i i i i G e      91 600.720939  608.425345  526.957152  597.978528 
Random 49  ) 45 exp( 1 0 i i i i G e      91 609.886674  617.591080  536.202910  607.231862 
Random 50  ) 45 exp( 1 0 i i i i G e      91 606.023040  613.727446  532.412195  603.432068 
Random 51  ) 45 exp( 1 0 i i i i G e      91 603.213627  610.918033  530.507036  601.529117 
Random 52  ) 45 exp( 1 0 i i i i G e      91 611.032407  618.736813  537.409128  608.430500 
Random 53  ) 45 exp( 1 0 i i i i G e      91 601.660757  609.365163  528.045529  599.068785 
Random 54  ) 45 exp( 1 0 i i i i G e      91 605.258893  612.963299  532.114011  603.136507 
Random 55  ) 45 exp( 1 0 i i i i G e      91 602.458332  610.162738  529.739668  600.762311 
Random 56  ) 45 exp( 1 0 i i i i G e      91 608.168092  615.872498  534.789154  605.809419 
Random 57  ) 45 exp( 1 0 i i i i G e      91 602.729019  610.433425  529.899757  600.923639 
Random 58  ) 45 exp( 1 0 i i i i G e      91 845.798522  853.502928  633.764914  703.295557 
Random 59  ) 45 exp( 1 0 i i i i G e      91 612.796409  620.500815  538.702946  609.721710 
Random 60  ) 45 exp( 1 0 i i i i G e      91 605.750367  613.454773  532.474824  603.496660 
Random 61  ) 45 exp( 1 0 i i i i G e      91 605.249045  612.953451  532.159185  603.181024 
Random 62  ) 45 exp( 1 0 i i i i G e      91 610.502165  618.206571  537.039513  608.059681 
Random 63  ) 45 exp( 1 0 i i i i G e      91 596.081241  603.785647  522.142957  593.182254 
Random 64  ) 45 exp( 1 0 i i i i G e      91 605.554574  613.258980  532.165617  603.196504 
Random 65  ) 45 exp( 1 0 i i i i G e      91 603.894797  611.599203  530.459547  601.489820 
Random 66  ) 45 exp( 1 0 i i i i G e      91 604.625235  612.329641  531.146424  602.173575 
Random 67  ) 45 exp( 1 0 i i i i G e      91 609.188967  616.893373  535.509324  606.532238 
Random 68  ) 45 exp( 1 0 i i i i G e      91 604.273669  611.978075  530.921657  601.951211 
Random 69  ) 45 exp( 1 0 i i i i G e      91 609.312593  617.016999  535.761283  606.789585 
Random 70  ) 45 exp( 1 0 i i i i G e      91 603.143825  610.848231  529.920201  600.952429 
Random 71  ) 45 exp( 1 0 i i i i G e      91 604.710004  612.414410  532.020146  603.043395 
Random 72  ) 45 exp( 1 0 i i i i G e      91 603.168681  610.873087  530.048085  601.076981 
Random 73  ) 45 exp( 1 0 i i i i G e      91 606.700860  614.405266  533.744670  604.759334 
Random 74  ) 45 exp( 1 0 i i i i G e      91 610.354973  618.059379  536.903836  607.923550 Appendix E 
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Random 75  ) 45 exp( 1 0 i i i i G e      91 602.428887  610.133293  529.578966  600.603398 
Random 76  ) 45 exp( 1 0 i i i i G e      91 606.978669  614.683075  532.963213  603.997184 
Random 77  ) 45 exp( 1 0 i i i i G e      91 610.571738  618.276144  536.299174  607.328080 
Random 78  ) 45 exp( 1 0 i i i i G e      91 607.038241  614.742647  533.334869  604.362105 
Random 79  ) 45 exp( 1 0 i i i i G e      91 606.388341  614.092747  533.163571  604.184198 
Random 80  ) 45 exp( 1 0 i i i i G e      91 596.286813  603.991219  524.605675  595.621671 
Random 81  ) 45 exp( 1 0 i i i i G e      91 603.990405  611.694811  529.796006  600.816695 
Random 82  ) 45 exp( 1 0 i i i i G e      91 600.453838  608.158244  528.000680  599.028160 
Random 83  ) 45 exp( 1 0 i i i i G e      91 606.314463  614.018869  532.686381  603.720598 
Random 84  ) 45 exp( 1 0 i i i i G e      91 604.574409  612.278815  531.153201  602.181261 
Random 85  ) 45 exp( 1 0 i i i i G e      91 607.277628  614.982034  534.162393  605.176753 
Random 86  ) 45 exp( 1 0 i i i i G e      91 605.569972  613.274378  532.054953  603.084787 
Random 87  ) 45 exp( 1 0 i i i i G e      91 607.381718  615.086124  534.939131  605.954667 
Random 88  ) 45 exp( 1 0 i i i i G e      91 609.526113  617.230519  535.872546  606.892748 
Random 89  ) 45 exp( 1 0 i i i i G e      91 602.025641  609.730047  528.519946  599.545851 
Random 90  ) 45 exp( 1 0 i i i i G e      91 604.388393  612.092799  530.713100  601.734608 
Random 91  ) 45 exp( 1 0 i i i i G e      91 608.479036  616.183442  534.825439  605.846241 
Random 92  ) 45 exp( 1 0 i i i i G e      91 609.688141  617.392547  536.086960  607.110063 
Random 93  ) 45 exp( 1 0 i i i i G e      91 606.072333  613.776739  532.669251  603.687401 
Random 94  ) 45 exp( 1 0 i i i i G e      91 605.393509  613.097915  531.737609  602.751588 
Random 95  ) 45 exp( 1 0 i i i i G e      91 600.221389  607.925795  527.671037  598.698375 
Random 96  ) 45 exp( 1 0 i i i i G e      91 608.808338  616.512744  534.693288  605.718945 
Random 97  ) 45 exp( 1 0 i i i i G e      91 610.172743  617.877149  536.710503  607.740176 
Random 98  ) 45 exp( 1 0 i i i i G e      91 603.362964  611.067370  530.611640  601.625018 
Random 99  ) 45 exp( 1 0 i i i i G e      91 610.748860  618.453266  537.073551  608.093716 
Random 100   ) 45 exp( 1 0 i i i i G e      91 604.425023  612.129429  531.453545  602.482296 
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Appendix F 
Chlamydia Decision Tree Model for Evaluating Screening 
Options 
 
 
Decision tree model for evaluating Chlamydia screening options in Chapter 6 is 
shown in Figure E1. Users need to enter some information in order to carry out 
the calculation e.g. number of women to start with, and the probabilities of each 
event. Grouping idea is demonstrated in decision tree model, there are two groups 
of population (i) between ages 16-25 and (ii) over age 25. After entering all the 
information in Figure E1, users need to click the “Calculate” button in Figure E2 
to start calculate. And the results are summarized in Figure E2. 
 
 Figure E1. Information page for the decision tree model. Users need to enter the 
number of women to start with, and the probabilities that associated to each events. 
 
Users need 
to confirm 
the 
screening 
option at 
this state. Appendix F 
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Figure E2. Results summary of decision tree model. 
 
A set of probabilities from NHS reports and HPA website were used, but the 
probabilities are allowed to change in order to compare the efficiency between 
different options (HPA, 2006; Primarolo, 2006). 
 
 
Click on this 
button to start. Appendix G 
  215
Appendix G 
Chlamydia Simulation Model 
 
 
The simulation model in Chapter 7 is discussed in details in this Appendix. To 
start simulation users need to enter some information like the start and the end 
date of the simulation period. The simulation period is measured in months and 
the number of simulated average patients per month are needed. All information 
needed is shown in Figure F1. 
 
The simulation model is required to attach with a random number generator, 
which is called “ITVCMath.dll”. Please follow the following instructions in order 
to link the generator and the model together. 
 
Instruction 
Step 1: Go to Tool within Excel 
Setp 2: Select Macro from Tool 
Setp 3: Select Visual Basic Editor 
Setp 4: Go to Tool within the Visual Basic Editor 
Setp 5: Go to references 
Setp 6: Browse the random number generator and click “OK” 
 
Each of the patients is simulated and flows through the simulation model, which is 
similar to the real life process and the simulated results are summarized in Figure 
F1 below. 
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Figure F1 Simulation user interface, details of information is needed for starting 
the simulation process and results will be displayed in the results section. 
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Presentations 
 
 
Both of the cervical cancer and Chlamydia applications have been presented at a 
number of international conferences. The details of conferences at which the 
author presented the research are listed below. 
 
Cheng, M.Y.E., Atkinson, P.M., Shahani, A.K. (2006) Investigating the relations 
between cervical cancer geographical variation in socio-economic deprivation 
[oral presentation]. International conference in GIS and public health, Hong Kong, 
27-29 June 2006. 
 
Cheng, M.Y.E., Atkinson, P.M., Shahani, A.K. (2007) Geographically weighted 
Poisson regression of the relation between cervical cancer and socio-economic 
deprivation in the UK [poster]. Research show cases, University of Southampton, 
22 March 2007. 
 
Cheng, M.Y.E., Atkinson, P.M., Shahani, A.K. (2007) Bayesian hierarchical 
modelling of the relation between cervical cancer and socio-economic deprivation 
in the UK [oral presentation]. The International Conference of the Royal 
Statistical Society, York, 16-20 July 2007. 
 
Cheng, M.Y.E., Atkinson, P.M,, Shahani, A.K. (2007) Geographically weighted 
Poisson regression of the relation between cervical cancer and socio-economic 
deprivation in the UK [oral presentation]. The 7th International workshop of 
Geographical Information System (IWGIS), Beijing, 14-15 September 2007. 
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